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Bovine herpesvirus-1 (BoHV-1) is a pathogen of cattle, which most commonly 
affects the upper respiratory tract to cause infectious bovine rhinotracheitis (IBR). It 
can also spread systemically to cause fatalities in calves and abortion in pregnant 
cattle. The virally encoded mechanisms of this systemic spread are poorly 
understood and therefore have been addressed by comparing isolates from the 
respiratory form of disease with isolates that have previously demonstrated systemic 
spread. 
 
A survey of 400 bovine abortions in Scotland from 2007-2009 demonstrated a 
BoHV-1 prevalence of 2.5%. It also demonstrated the importance of real-time PCR 
as a diagnostic technique when analysing samples from natural cases. The study of 
BoHV-1 distribution in the placenta and foetal tissue provided support for a 
haematogenous route of viral spread. 
 
Whole genome sequencing of 11 BoHV-1 isolates using Illumina Solexa technology 
was completed and added significantly to the sequencing data of BoHV-1. In terms 
of identifying genetic variation between isolates causing respiratory infection and 
those causing systemic infection, no differences were observed by SNP or 
phylogenetic analysis. However, there were significant differences in the extent of 
variation between essential and non-essential genes, which may reflect the evolution 
of BoHV-1. 
 
An in vivo challenge of the natural host to compare two isolates representing the 
respiratory and systemic forms of infection showed differences in clinical 
presentation, histopathological analysis, viral distribution and viral transcript 
expression, measured throughout the infection period. In particular, it was noted that 
a more severe ocular infection, rather than respiratory based infection was caused by 
infection with the ‘systemic’ isolate. Differences in the tropism of the virus were 
observed early in the infection with the ‘systemic’ isolate showing more association 
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with the nasal mucosa than the trachea. The tonsils demonstrated different responses 
to the virus and differences in viral transcript expression. However, this may simply 
represent different stages of virus infection. Both isolates demonstrated spread to the 
brain at day 10 post infection. 
 
In vitro methods were used to study the differences in transcript expression in more 
detail. In a bovine turbinate cell infection faster replication of the respiratory isolate 
was observed by a significantly faster development of cytopathic effect. This was 
also reflected in the higher gene expression levels of the respiratory isolate in the 
first 12 hours of infection. More isolates were studied to investigate whether these 
differences were consistent, or as suggested by the sequencing, random differences 
between isolates. Six isolates were used to infect bovine lung slices. Differences in 
transcript expression were minimal between the two isolate groups. 
Immunofluorescence did not provide the sensitivity to detect virus in all samples 
where PCR showed replication. This compromised the study of co-localization but 
did show promise as a model to study the tropism of respiratory viruses.  
 
Overall, this work has showed that systemic spread of BoHV-1 does not appear to be 
controlled by virally encoded mechanisms. The in vivo experimental infection 
suggested host factors may play a large part. Further work is also needed to consider 




Chapter One: Introduction 
 
1.1 General Introduction 
 
Bovine herpesvirus-1 (BoHV-1) is a pathogen of cattle which most commonly 
infects the respiratory tract, resulting in a disease called infectious bovine 
rhinotracheitis (IBR). The virus is a member of the herpesvirus family, an established 
virus group with hosts in every order of living organisms. The disease can have a 
significant economic impact on the farming industry, particularly when more serious 
disease such as systemic spread and abortion occurs. Viral genetic factors and host 
mechanisms may be at play in the systemic dissemination of the virus. The first of 
these possibilities will be investigated in this project. This section will begin by 
introducing the background to the virus and the disease before detailing the specific 




The Herpesvirales order consists of three herpesvirus families that includes the 
Herpesviridae family that infect mammals, reptiles and birds, and also the two more 
distantly related new additions to the order, Alloherpesviridae which infect fish and 
amphibians and finally the Malacoherpesvridae that infect bivalves (Pellet & 
Roizman 2007). Herpesviruses are diverse, widely successful viruses able to infect a 
wide range of animals from mussels to humans, with most animal species having at 
least one associated herpesvirus. Two hundred had been identified up to 2007 but it 
is expected that many more exist and are yet to be discovered (Pellet & Roizman 
2007).  
 
1.2.1 General properties 
Herpesviruses are traditionally classified by their structure (figure 1.1). A core of 
linear double stranded DNA is surrounded by an icosahedral capsid, coated by the 
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tegument (Thiry et al. 2006b). The whole virus is surrounded in an envelope studded 
with glycoproteins, which are important for cell-cell spread and cell entry 
(Mettenleiter 1994). DNA in the core has been reported to be arranged in the form of 
a toroid, possibly supported by a spindle made up of proteinaceous fibres embedded 
in the capsid, although the precise arrangement of the DNA is not known (Pellet & 
Roizman 2007; Roizman & Baines 1991). The capsid consists of 162 capsomeres of 
9.5x12.5nm with a total diameter of ~100nm. During a cell infection non-enveloped 
capsids exist in 3 forms: A-capsids have no core structure, B-capsids contain a 
scaffold but no genome and C-capsids contain the DNA genome that replaces the 
scaffold (Pellet & Roizman 2007).  
 
The tegument refers to the structure between the capsid and envelope that has 
varying thickness depending on the infection stage and was reported to have no 
distinctive features (Roizman & Baines 1991). Despite this, evidence of structural 
polarity suggests it is an ordered structure. Layers are added as the virion moves 
through the cytoplasm after nuclear egress. The amount of tegument is thought to 
depend on the location within the cell, with more tegument observed in cytoplasmic 
vacuoles compared to perinuclear space, and is considered to be determined by the 
virus rather than the host (Pellet & Roizman 2007). One of the important roles of the 
tegument is to provide pre-synthesized proteins that can influence the host 
environment on cell entry to suit the virus, including shutting down host protein 
synthesis and inhibiting infection defences (Pellet & Roizman 2007).  
 
The envelope is made up of lipids and virus-specific glycoproteins in greater 
numbers than other enveloped viruses. It has a trilaminar appearance and is thought 
to be derived from altered cell membranes (Pellet & Roizman 2007).  
 








Although highly divergent, all the herpesviruses have four common characteristics: 
1) They encode a range of enzymes involved in nucleic acid metabolism, DNA 
synthesis and processing of proteins. 
2) The initial synthesis of viral DNA and capsid assembly occurs in the cell 
nucleus, whereas the final processing of the virion occurs in the cell cytoplasm.  
3) When infectious progeny are produced by the parent virus the cell is destroyed. 
4) The most well known property of the herpesviruses is their ability to persist in 
latent form for the host’s lifetime, from this latent state the virus can be 
reactivated and the animal becomes infectious again  (Pellet & Roizman 2007; 
Roizman et al. 1992).  
 
The variation of the Herpesviridae is represented by their latency sites, their host cell 
ranges and the length of replicative cycles to result in a wide range of host clinical 
signs and disease, individual to each virus and its preferred host.  
 
1.2.2 Herpesviridae subfamilies 
To further classify some of the differences observed between members of the 
Herpesviridae, the family is split into 3 subfamilies, based originally on biological 
properties (Roizman et al. 1992). This classification was made before the widespread 
use of viral DNA sequencing, but it has been supported by new information gained 
from viral DNA. They are defined as alpha, beta and gamma herpesvirinae, each 













Figure 1.2. Phylogenetic diagram to show relationships within the Herpesviridae family that infect 
mammals and birds. Adapted from (Fauquet et al. 2005).   
 
The subfamily Alphaherpesvirinae is distinguished from the other two groups by 
their ability to target a wide range of natural hosts, having a short reproductive cycle, 
rapid spread in culture, destruction of infected cells and latency usually being 
established in sensory ganglia (Pellet & Roizman 2007). The wide host range is 
thought to be due to their low nucleotide substitution rate, resulting in relatively slow 
evolution and high levels of genetic conservation between the species (Thiry et al. 
2006a). Characteristic genes are found in the unique long region and both of the 
repeat regions of the genome. Alphaherpesviruses can be cultured in fibroblasts in 
vitro and in epithelial cells in vivo and usually cause visceral epithelial lesions in 
their natural hosts (Fauquet et al. 2005).  
 
Alphaherpesvirinae consists of four genera: simplexvirus, varicellovirus, mardivirus 
and iltovirus. Simplexviruses mainly affect primates, have a rapid cytolytic 
productive cycle and establish latency in neurons; for example herpes simplex virus-
1 (HSV-1) which causes cold sores in humans. Members of the varicellovirus genus 
have been found in a wide-range of mammalian hosts. They frequently cross-react 
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serologically and establish latency in the sensory nervous system. They include 
varicella-zoster, the cause of chickenpox and shingles in humans and BoHV-1. 
Mardiviruses affect only birds, and are associated with malignancy; for example 
Marek’s disease virus that causes a lymphoproliferative disease in chickens. Cell free 
virus is shed from the feather follicle epithelium, after replication in lymphocytes and 
possibly macrophages. The Iltovirus genus also only affects birds and includes only 
one species, gallid herpesvirus-1 that causes avian infectious laryngotracheitis. It 
was designated a separate genus due to a distinct predicted amino acid sequence 
(Fauquet et al. 2005). Reptilian herpesviruses also belong to the alphaherpesvirus 
subfamily but have not been assigned to one of the current genera (Pellet & Roizman 
2007). 
 
In contrast to the alphaherpesvirinae, the betaherpesvirinae demonstrate a much 
smaller host range, a longer reproductive cycle and a slower infection in cell culture. 
Cytomegaly (the enlargement of cells) is frequently observed along with the 
establishment of carrier cultures. A wide range of latency sites have been observed 
including secretory glands, lymphoreticular cells and kidneys among others. The 
subfamily includes Cytomegalovirus, Muromegalovirus, Roseolovirus and 
Proboscivirus (Pellet & Roizman 2007). The viruses in this subfamily mainly affect 
humans and primates with the exception of the Muromegalovirus genera which 
represents murine cytomegalovirus. Human cytomegalovirus is responsible for 
largely asymptomatic persistent infections. However, without the presence of an 
adequate immune response they can pose a problem and therefore incidence has 
increased in immuno-compromised people such as organ transplant and HIV 
patients. It is also the leading infectious cause of birth defects (Landolfo et al. 2003). 
 
The host range of gammaherpesvirinae is restricted to members of the family or 
order of the natural host. All gammaherpesviruses replicate in lymphoblastic cells in 
vitro. They are usually specific for either T or B lymphocytes and latency is 
established in lymphoid tissue. The two established genera of the 
gammaherpesvirinae are Lymphocryptovirus, including Epstein-Barr virus and 
Rhadinovirus that historically contain viruses hosted by primates. However, it has 
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been suggested that new genera, Macaviruses including the malignant catarrhal fever 
virus affecting ruminants and Percaviruses of the perssodactyls and carnivores 
should also be included (Pellet & Roizman 2007; McGeoch, Rixon & Davison 
2006).   
   
1.2.3 Herpesvirus genetics 
All herpesviruses have a double stranded DNA genome that exists in a linear form, 
except when released from the capsid into the nucleus of an infected cell, when the 
genome has been shown to circularise (Pellet & Roizman 2007). However, beyond 
that similarity, extensive diversity can be observed in the genome length, GC content 
and sequence arrangement of the herpesviruses. The length of herpesvirus genomes 
ranges from the 124kbp of the simian varicella virus to the 241 kbp of the 
chimpanzee cytomegalovirus (McGeoch et al. 2006).  They all contain several key 
genes (table 1.1), but differences in genome length can be observed between 
individual viruses of the same species due to repeated sequences at both terminal and 
internal loci that vary in the number of repetitions. The herpesvirus genomes also 
have highly variable G and C nucleotide content ranging from 31-77% that fluctuates 
across the length of the genome with the highest G and C content generally observed 
in the terminal repeat region (Pellet & Roizman 2007; Roizman et al. 1992). 
Genomes contain unique regions flanked by repeat regions and, can occur in 6 
sequence arrangements identified for the herpesviruses discovered so far (figure 1.3). 
Different isomers are thought to occur by recombination between repeats in 
concatameric DNA but they do not appear to affect functionality (McGeoch et al. 
2006). For example sequence arrangement E representing HSV-1 is known to have 











Table 1.1 Genes conserved in all herpesvirus subfamilies. Adapted from (Pellet & Roizman 2007). 
 
Gene function category Gene function HSV homolog 
Gene regulation Multifunctional regulatory protein UL54 
Nucleotide metabolism 
Ribonucleotide reductase, large subunit UL39 
Uracil DNA glycosylase UL2 
dUTPase UL50 
DNA replication 
Helicase/primase complex (3 subunits) UL5, UL8, UL52 
DNA polymerase UL30 
ssDNA binding UL29 
DNA polymerase processivity factor UL42 
Virion maturation 
Alkaline exonuclease UL12 
Genome cleavage/packaging UL28, UL32, 
UL33 Terminase/packaging UL15a 
DNA packaging UL25 
Scaffold protease UL26 
Scaffold UL26.5 
Capsid nuclear egress UL31, UL34 
Virion UL16 
Capsid 
Major capsid protein UL19 
Minor capsid protein, portal protein UL6 
Capsid triplex UL18, UL38 
Hexon tips UL35 
Tegument 
Large tegument protein UL36 
Tegument protein UL7 
Protein kinase UL13 
Myristoylated UL11, UL14, 
UL17, UL37, 
UL51 Envelope 
Glycoprotein B UL27 
Glycoprotein H UL22 
Glycoprotein L UL1 
Glycoprotein M UL10 
Glycoprotein N UL49.5 













Figure 1.3. Herpesvirus sequence arrangements adapted from (Pellet & Roizman 2007). Lines 
represent unique genome regions, blocks represent repeat regions, and broken blocks represent 
reiterations of the same sequence. LTR/RTR = left and right terminal repeats. RTS = reiterated 
terminal repeats. IR/TR = internal/terminal repeat. Sequence E has several repeat regions with 
sequence a reiterated n times associated with either sequence b or c. Sequence arrangement F has not 
yet been described. Only one isomer is found for arrangements A, B, C and F. There are four possible 
isomers for arrangement D with the 2 forms of inversions of the Us region most commonly observed. 
Four isomers have also been identified for arrangement E. Examples of viruses of each arrangement 
are: A-Human herpesvirus-6, B- Herpesvirus saimiri, C- Epstein-Barr virus, D- Varicella-Zoster virus, 




Complete genome sequences are available for 47 species (RefSeq 2010). Herpesvirus 
genomes encode between 70 and 200 genes as well as non-coding RNAs. Most 
herpesvirus genes are transcribed by RNA polymerase II and transcription is initiated 
by a promoter sequence 50-200bp upstream of a TATA box. Downstream of the 
TATA box a transcription initiation site, 5’ non-translated leader sequence and a 
translation initiation codon within a single major open reading frame also facilitate 
DNA replication (Pellet & Roizman 2007). Introns are generally rare but can be 
found in up to 10% of genes in some species and are most common in the beta- and 
gamma herpes viruses (McGeoch et al. 2006). Gene functions are still being 
identified and are mainly compared to the findings in the well-studied HSV-1. 
Several gene products have been found to interact with numerous proteins, therefore 
establishing one function of a gene is rarely a definitive result. The role of viral-
encoded proteins has been identified as important although 50% of genes are 
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considered ‘non-essential’ for growth in cell culture. However, many of these 
proteins are required for viral replication or reactivation from latency. 140 
microRNAs have been identified across all 3 subfamilies of virus. MicroRNAs are 
~22bp short RNAs that regulate gene expression post transcriptionally, so far they 
have been identified to have roles in both cellular and viral processes including 
immunity, angiogenesis, apoptosis, herpesvirus latency and reactivation (Boss, 
Plaisance & Renne 2009) 
 
1.2.4 Herpesvirus replication 
For the replication of herpesviruses, key proteins include those involved in cell entry, 
viral gene expression regulation, nucleotide metabolism, synthesis of viral DNA, 
structural proteins and virion assembly (table 1.1). It is also necessary for the virus to 
avoid the host response to viral gene expression. This will usually involve 
programmed cell death, which the virus needs to delay long enough to allow viral 
replication(Pellet & Roizman 2007). Upon the infection of a cell and release of viral 
DNA into the nucleus, viral replication depends on ‘temporal’ phasic gene 
expression of 4 key groups of genes. The α (or immediate-early gene) expression is 
stimulated by tegument proteins such as the α-TIF (alpha gene trans inducing factor).  
The resulting proteins initiate viral gene replication by stimulating expression of β 
(or early genes) including genes important in DNA replication such as DNA 
polymerase. γ (or late genes) are then expressed, sometimes as two groups, ‘leaky-
late’ genes that just require the onset of viral DNA synthesis and ‘true’ late genes 
that are entirely dependent on prior viral DNA synthesis. This final phase of gene 
expression includes the synthesis of many of the structural proteins such as the 
glycoproteins, allowing the formation and assembly of progeny virions as capsids 
containing the viral genome core. Progeny virions are released from the nucleus into 
the cytoplasm where final processing takes place and the tegument and envelope is 
formed before release from the cell (Pellet & Roizman 2007). The specific genes and 
mechanisms involved with specific reference to BoHV-1 replication will be detailed 





1.2.5 Herpesvirus latency 
The latent state of herpesviruses is exemplified by failure to isolate infectious virus 
in latently infected cells (Engels & Ackermann 1996). As has been described above, 
latency is an important characteristic of all herpesviruses; however the sites of 
latency vary widely between the different subfamilies and species. The latency 
mechanisms of BoHV-1 will be described in detail in section 1.3.5. The latency of 
alphaherpesviruses has been well-studied, with HSV-1 frequently being used as the 
model. Typically, they establish latency in sensory neurons such as the trigeminal 
ganglia, and a latency-associated transcript (LAT) is expressed which prevents host 
cell apoptosis, viral replication and infection (Perng & Jones 2010; Quinn, Dalziel & 
Nash 2000). The process of establishing latency can be more challenging for the 
gammaherpesviruses, which most commonly establish latency in dividing cells such 
as B cells. This means they must find a way to stop the viral genome from being 
diluted by the process of mitosis in the host cells. In KSHV the viral genome is 
thought to replicate before mitosis and segregate to the daughter cells. A protein 
known as latency associated nuclear antigen (LANA) is consistently expressed 
throughout latency (Coscoy 2007). However, it is thought to restrict its own 
translation and prevents proteasomal degradation to reduce the production of viral 
epitopes that could be made available for MHC 1 molecules on the cell surface. This 
also occurs in Epstein-Barr and murine gammaherpesvirus 68. This demonstrates 
possible conservation of an immune evasion mechanism between several 
gammaherpesviruses (Coscoy 2007). After the initial infection the virus will enter 
the cell types associated with latency for that species. Regulation of this state and 
reactivation of the virus when viral DNA replication reoccurs usually involves some 
genetic component, but there are no genetic factors known to control maintenance in 
a latent form or reactivation from latency common to all herpesviruses (Pellet & 
Roizman 2007). 
 
1.2.6 Herpesvirus evolution 
The three subfamilies of Herpesviridae are estimated to have arisen between 180 and 
220 million years ago (McGeoch et al. 1995). Studying sequence homology from the 
different genomes is key to identifying conserved functions and learning more about 
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herpesvirus evolution (Alba et al. 2001). The core genes identified as common across 
all 3 subfamilies (table 1.1), are mainly located in the central region of the genomes 
with non-core, more recently evolved genes located at more terminal locations 
(McGeoch et al. 2006). Genetic diversity has been gained by gradual mutation by 
methods including nucleotide substitution, insertion and deletion which can lead to 
changes in gene function, or whole genes are gained or lost. Recombination 
mechanisms have also been shown to play a role in creating genetic diversity 
(Davison 2002). Gene duplication has occurred in the herpesviruses, particularly in 
the beta subfamily. Lateral transfer from host cells is also possible, as demonstrated 
by the capture of β-1,6-N-acetylylglucosaminyltransferase-mucin gene by bovine 
herpesvirus-4. Lateral transfer between viruses is also thought to have occurred, 
resulting in distinct genotypes with geographical associations, for example in genes 
associated with latency in Epstein Barr virus  (McGeoch et al. 2006).  
 
Phylogenetic studies have been used to document the history of herpesvirus 
evolution. The separation of the three subfamilies can clearly be demonstrated, with 
further divisions indicating the different genera showing that the biological 
properties used to define the different subfamilies and genera are supported by 
sequencing data. Another of the main findings from this work has been that features 
of the phylogeny correspond with host organisms, proving evidence of co-evolution 
of viruses alongside their hosts (McGeoch et al. 1995; McGeoch, Dolan & Ralph 
2000). Models of co-evolution can be particularly useful to calculate a time scale for 
virus evolution, as there is no fossil record available. Current evidence shows 
herpesviruses have existed for longer than phylogenetic trees can measure, and 
generally they evolve faster than their hosts (Davison 2002). Another study used a 
whole genome approach to study molecular functions of homologous protein 
families from 19 herpesviruses to create genome-wide phylogenetic trees and 
determine conserved functions, which were found to agree with molecular sequence 
derived trees (Alba et al. 2001). This is a growing field of virology and as more 




1.3 Bovine herpesvirus-1 (BoHV-1) 
 
1.3.1 BoHV-1 Classification 
BoHV-1 was first isolated in bovine embryonic kidney cells in 1956 from outbreaks 
of infectious bovine rhinotracheitis (IBR)  in California where the disease was first 
reported 3 years earlier (Madin, York & McKercher 1956). BoHV-1 is in the 
Varicella genus of the alphaherpesvirus sub-family, and is closely related to suid 
herpesvirus-1 (pseudorabiesvirus), equine herpesvirus-1 and human herpesvirus-3 
(varicella-zoster virus). It has a typical alphaherpesvirus structure and a type D 
genome as described in 1.2.1 and 1.2.3. Its main host is cattle, however as is typical 
of an alphaherpesvirus it has the potential to cause cross-species infection. Sheep and 
goats have shown mild symptoms, and latency has been demonstrated after an 
experimental infection, although reactivation from latency was not observed (Engels 
et al. 1992). Red deer and reindeer have been found to be positive for BoHV-1 after 
experimental challenge but titres of virus excreted were very low and considered 
unlikely to be sufficient to facilitate further spread of the virus (Thiry et al. 2006b).      
 
BoHV-1 isolates have been divided into 3 subtypes based on genetic variation and on 
differences in the clinical aspects of the resulting infection (figure 1.4). BoHV-1.1 is 
most commonly found in respiratory cases of IBR, but can also cause abortion and 
systemic infection. This subtype was originally seen in the USA in the 1960’s but is 
now also the most common subtype found in the UK (Graham 2007). BoHV-1.2a is 
usually found in genital cases causing infectious pustular vulvovaginitis (IPV) in 
cows and heifers or infectious pustular balanoposthitis (IPB) in bulls and has also 
been isolated in cases of abortion (Miller, Whetstone & Van Der Maaten 1991). This 
subtype is not currently present in the UK. BoHV-1.2b is also associated with genital 
disease but has not been found in abortion cases. BoHV-1.2b was the subtype most 
common in the UK when BoHV-1 was first observed in the UK in 1961, however 
since 1977 the genital form of BoHV-1 has been less common and most outbreaks 
are associated with BoHV-1.1, causing the respiratory form of the disease (Graham 
2007). Despite the subtypes usually being associated with different routes of 
infection, all 3 subtypes can cause infection of both the respiratory and genital tracts 
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(Spilki et al. 2004). Historically, bovine herpesvirus-5 (BoHV-5) was originally 
grouped as subtype BoHV-1.3 which showed neuropathogenic characteristics and 
has since been reclassified as BoHV-5 (Edwards, White & Nixon 1990). The 
subtypes can be distinguished using restriction enzyme digestion with Hind III 
(Misra, Babiuk & le Q Darcel 1983; Mayfield et al. 1983; Edwards et al. 1990).  
 











1.3.2 BoHV-1 history and epidemiology 
BoHV-1 is found worldwide with high prevalence of infection but a low incidence of 
disease. Most direct economic losses are from death and abortions in more serious 
incidences of disease, but it also has an impact on international trade. Seroprevalence 
varies extensively from 10-50% or even higher depending on geographical area, herd 
vaccination practices and frequency of mixing of animals with different infection 
statuses. Due to the more frequent introduction of susceptible individuals, morbidity 
and mortality have been reported to be higher in feedlot cattle (20-30% and 1-10% 
respectively) compared to dairy herds (8 and 3 % respectively) (Radostits et al. 
2000). Several risk factors have been identified for seroprevalence including age, sex 
(with more positive males), herd size, contact with animals from other herds, farm 
and cattle density (Muylkens et al. 2007).  
 
While a worldwide disease, it is most common in North and South America and 
Europe. The genital form of the disease was first reported in Germany in the 1920’s 
(Ackermann & Engels 2006). This was the most common form of BoHV-1 infection 
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in the UK until the 1970’s when stricter measures were introduced in artificial 
insemination centres (Radostits et al. 2000). The more serious respiratory disease 
was first reported in the 1950’s, and the virus was subsequently isolated in 
California, from where it spread to other parts of North America. In 1977 the first 
outbreaks of the respiratory disease occurred in the north east of Scotland, from 
where it spread to other parts of the UK. Throughout the 1990’s several countries in 
Europe have attempted to eradicate the virus, so far Denmark, Sweden, Switzerland, 
Finland and Austria have been successful (Ackermann & Engels 2006; Graham 
2007; Radostits et al. 2000). However, there is still some debate over whether 
eradication is the best long term solution due to the losses of healthy virus carriers 
and high associated costs (Ackermann & Engels 2006). 
 
1.3.3 BoHV-1 genetics 
BoHV-1 has a 135kb double stranded DNA genome sequence containing 73 known 
open reading frames (ORFs) (table 1.2) (Robinson et al. 2008). The genome, fully 
sequenced in 1995, demonstrated the 73 ORFs represented 69 unique genes and two 
genes replicated in each of the repeat regions (Schwyzer & Ackermann 1996). The 
BoHV-1 genome represents sequence arrangement D of the 6 observed herpesvirus 
genome sequence arrangements (figure 1.3). This means it consists of two unique 
coding regions, a long segment UL and a short segment US. These regions are 
separated by an internal repeat region, which is the inverted sequence of that found in 
the terminal repeat region found on the US end (figure 1.5).  
 
Figure 1.5. Diagram representing basic genome structure of BoHV-1. IR= internal repeat; TR= 




Most of the genes in BoHV-1 have counterparts in HSV-1, and were therefore named 
after the homologs (table 1.2). However, some novel genes have been identified, 







HSV-1. At least 10 genes encode the glycoproteins which are part of the virion 
envelope (figure 1.1) and are therefore mainly associated with the initial interaction 
with host cells and also with the host’s immune response. There are several enzymes 
important in genome replication including ribonucleotide reductase, thymidine 
kinase, dUTPase and DNA polymerase. Other proteins are involved in virion 
assembly, structure and tegument proteins. The final group of genes are the 
regulatory genes that control both lytic and latent replication (Schwyzer & 
Ackermann 1996). Since the sequencing of the whole genome, much analysis of 
individual and groups of genes has been conducted to learn more about gene 
function. In particular, there has been a focus on identifying whether genes are 
essential or non essential for replication in cell culture (Robinson et al. 2008). A full 
study of BoHV-1 genes found 33 essential and 36-non essential genes. Most were 
consistent with HSV-1 homolog requirements. However, UL54, UL53, UL49.5, 
UL49, UL35, UL20, UL16 and UL7 differed in their requirement, the significance of 
this is as yet unknown. There was also a difference found in the requirement of circ, 
which had previously been identified as non-essential in the Jura strain, but in 1.2b it 
does appear to be essential (Robinson et al. 2008). This study also highlighted that 
demonstration of cytopathic effect may not be sufficient to identify essential or non-
essential genes as real-time PCR showed presence of viral DNA when no cytopathic 
effect was observed.  
 
The lytic phase of viral replication involves many of the regulatory genes by the 
process of a temporal cascade of gene expression (Misra, Blumenthal & Babiuk 
1981; Wirth et al. 1989; Seal, Irving & Whetstone 1991). It is initiated by activation 
of immediate early genes, the first of the temporally controlled phases of gene 
expression that are largely associated with gene regulation, followed by early and 
late gene expression phases (table 1.2).  
 
In addition to the standard cascade expression of genes in the lytic phase of the virus 
there have recently been discoveries of microRNAs encoded and expressed by 
BoHV-1 during infection. A recent study showed that of 10 microRNAs encoded by 
the BoHV-1 genome, four of these are found in repeat regions and therefore the total 
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number could be considered 14. Similar findings have been demonstrated in other 
herpesviruses and may be a characteristic of the group (Glazov et al. 2010). More 
research is required to establish the importance of these microRNAs in the regulation 
of gene expression. In other herpesviruses they have been identified as potentially 
important in the transition between the lytic and latent replication (Cullen 2009). 
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Table 1.2. Products and functions of the genes of BoHV-1 (IE – immediate early, E- early, L-late, Essential refers to whether they are required for growth in cell 






Circ Circ protein IE Unknown, potentially envelope associated Y Y
UL54 Multifunctional expression regulator (ICP27) E Gene regulation/RNA transport and metabolism N N
UL53 Envelope glycoprotein K L Virion morphogenesis/membrane fusion N Y
UL52 Helicase-primase primase subunit E DNA replication N Y
UL51 Tegument protein L Virion morphogenesis N N
UL50 dUTPase E Nucleotide metabolism N N
UL49.5 Envelope glycoprotein N L Virion morphogenesis N N
UL49 Tegument protein VP22 L
Virion morphogesis/possible RNA transport to 
uninfected cells N N
UL48 Transactivating tegument protein VP16 L Gene regulation/virion morphogenesis N N
UL47 Tregument protein VP8 L Possible gene regulation N N
UL46 Tegument protein VP11/12 L Possible gene regulation N N
UL44 Envelope glycoprotein C L Cell attachment N N
UL43 Envelope protein L Possible membrane fusion N N
UL42 DNA polymerase processivity subunit E DNA replication N Y
UL41 Tegument host shut off protein L Cellular mRNA degradation N N
UL40 Ribonucleotide reductase subunit 2 E Nucleotide metabolism N N
UL39 Ribonucleotide reductase subunit 1 E Nucleotide metabolism N N
UL38 Capsid triplex subunit 1 L Capsid morphogenesis N Y
UL37 Tegument protein L Virion morphogenesis N Y
UL36 Large tegument protein L Capsid transport N Y
UL35 Small capsid protein L Capsid morphogenesis/possibly capsid transport N N
UL34 Nuclear egress membrane protein Unknown Nuclear egress N Y
UL33 DNA packaging protein Unknown DNA encapsidation N Y
UL32 DNA packaging protein L DNA encapsidation N Y
UL31 Nuclear egress lamina protein L Nuclear egress N Y
UL30 DNA polymerase catalytic subunit E DNA replication N Y
UL29 Single-stranded binding protein E DNA replication/ possible gene regulation N Y
UL28 DNA packaging terminase subunit 2 L DNA encapsidation N Y
UL27 Glycoprotein BALF4 L Cell entry/cell-cell spread N Y
UL26 Capsid maturation protease L Capsid morphogenesis N Y
UL26.5 Capsid scaffold protein L Capsid morphogenesis N Y
UL25 DNA packaging tegument protein L DNA encapsidation N Y  
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UL24 Nuclear protein L Unknown N N
UL23 Thymidine kinase E Nucleotide metabolism N N
UL22 Envelope glycoprotein H L Cell entry/cell-cell spread N Y
UL21 Tegument protein Unknown Virion morphogenesis N N
UL20 Envelope protein L Virion morphogenesis/membrane fusion N Y
UL19 Major capsid protein L Capsid morphogenesis N Y
UL18 Capsid triplex subunit 2 L Capsid morphogenesis N Y
UL17 Tegument protein L DNA encapsidation/capsid transport N Y
UL16 Tegument protein L Possible virion morphogenesis N Y
UL15 DNA packaging terminase subunit 1 L DNA encapsidation N Y
UL14 Tegument protein L Virion morphogenesis N Y
UL13 Tegument serine/threonine protein kinase L Protein phosphorylation N N
UL12 Deoxyribonuclease E DNA processing N N
UL11 Alkaline exonuclease L Virion morphogenesis N N
UL10 Envelope glycoprotein M L Virion morphogenesis N N
UL9 DNA replication origin-binding helicase L DNA replication N Y
UL8 Helicase-primase primase subunit E DNA replication N Y
UL7 Tegument protein E Virion morphogenesis N N
UL6 Capsid portal protein E DNA encapsidation N Y
UL5 Helicase-primase subunit BBLF4 E DNA replication N Y
UL4 Nuclear protein Unknown Unknown N N
UL3.5 Protein V57 L Possibly virion morphogenesis Y Y
UL3 Nuclear protein UL3 L Unknown N N
UL2 Uracil DNA glycosylase E DNA repair N N
UL1 Envelope glycoprotein L L Cell entry/cell-cell spread N Y
UL0.7 Unknown Unknown Unknown Y N
UL0.5 Unknown Unknown Unknown Y N
BICP4 Transcriptional regulator ICP4 IE Gene regulation N Unknown
BICP0 Ubiquitin E3 ligase ICP0 IE Gene regulation/cellular protein N N
BICP22 Regulatory protein IE Gene regulation/cell-cycle regulation N Unknown
US1.67 Virion protein V67 Unknown Unknown Y Unknown
US2 Virion protein  Unknown Unknown N N
US3 Serine/threonine kinase E Protein phosphorylation/nuclear N N
US4 Envelope glycoprotein G L Cell to cell spread N N
US6 Envelope glycoprotein D L Cell attachment N Y
US7 Envelope lycoprotein I L Cell to cell spread N N
US8 Envelope glycoprotein E L Cell to cell spread N N
US9 Membrane protein E Axonal transport N N
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1.3.4 BoHV-1 pathogenesis 
Transmission of infection usually occurs by direct contact, either nose to nose, direct 
genital contact, or via virus infected semen during mating (Muylkens et al. 2007). 
Aerosol transmission has also been demonstrated over short distances (Mars et al. 
2000). In the case of the respiratory form of the infection, the virus enters the nasal 
passages and upper respiratory tract where it targets epithelial cells and the first 
round of viral replication occurs (Engels & Ackermann 1996).  
 
When infection occurs through the respiratory route, and following exposure of 
respiratory epithelium, cell entry is a multistep process primarily involving the 
glycoproteins found in the viral envelope. It is well documented that glycoprotein C 
binds to heparan sulfate (HS) proteoglycans located on the cell surface of many cell 
types (Okazaki et al. 1991), glycoprotein D then completes the attachment by 
binding to the second cellular receptor. It has also been found that glycoprotein B 
plays an important role and binds initially to HS before binding to the secondary 
non-HS receptor (Li et al. 1995). Interactions between glycoproteins B, H and L then 
allow fusion of the viral envelope with the cell membrane, to ultimately release the 
capsid into the cell cytoplasm (Nandi et al. 2009) (figure 1.6).  
 
Figure 1.6. Schematic diagram showing mechanisms of BoHV-1 cell entry. HS = heparan sulfate, R2 






Upon cell entry, a dynein motor complex, together with microtubules, transports 
virus particles through the cytoplasm to the cell nucleus where the viral DNA is 
released. Tegument proteins are released in the cytosol at this stage and are likely to 
play a role in the early stages of viral infection such as shut down of host cell protein 
synthesis by the host shut off (vhs) protein, common to all alphaherpesviruses, which 
degrades cellular mRNA by endoribonucleolytic cleavage (Elgadi, Hayes & Smiley 
1999). The largest BoHV-1 virion protein (VP) 8 (UL47), a homologue of VP13/14 
in HSV-1, is also released at this stage and a nuclear localization signal causes its 
abundance in the nucleus soon after infection, although its function is unknown 
(Muylkens et al. 2007). VP 16 (UL48/α-trans inducing factor) is also released at this 
stage which initiates the cascade of viral DNA replication. VP16, combined with 
cellular proteins, binds to a specific motif in the promoter sequence of two 
immediate-early transcription units (IEtu1 and IEtu2) (Wirth, Vogt & Schwyzer 
1991; Misra et al. 1995). IEtu1 encodes bICP0 and bICP4 that have homologs in 
HSV-1, but it also activates circ that is specific to BoHV-1 and is present throughout 
the viral cycle, IEtu2 encodes BICP22 (figure 1.7) (Schwyzer & Ackermann 1996). 
Regulation of immediate-early genes in BoHV-1 potentially differs from those found 
in HSV-1 as they are found to accumulate throughout the replication cycle rather 
than degrade after a peak, 3 hours post infection (Seal et al. 1992).  
 
Figure 1.7. Schematic view of immediate early genes (blue) and latency related transcript (LR) (red). 




After the synthesis of bICP0, bICP4 and bICP22 proteins, early gene expression is 
activated encoding proteins necessary for viral DNA replication such as DNA 
polymerase, although the exact mechanisms stimulating this are not known. The 
process of DNA replication is still being researched, but work on HSV-1 suggests 
circularised DNA undergoes theta replication from two origin of replication sites 
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(ori), within the inverted repeat sequence (Chew, Choi & Leung 2005). Bidirectional 
replication then forms concatameric DNA with genomes arranged head to tail, and 
would allow recombination events to form the four possible isomers seen in HSV-1. 
However, BoHV-1 genomes are rarely found in the inverted UL region isomer. 
Experiments have shown that this is due to the cleavage and packaging of DNA, 
rather than the UL region not inverting, as adjacent UL regions are found in 
abundance in concatameric DNA (Schynts et al. 2003a). As viral DNA replicates, 
capsid shell proteins assemble containing a scaffold that the DNA genome then 
replaces during packaging. The first wave of late gene expression, sometimes 
referred to as ‘leaky-late’ or γ1 genes are detected during DNA replication but the 
second phase of late gene expression is entirely dependent on the completion of 
DNA synthesis. Late gene expression controls virion assembly and release of the 
progeny viruses. The late genes largely consist of genes associated with the structure 
of the virus such as the glycoprotein and envelope proteins that are needed to 
complete the production of progeny viruses in the cytoplasm of the host cell (table 
1.2) (Muylkens et al. 2007). 
 
The capsids containing the genome are released into the cytoplasm for the final 
phase of gene expression, which translate proteins to complete the virion structure 
and the final stages of assembly take place (Muylkens et al. 2007). Currently the 
view of capsid release and acquisition of the envelope is not fully determined. 
Capsid egress from the nucleus is a three step process, beginning with the acquisition 
of a primary envelope by budding through the inner nuclear membrane. Secondly, 
the virus fuses the primary envelope with the outer membrane of the nucleus to gain 
entry to the cytoplasm; this process has been shown to require viral kinase activity. 
Finally, virions must gain their tegument layer in the cytoplasm and the secondary 
envelope thought to be acquired by budding into the trans Golgi compartment (Wild 
et al. 2005; Leuzinger et al. 2005). However, it should be noted this mechanism of 
capsid egress does have two alternative theories. One suggests budding through the 
inner nuclear membrane contributes to the primary envelope, and the virion is then 
transported to the endoplasmic reticulum and Golgi secretory pathway by intra-
luminal transport (Muylkens et al. 2007). The second theory, supported by 
microscopic observations suggests dilation of nuclear pores allows the capsids direct 
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egress to the cytoplasm, and envelopes are gained by budding at any cell membrane 
(Wild et al. 2005). 
 
In a natural infection, the new progeny viruses are then shed in the nasal, tracheal 
and ocular mucus. Progeny viruses may also spread to other cells within the host by 
two mechanisms. Viruses released into the extracellular matrix are fully enveloped 
and able to interact with cell receptors to enter via the epithelial surface by the route 
previously described (Muylkens et al. 2007). Viral particles can also spread directly 
from cell-cell across cell junctions, avoiding the host immune response, which 
requires glycoproteins B, D, G, H, L, E and I (Johnson & Huber 2002). VP22 coded 
for by UL49 has been identified as essential for this process in a study of gE and 
VP22 mutant viruses (Kalthoff et al. 2008). 
 
In vitro the cytopathic effect (CPE) can be observed in infected bovine cells in 
culture, in the form of the rounding, shrinking and clumping of cells first described 
in 1956 (figure 1.8) (Madin et al. 1956). Its ability to grow well in culture has 
resulted in BoHV-1 becoming a well studied virus, often used as a model for 
studying alphaherpesviruses.  
 
Figure 1.8. BoHV-1 infection in cell culture. A) Uninfected cells; B) BoHV-1 infected cells. 
A)                                                                 B) 
 
 
In vivo, the process of viral infection of a cell and production of progeny viruses 
results in cell death due to necrosis and apoptosis (Muylkens et al. 2006). This cell 
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death triggers an inflammatory response that leads to the clinical signs observed 
during a BoHV-1 infection (Nandi et al. 2009). These effects may be increased by 
prevention of repair of the airway epithelium by inhibition of new epithelial cell 
migration to damaged sites, shown in a sheet-migration assay (Spurzem et al. 1995).  
 
1.3.5 BoHV-1 latency and reactivation 
After the initial infection process, or vaccination with an attenuated strain, the virus 
is able to establish latency (figure 1.9), when viral genomes can remain in an inactive 
non-replicative state for up to the lifetime of the animal. In BoHV-1 this occurs most 
commonly in the trigeminal ganglion. Neuroinvasion is thought to occur through the 
olfactory and trigeminal nerves, by infection of the nerve endings at the oro-nasal 
mucosa; this route is also used by closely related neurotropic viruses suid 
herpesvirus-1 and BoHV-5. BoHV-1 predominantly uses the trigeminal route and 
usually stops in the cell body of the sensory neuron, in the trigeminal ganglia, where 
latency is established rather than continuing on to cause neurological clinical signs, 
as seen in BoHV-5 and PrV (Enquist et al. 1998). Past research has also 
demonstrated evidence of latency and reactivation of BoHV-1 in the lymphoid tissue 
of tonsils (Winkler, Doster & Jones 2000).  
 






The latent state of the virus is maintained by virally encoded genes, primarily by the 
expression of the BoHV-1 latency related (LR) transcript (figure 1.7). The LR 
transcript is antisense to the BICP0 regulatory gene and is thought to be a key 
component. The LR transcript shows similar properties to the latency associated 
transcript (LAT) identified in HSV-1; in particular it inhibits BICP0 expression 
during latency, which prevents initiation of the viral replication cycle (Jones et al. 
2006; Jones 2003). Although this relationship between LAT and ICP0 in HSV-1 
latency and reactivation has been questioned in studies of LAT and ICP0 mutant 
viruses (Quinn et al. 2000). The process can be divided into three main steps; firstly 
the establishment of latency by the entry of the genome into the sensory neurons 
where replication will continue to occur during infection. Secondly, the viral gene 
expression described above is then replaced by LR expression in BoHV-1 or LAT 
expression in HSV-1, which marks the transfer into the second stage, maintenance of 
latency, during which no viral DNA replication or lytic viral gene expression occurs 
(Jones 2003). The host immune system is also thought to play a role in confining the 
virus to sensory ganglia in its latent state. For example CD8+ T cells were shown to 
be present in close proximity to neurons containing latent HSV-1 in a mouse model 
(Liu et al. 2000). The third stage refers to the reactivation of the virus. 
 
Reactivation has been shown to be stimulated by situations of stress such as 
parturition (Thiry et al. 1985) and transport (Thiry et al. 1987). It can also be 
stimulated experimentally by a large dose of corticosteroids (Graham 2007). This 
final stage of latency initiates viral DNA replication as described previously, 
temporal gene expression and production of infectious virus (Jones 2003). This 
switch from latency to lytic gene expression allows re-release of virus. The virus is 
transported intra-axonally back down the sensory neurons to replicate in epithelial 
cells, and virus can be shed from the initial point of entry (Engels & Ackermann 
1996). Whether infectious virus is shed in detectable titres that can spread to other 
animals and cause recrudescence of disease depends on the immune status of the 
animal and progeny virus phenotype (Muylkens et al. 2007). Reactivated virus from 
latently infected animals can infect susceptible animals at birth, following transport, 
and on introduction of naïve animals to the herd. Identifying latent carriers, usually 
by serology, is vital for the local control of disease (Muylkens et al. 2007). 
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1.3.6 Genetic variation in BoHV-1 and closely related viruses 
Several of the genetic differences found between BoHV-1 and other species in the 
group have been connected to variations in the glycoproteins (g). For example 
differences in gC have been found between BoHV-1 and BoHV-5 (Esteves et al. 
2008; Ros & Belak 2007); this could potentially represent differences in cell tropism 
as gC is strongly associated with cell entry and the two viruses represent different 
cell entry patterns, given the neurotropic characteristics of BoHV-5. A comparison 
between five ruminant alphaherpesviruses including BoHV-5, caprine herpesvirus-1, 
cervine herpesvirus-1, rangiferine herpesvirus-1 and BoHV-1 showed gB to be 
highly conserved but that gD was much more variable, with identity ranging from 
71.3-98.9% (Ros & Belak 2007).  
 
DNA polymerase and thymidine kinase have been the focus of other studies relating 
genetic variation to clinical outcome of disease. In equine herpesvirus-1, closely 
related to BoHV-1, a single point mutation in the DNA polymerase coding region 
was found to have an effect on the neuropathogenicity of the infection (Goodman et 
al. 2007; Nugent et al. 2006). The differences were determined by sequencing of two 
strains, Ab4, which frequently caused severe clinical disease including abortion and 
signs of neurological damage, and strain V592 which caused less serious clinical 
signs of fever and mild respiratory illness. After sequencing it was possible to 
identify the same differences in field isolates by PCR and sequencing methods at 
nucleotide 2254 of ORF30 that encodes DNA polymerase (Nugent et al. 2006). An 
experimental infection also comparing these strains found a higher and longer 
duration of leukocyte associated viraemia in isolates with neuropathogenic potential 
(Allen & Breathnach 2006). These studies are also supported by a study 
investigating this mutation in terms of its pathogenic potential (Goodman et al. 
2007). However, it is not entirely clear what mechanism this mutation acts on as it 
was found not to have any effect on growth kinetics of the virus in cultured murine 
neuronal cells (Yamada et al. 2008).  
 
Thymidine kinase (TK) is thought to be related to BoHV-1 virulence and has been 
specifically associated with abortion in experimental infection studies. An 
intravenous infection showed a thymidine kinase deletion mutant significantly 
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reduced abortifacient activation of BoHV-1 compared to the wild type Cooper 
isolate (Miller et al. 1991). However, the intravenous route of inoculation does not 
represent a natural route of infection, which resulted in the Cooper isolate (control) 
infected group showing more abortifacient activity than would usually be expected 
from a BoHV-1 infection. The differences seen could therefore be due to other 
factors such as speed of replication. Little work investigating this finding further has 
been conducted since.   
 
There have also been reports of differences in BoHV-1 gene expression between 
different BoHV-1 subtypes. The subtype 1.1 Jura strain was found to show earlier 
transcript expression in much higher abundance than the 1.2b strain K22 in a study 
to spatially and temporally classify BoHV-1 transcripts using northern blot analysis 
(Wirth et al. 1989).  
 
Recombination has been shown to be an important source of variation in 
herpesviruses and BoHV-1 is no exception. An in vivo infection with two strains of 
BoHV-1 has demonstrated that recombination is a frequent event (Schynts et al. 
2003b). A later study showed this was restricted to two very closely related viruses, 
and the infections have to be simultaneous or very close to allow recombination to 
occur. It is thought that this can result in both a mechanism for long term evolution, 
as well as immediate strain diversity that can play a role in strain virulence (Thiry et 
al. 2006a). 
 
1.3.7 Clinical presentations of BoHV-1 
The main disease associated with BoHV-1 is the respiratory disease IBR, which can 
be recognized by the presence of typical clinical signs. A high fever is usually 
observed within 24 hours of infection, although if not closely monitored, this stage 
of the infection may be missed. This is followed by nasal discharge containing 
infectious virus, conjunctivitis and dry coughing due to tracheal lesions. In dairy 
cattle, a drop in milk yield is often seen two to three days post infection. The clinical 
signs usually peak on day 4 post infection, and where there are no complications, 
disappear within 8-10 days, as the virus enters its latent phase (Graham 2007; 
Muylkens et al. 2007).  
43 
 
Complications of BoHV-1 infection can cause other clinical presentations, generally 
more severe and in some cases with fatal consequences, such as encephalitis, 
abortion or systemic infection. Secondary bacterial infections are particularly 
common in calves infected with BoHV-1, as it increases susceptibility to 
P.multocida and M. haemolytica due to lysis of ciliated respiratory epithelium, 
disrupting the normal bacterial clearance mechanisms and also suppression of the 
immune response, which can lead to pneumonia. These mixed infections are known 
as BoHV-1 associated bovine respiratory disease (BRD) that results in severe lower 
respiratory tract disease (Ellis 2009; Jones & Chowdhury 2007; Jones & Chowdhury 
2010; Srikumaran, Kelling & Ambagala 2007). The effect of a combined BoHV-1 
and P. haemolytica has been demonstrated in experimental coinfections, where 
BoHV-1 destroyed the mucociliary apparatus, which facilitates the proliferation of 
the bacteria and increased the endotoxin  released by P. haemolytica, found in the 
bronchoalveolar lavage fluid (Narita et al. 2000a). There have also been sporadic 
reports of BoHV-1 being isolated from cases of encephalitis (Penny et al. 2002; 
Higgins & Edwards 1986; Straub 1991). It appears the neuroinvasion may extend 
beyond latency in the trigeminal ganglia in these cases, but it is considered to be due 
to differences in host susceptibility to CNS infection rather than a tropism for the 
CNS in particular strains (Muylkens et al. 2007). In young calves and pregnant cows 
the virus has also been found to spread systemically causing systemic infection or 
abortion (Higgins & Edwards 1986; Ormsbee 1963; Miller et al. 1991).  
 
1.3.8 BoHV-1 systemic infection and abortion 
Research by Ormsbee recorded the first abortion in which BoHV-1 was considered 
to be the causal agent in 1963 (Ormsbee 1963). This was several years after IBR was 
first observed. It may simply have not been recognised and recorded until this point, 
or it could indicate adaptation of the virus to enable systemic spread. Clinical signs 
of IBR disease are not always observed in the dam and abortion usually occurs in the 
third trimester of pregnancy (Straub 1991). Abortions due to natural BoHV-1 
infections are generally observed between 4 and 8 months gestation (Smith 1997). 
From the time of foetal infection, foetal death is thought to occur within 24-48 hours, 
but the foetus may be retained for up to 7 days before abortion (Kendrick, Schneider 




Surveys conducted to establish the prevalence of BoHV-1 as an abortifacient agent 
have produced mixed results. In a survey of 149 bovine abortions between 1984 and 
1986 in the north west of England 13% were estimated to be related to BoHV-1 
using histopathology and paired serology (Murray 1990). A 10 year study in North 
America investigating viral causes of abortion found BoHV-1 to be the most 
common cause. A prevalence of 5.41% in bovine abortion cases was found based on 
gross and histo- pathology, virus isolation and immunofluoresent antibody test 
(Kirkbridge 1992b). However, currently in the UK it is not considered a common 
cause for abortion. A study of abortions in Scotland in 1995 did not identify any 
cases of BoHV-1, but as the authors highlight it was most likely due to the reliance 
of detection of foetal antibody (Caldow et al. 1996). The most recent survey of 
bovine abortions in the UK found less than 2% of bovine abortions were related to 
BoHV-1 between 2004 and 2008 in Scotland (SAC VS 2009).  
 
Several studies have been conducted describing the pathology of foetal infection 
leading to several key findings (Owen, Chow & Molello 1964; Molello et al. 1966; 
Kendrick et al. 1971; Rodger et al. 2007). All studies consistently report extensive 
multifocal necrotic lesions in the foetal liver. However, observations in the placenta 
have been more varied. An early study focussing on placental changes during 
infection suggested placental infection was secondary to foetal infection as a result 
of failure of foetal circulation (Molello et al. 1966). However, the spread of infection 
has been described in other studies to involve a slow cell-cell spread of the virus 
between placentomes, explaining the time lapse between initial infection and foetal 
death (Kendrick et al. 1971). There have also been reports of association of BoHV-1 
with the endothelium of blood vessels in the placenta and foetal tissues (Rodger et 
al. 2007). However, these last results should be interpreted cautiously as this was as 
a result of an intravenous experimental challenge. A haematogenous route via the 
umbilical vein has been suggested as a likely route of spread to the foetus due to the 
consistent liver lesions observed in foetuses (Smith 1997; Rodger et al. 2007). 





There have also been reports of systemic spread of the virus in neonatal calves 
causing a severe systemic infection with a 31% mortality rate (Higgins & Edwards 
1986). In a more recent review, the fatality rate has been reported to be nearly 10% 
in newborn calves (Radostits et al. 2000). These incidents are mainly reported to be 
related to calves born to newly introduced heifers (Higgins & Edwards 1986; Ross et 
al. 1983). Noticeable pathology has been reported in the liver in the form of 
multifocal necrosis, similar to that observed in foetal livers in the abortive 
presentation. In these cases of systemic spread, virus showed an extensive 
dissemination, and was isolated from  liver, spleen, lymph nodes, pharyngeal mucosa 
and brain (Higgins & Edwards 1986).  
 
Despite the evidence of systemic infection, very little is known about the 
mechanisms associated with the systemic spread of the virus. There is extensive 
evidence of cell-associated mechanisms of viraemia in the closely related 
pseudorabies virus (Nauwynck & Pensaert 1992) and equine herpesvirus-1 (Allen & 
Breathnach 2006). However, so far attempts to clearly demonstrate the same process 
in BoHV-1 infection have been unconvincing. After intranasal infection with a 
highly virulent strain, one study demonstrated presence of virus in serum for several 
days post infection, indicating a cell-free viraemia 4-9 days post infection  
(Kaashoek et al. 1996). However, this was only observed in calves infected with the 
Iowa strain and has not been reported in other experimental infections via the 
intranasal route since. There has also been some evidence of cell association with 
lymphocytes and monocytes in vitro (Nyaga & McKercher 1979). Reports of 
isolation of BoHV-1 from blood buffy coats have predominantly been reported in  
studies using an intravenous method of inoculation (Miller et al. 1991). Only one 
study has isolated BoHV-1 in the blood buffy coat following intranasal experimental 
infection, although this was during a multiple virus infection in which a bovine viral 
diarrhoea virus challenge had been given intravenously. Under these circumstances, 
the immunosuppression associated with the bovine viral diarrhoea infection, may 
have influenced the IBR infection (Castrucci, Ferrari & Tartaglione 1992). Therefore 





1.3.9 Host immune response to BoHV-1  
The host immune response has to be fast acting due to the rapid infection by the 
virus; viral antigen expression on the cell surface occurs within 2-4 hours post 
infection. This is the point in a primary infection when the host starts to initiate an 
immune response. The virus replication initially triggers a non-specific or innate 
immune response including complement activation and the secretion of interferon-α 
and interferon-β by the infected cells. Specifically this α and β IFN activity has been 
shown to inhibit herpesvirus thymidine kinase activity (Otsuka, Qavi & Kit 1982). 
Macrophages, neutrophils and natural killer (NK) cells in the form of large granular 
lymphocytes are recruited and activated at the site of infection, which act in the 
infected epithelium by killing virus infected cells after cytokine activation. Research 
has demonstrated that the primary viral targets for the NK cells are gB and gD 
(Palmer et al. 1990). These cells induce an early wave of cytokines are induced, such 
as IL-1 and IL-6 (Babiuk, van Drunen Littel-van den Hurk & Tikoo 1996; Muylkens 
et al. 2007). IL-1 and IL-6 stimulates parenchymal cells and lymphocytes to produce 
GM-CSF, which in turn stimulates macrophages to produce molecules such as   
TNF-α (Heidenreich et al. 1989).  
 
After this first response of the innate mechanisms, there is a specific immune 
response mediated by the recognition of the antigen that usually coincides with the 
recovery from clinical signs. Antigen presentation occurs by both the MHC class 1 
and 2 pathways. A cell mediated response is vital to tackle a virus that initially 
spreads via a cell-cell route (Deshpande et al. 2002). This phase is mainly driven by 
the Th1 specific cytokine production (CD4 Th1 cells), which activates the direct 
cytotoxicity of CD8 T cells and result in the production of specific late cytokines 
including IL-2, IL-12 and IFN-γ. In this response, CD8 or cytotoxic T cells play a 
major role, both killing infected cells and secreting cytokines (Babiuk et al. 1996). In 
vitro work in bovine cells has suggested gC and gD are the main target antigens for 
the cytotoxic T cells, although the in vitro method used was shown to influence these 
results (Denis et al. 1993). The Non-MHC-restricted cytotoxicity via the monocyte 
and macrophages described earlier is considered to be the more abundant cell 
mediated response but requires the IFN-γ produced by the T-lymphocytes to help 
activate the macrophages (Babiuk et al. 1996). CD4 or helper T lymphocytes also 
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migrate into the site of lesions and secrete the second or late wave of cytokines, such 
as IFN-γ (Babiuk, van Drunen Littel-van den Hurk & Tikoo 1996; Turin, Russo & 
Poli 1999).  
 
The adaptive immune response is most active between 5 and 10 days post infection 
and plays a major role in resolving the infection and remission of any clinical signs 
of the disease.  This includes a Th2 response, most relevant towards the late phases 
of the infection and regulated by a different range of late cytokines including IL-4, 
IL-5 and IL-6. IgM, IgG and IgA antibody production is stimulated, which neutralize 
any extra-cellular virus believed to be important in preventing reactivation and 
shedding of latent virus (Graham 2007; Babiuk et al. 1996; Engels & Ackermann 
1996; Turin et al. 1999). The antibody response is considered more important in 
preventing an infection than in recovery of a current infection. It is particularly 
effective when high levels of antibody are found in the nasal passages during a 
reactivation event, which immediately neutralize the infecting virus and prevents 
further spread or clinical signs to develop (Babiuk et al. 1996). A study investigating 
antibody isotypes during an initial infection and reactivation found that IgM was 
detectable first from 9 days pi followed by IgA from day 12 and IgG from day 13 pi. 
IgA was only detectable for 3 weeks in the sera but persisted in the mucosal 
secretions and increased significantly in nasal and ocular titres after reinfection and 
reactivation as well as rapidly appearing in the serum. This led to suggestions that 
IgA would offer a sensitive indicator at reinfection (Madic et al. 1995a; Madic et al. 
1995b). Intranasal immunization has been found to be an effective way of 
stimulating a muscosal IgA response (Papp, Babiuk & Baca-Estrada 1998). 
 
Due to this extensive immune response by the host, the virus has evolved several 
ways to try to evade the immune response. For example, gG binds to chemokines to 
prevent their action and Type I-IFN expression is down regulated by the BICP0 gene 
product by inhibition of transcription. Glycoprotein C interacts with the third 
component of the complement to reduce complement activation, an immune evasion 
factor conserved in other related alphaherpesviruses. During the acute phase of the 
disease BoHV-1 infects and causes apoptosis of epithelial cells to ensure efficient 
virus release, but later during the latency phase, the latency related gene inhibits 
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apoptosis in latently infected cells. BoHV-1 infection can cause apoptosis of CD4 T 
lymphocytes in peripheral blood and lymph nodes which are important in the 
specific immune response (Srikumaran et al. 2007) and (Winkler et al 1999). The 
UL49.5 protein acts to down-regulate the expression of the MHC I by the virus 
infected cells by blocking the transporter associated with antigen processing 
(Koppers-Lalic et al. 2005). This means these cells are not recognised and removed 
by the cytotoxic T lymphocytes (CD8) (Muylkens et al. 2007). In vitro it has been 
reported to reduce the proliferation of leukocytes by suppressing the mitogen that 
usually stimulates cell division (Srikumaran et al. 2007). These actions allow the 
survival of the virus, and also lead to a state of immune suppression that leaves the 
host vulnerable to secondary bacterial infection. 
 
1.3.9 Diagnosis and control 
Diagnosis of IBR is traditionally achieved by virus isolation from nasal swabs, 
broncho-alveolar lavage or tissue samples in cultured bovine cells. The presence of 
virus is detected by the characteristic cytopathic effect within 3 days of inoculation 
characterized by grape-like clustering of rounded cells around a microplaque (figure 
1.8) (Nandi et al. 2009; Beer 2010). A quicker test, known as IFAT, involves 
staining the viral antigen within smears or cytospin respiratory sample cells. This can 
be done either directly using monospecific antiserum conjugated with a fluorescent 
dye, or indirectly with the anti-species secondary antibody conjugated to a 
fluorochrome. While virus isolation is more sensitive and specific than the 
fluorescent antibody technique, it is a more time consuming method (Beer 2010).  
 
Histopathology can also be used for diagnosis in cases where abortions or deaths 
have occurred. Multifocal necrosis of the liver is common in both neonatal systemic 
infection and abortion, and can be confirmed to be caused by BoHV-1 by 
immunohistochemical labelling using a BoHV-1 specific monoclonal antibody 
(Rodger et al. 2007). However, the usefulness of histopathology, as well as virus 
isolation, can be limited by the autolysis, especially in abortion material.  
 
More recently, molecular methods are being favoured for virus detection which 
provides fast, sensitive and accurate detection from a range of sample types. They 
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also allow the detection of latently infected cells in tissue samples, which cannot be 
achieved by virus isolation of histopathology/immunohistochemistry.  Conventional 
PCR can detect virus in tissue following DNA extraction, and adding it to the PCR 
assay. Heat is used to denature the DNA, primers bind to specific regions of the viral 
DNA and Taq DNA polymerase extends the primers to produce another copy of this 
region (figure 1.10A). This process is repeated by thermal cycling to amplify the 
specific region of viral DNA, enabling detection of low virus titres (Mweene, 
Okazaki & Kida 1996; Takiuchi et al. 2005; Vilcek et al. 1994; Beer 2010). There 
have also been multiplex PCRs, where several sets of primers recognising different 
sequences are used simultaneously, combined with a restriction typing assay that 
allow distinction between the different bovine herpesviruses (De-Giuli et al. 2002; 
Vilcek et al. 1994; Claus et al. 2005). However, amplifying DNA for the purposes of 
diagnosis can have associated problems. Post PCR product handling is necessary to 
analyse the results visually on an agarose gel using electrophoresis. This provides 
many opportunities for viral DNA to contaminate other samples (Mackay, Arden & 
Nitsche 2002). These problems explain the welcome response to the prospect of 
using real-time PCR, in which assays take place in a single sealed tube.  
 
Real-time PCR monitors the amplification of the targeted DNA region throughout 
the reaction in an enclosed system. In addition to specific primers a fluorescent 
labelled probe is also designed to bind to the target sequence (Klein 2002). There are 
five chemistries in use which I will briefly describe here. DNA binding fluorophores 
such as SYBR green, a fluorescent dye that binds DNA, can also be used instead of a 
probe but this is not specific to the target sequence, and therefore will bind to all 
double stranded DNA produced in the reaction, which may produce some false 
positives due to primer/dimer combinations, making it a less suitable tool for 
diagnostics. Hybprobes are linear oligoprobes containing a donor fluorophore on the 
upstream probe 3’end and an acceptor fluorophore on the downstream probe 5’ end. 
Upon hybridization these fluorophores interact to produce a FRET signal.  5’ 
nuclease oligoprobes such as Taqman probes use a fluorophore reporter and 
quencher remain in proximity of the probe, no fluorescence occurs, but following 
specific binding to the target sequence 5’-3’endonuclease activity of Taq polymerase 
degrades the probe allowing the fluorophore reporter and quencher to become 
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separated, leading to fluorescence to confirm detection and quantification of the 
target sequence (figure 1.10B). Hairpin oligoprobes have a quencher and fluorophore 
on terminal ends and remain in close proximity until hybridization with the target 
sequence when the hairpin structure is shifted to an open configuration to allow a 
FRET signal to be released. Similar to the hairpin oligos are self fluorescing 
amplicons that include scorpion and sunrise primers, which become incorporated 
into the PCR products (Mackay et al. 2002). The lack of any post PCR product 
handling and the improved technology resulting in reduced cycle times means that 
real-time PCR can also decrease time taken for diagnosis (Mackay et al. 2002). 
Using real-time PCR, it is also possible to accurately quantify viral load in samples, 
which is useful for monitoring for clinical purposes and research (Niesters 2001). 
Disadvantages of real-time PCR include being unable to establish the size of the 
amplified DNA fragment without opening the system and there being some 
limitations of current multiplex possibilities due to the number of detection channels 
available (Mackay et al. 2002). Recently, a protocol for the detection of BoHV-1 
using real time PCR was developed focussing on detecting the target sequence in gB 
of BoHV-1 in bull semen, which included an international ring trial (Wang et al. 
2007; Wang et al. 2008). This method is rapidly becoming the preferred method of 
diagnosis where facilities are available.  
 
Figure 1.10. A) Standard PCR process. B) Extension step of real-time PCR using a 5’nuclease 
Taqman probe.   







Serological tests such as antibody detection ELISAs and serum neutralization tests 
(SNTs) are used to identify seropositive animals, using specific BoHV-1 antigens 
which are recognized by specific serological antibodies in the serum. However, they 
cannot distinguish between a distant and recent infection unless paired samples are 
taken. A rising BoHV-1 antibody titre is an indication of a recent BoHV-1 infection 
(Nandi et al. 2009). There are several ELISA kits available commercially that use 
both blocking and indirect mechanisms, the antigen targets are often glycoproteins 
such as gB, gE and gC (Das Neves et al. 2009). The use of gB as a target antigen is a 
standard ELISA test that was found to be more sensitive than the gE ELISA and 
indirect ELISA in a ring trial (Kramps et al. 2004). The gE ELISA is used to identify 
between vaccinated and unvaccinated animals in eradication schemes (Kaashoek et 
al. 1995). The gC ELISA can be used to discriminate between subtypes (Spilki et al. 
2005). SNTs look at the immune response to the whole virus rather than specific 
proteins. This does not enable any discrimination between subtypes but provides a 
good initial screening option and can be used to confirm ELISA test results (Varela 
et al. 2010). 
 
These serological tests can be important in monitoring prevalence and identifying 
latently infected animals, which should test seropositive. This is important as latently 
infected animals pose risk to the rest of the herd, especially after transportation or 
during parturition. However, serology is not always reliable, as some young calves 
may become infected while still possessing some maternally derived antibody and do 
not produce an active humoral response, allowing them to go unnoticed in 
serological tests (Graham 2007).  
 
Control is mainly in the form of vaccination to prevent initial infection. Eradication 
schemes have been successful in several European countries using vaccination 
methods or culling of seropositive animals in regions with low seropositivity 
(Ackermann & Engels 2006). Many vaccines are available and are widely used to 
control outbreaks of IBR in the form of modified live, inactivated, marker and 
multivalent vaccines (Radostits et al. 2000). Vaccines containing live virus produce 
latent infection and may induce viral shedding of reactivated vaccine virus when 
given by the intranasal route (Graham 2007). There are also reports of abortion in 
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pregnant animals of unknown vaccine status given modified live vaccines (McFeely, 
Merritt & Stearly 1968). Inactivated vaccines consist of an adjuvant to initiate an 
immune response combined with high levels of inactivated virus or parts of the virus 
such as glycoproteins (Beer 2010). A recent study suggests inactivated forms of the 
vaccine provide similar efficacies as modified live vaccines, but may be safer to give 
during gestation (Zimmerman et al. 2007).  
 
Marker or DIVA vaccines were developed to differentiate between a wild-type 
infection and a vaccination by using a gE deletion mutant version of the virus in the 
vaccine (Beer 2010). Antibodies produced as a result of the vaccination do not 
recognise gE and therefore in a specific gE ELISA, vaccinated animals will give a 
negative result while remaining positive in other assays such as gB or whole virus 
based ELISA tests or SNTs (Kaashoek et al. 1995). These vaccines have been most 
heavily used as part of successful eradication schemes in several European countries. 
These gE deleted vaccines do offer the advantage that re-excretion is reduced if the 
virus is reactivated from latency (Mars, de Jong & Van Oirschot 2000). However, 
they have been criticised for a number of reasons; while vaccines do reduce virus 
replication and transmission, they do not prevent infection; therefore seroprevalence 
often remains high in areas where eradication with the aid of vaccination has been 
attempted (Ackermann & Engels 2006). As they are live vaccines they have been 
criticised as being contradictory to the aim of eradication (van Drunen Littel-van den 
Hurk 2006).  
 
In neonates, often the most vulnerable to infection, modified-live and killed vaccines 
show a low efficacy due to the immaturity of the immune system and interference of 
maternal antibodies. New approaches are using DNA vaccines to induce immunity as 
part of the vaccine strategy to address this problem. These new vaccines, described 
as antigen-encoding bacterial plasmids, are being tested to address this problem of 
BoHV-1 outbreaks in neonates (van Drunen Littel-van den Hurk 2006). There is also 
pressure to reduce the need for intramuscular delivery of vaccines due to damage to 
tissue resulting in rejected meat, therefore intranasal methods are favoured when 




None of the current vaccine strategies are specifically aimed at stopping systemic 
spread of the virus as so little is known about the mechanisms resulting in systemic 
spread. In vaccinations against the closely related EHV-1 virus, research into the 
immune response during infection has suggested that an effective vaccine to prevent 
systemic dissemination would require activation of a high virus neutralizing 
antibody titre combined with increased cytotoxic immune responses (Kydd, 
Wattrang & Hannant 2003; Kydd, Townsend & Hannant 2006). 
 
1.3.10 Use of model systems to investigate host-pathogen relationships of BoHV-1 
Model systems are frequently used in the study of viruses, as studies in the natural 
host are expensive and often ethically complicated. They can also be limited in terms 
of statistical significance due to the small numbers of animals that can be used. 
BoHV-1 is no exception, with many experiments being conducted in vitro using 
bovine cell cultures. However, the question always remains how well cell culture 
represents the in vivo environment, with only one cell type and no host immune 
response that is such an important part of a viral infection. There have also been 
several studies using alternative animal models to cattle such as the rabbit, which 
appears to provide a reliable infection model (Rock & Reed 1982; Brown & Field 
1990; Lupton, Barnes & Reed 1980; Valera et al. 2008). An evaluation of the rabbit 
model concluded that infection with BoHV-1 produced a wide range of clinical signs 
associated with IBR including respiratory tract infection and systemic spread, 
although BoHV-1 induced abortion in rabbits differed significantly to that found in 
cattle as no evidence of virus infection of the foetus was observed (Lupton et al. 
1980). Experimental infection in rabbits has also been shown to be able to model 
latency of the virus with experimental reactivation using corticosteroids, as can be 
achieved in cattle (Brown & Field 1990). 
 
More recently, an alternative option re-emerged and has been increasingly used as an 
infection model, using ex vivo thin tissue sections originating from the natural host, 
culturing them for a time period, to allow infection using the chosen infectious 
organism. This provides the advantage of a mixed cell population and maintenance 
of tissue structure that can be considered more representative of the host 
environment than cell culture of a single cell-type. Examples of the successful use of 
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these models include adenovirus infection in a lung slice model (Booth et al. 2004) 
and Maedi visna infection of both lung and trachea tissue with discs of tissue being 
placed in tissue culture dishes and maintained for 7 days in supplemented media 
(McNeilly et al. 2007). A similar system, described as an air-liquid interface bovine 
respiratory organ culture system has been used to culture canine tracheal tissue 
infected with Bordetella bronchoseptica (Anderton, Maskell & Preston 2004). This 
system has also been evaluated for its suitability as a model for BoHV-1 infection. 
Results demonstrated that as well as studies in pathogen adherence, these systems 
may also be suitable to measure host responses at the molecular and morphological 
level. Ciliary function and structural integrity was maintained for 72 hours and 
frequent, detailed sampling made this a reliable model that required no use of 
experimental animals with the exception of donors (Niesalla et al. 2009).  
 
1.4 Aims and Objectives 
 
As this literature review has demonstrated, extensive work has been conducted on 
BoHV-1, and the genetics, replication and latency strategies of the virus are 
reasonably well understood. This PhD project first studies the importance on BoHV-
1 as a cause of abortion in Scotland and analyzes the current diagnostic methods 
used to investigate abortion cases. Then, it focuses on the study of virus encoded 
variation between isolates which is hypothesized to influence dissemination of virus 
from the primary respiratory infection to cause systemic infection and abortion.  
Differences in clinical outcome of closely related viruses such as EHV-1 have been 
related to single point mutations in the viral genome. Genetic variation between 
BoHV-1 subtypes has been identified but there has been no research into the 
potential role of viral genetic variation in systemic spread and abortion. To test the 
hypothesis that viral factors such as genetic variation are important in the systemic 
spread of BoHV-1, differences between BoHV-1 isolates were analysed using in 
vitro and in vivo infections, whole genome sequencing and a prospective study of 





Specifically this project aimed to: 
 Establish the prevalence of BoHV-1 in aborted foetal material and identify 
whether current diagnostic methods were producing representative results of 
the importance of BoHV-1 as an abortive agent.  
 Investigate the distribution of BoHV-1 in foetal infection leading to abortion 
in natural conditions. 
 Identify any genomic differences that may contribute to the tissue tropism or 
biological behaviour of BoHV-1. 
 Carry out an experimental infection in the natural host to identify any 
differences between an isolate identified previously as causing a systemic 
infection and one resulting in IBR only, by measuring clinical host response, 
spread of the virus and viral expression throughout the infection.  
 Test the behaviour of different isolates in model infection systems and test 
the validity of lung slice culture as a BoHV-1 infection model.
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Chapter Two: Materials and 
Methods 
 
This chapter will cover the basic general materials and methods used throughout the 
work included in the results chapters and will be referred back to in the results 
chapters. More detail or any alterations specific to certain experiments will be 




2.1.1 Virus isolate sources 
BoHV-1 isolates were all sourced from submissions from across the UK to the virus 
surveillance unit (VSU) at Moredun Research Institute (table 2.1) with the exception 
of the reference strains. Isolate Colorado-1 (Cooper strain) was purchased from 
ATCC. IBR6660 was isolated at Moredun in 1978 from an Aberdeenshire case 
(Nettleton & Sharp 1980). In each case received by the VSU the virus was isolated 
from fresh tissue or swab sample, for cases received pre-2007 the tissue was 
homogenized using a mortar and pestle in 4ml virus transport medium (VTM) with 
sterile sand. For tissue received post-2007 tissue was homogenized in 4ml of VTM in 
gentleMACS M tubes (Thistle Scientific) on a dispomix machine. The homogenized 
tissue from either method was then centrifuged at 2000 x g for 10 minutes at 5°C and 
supernatant was collected for use in virus isolation. Swab samples were sonicated in 
VTM for 1 minute to release virus particles from the swab into the VTM. An aliquot 
of VTM was collected for testing and the swab discarded. All the isolates 
subsequently used in this work were identified as BoHV-1 using the virus isolation 
method. For the purposes of this work they were subsequently classified into 
respiratory, systemic and abortion groups determined by the tissue type the virus was 






2.1.2 Abortion study samples 
400 samples from bovine abortions were received from veterinary diagnostic centres 
across Scotland and Northern England between 2007 and 2009. These samples were 
used to retrospectively detect BoHV-1. No further selection of samples was carried 
out, therefore samples represented those considered to warrant further investigation 
by local vets. Foetal liver, lung, heart, brain, placenta and foetal fluid were all 
requested for each case but all tissues were not always available. Diagnostic testing 
was conducted including real-time PCR, virus isolation and histopathology as 
described in sections 2.2.2 and 2.7 below. Background information was also 
available for samples on previous clinical and diagnostic findings. 
 
Table 2.1 Virus isolate sources. 
Isolate no. Year Location Tissue Classification 
07/267 2007 Perth Lung Respiratory 
07/282 2007 Perth Organs Systemic 
07/1003 2007 Loughborough Trachea and lung Respiratory 
06/134 2006 Dumfries Spleen Systemic 
05/898 2005 Dumfries Spleen Systemic 
K739 2004 Penrith Placenta Abortion 
K514 2004 St Boswell Tissues Systemic 
08/68 2008 Inverness Spleen Systemic 
06/108 2006 Penrith Trachea and lung Respiratory 
05/1372 2005 Winchester Trachea Respiratory 
K1468 2004 Aberdeen Nasal Swabs Respiratory 
K303 2004 Dumfries Nasal swab Respiratory 
06/1889 2006 Thurso Trachea and lung Respiratory 
06/1093 2006 Penrith Nasal swabs Respiratory 
07/1530 2007 Dumfries Abortion Abortion 
06/068 2006 Penrith Trachea Respiratory 
K1527 2004 St Boswell Trachea Respiratory 
05/1570 2005 Penrith Trachea Respiratory 
07/184 2007 Edinburgh Nasal swab Respiratory 
 
 
2.2 Virus culture in cells 
 
2.2.1 Cell culture 
Virus stocks were cultured in a semi-continuous cell line of bovine turbinate (BT) 
cells from the cell line BT1802/1/4. Cells were cultured in monolayers using 
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standard methods (Peterson & Goyal 1988), in Iscoves Modified Dulbecco’s 
Medium (IMDM) (Sigma) supplemented with 10% FBS and 8mM glutamine. 
Briefly, they were raised from stocks stored in liquid nitrogen in v/v 10% DMSO and 
90% FBS, washed in IMDM, and then maintained by splitting twice weekly to 
produce a seeding rate of ~1x10
5 
cells/ml. To split cells, the cell monolayer was 
washed in PBS and the cells were trypsinized to detach them from the flask. If 
necessary, cells were counted by staining with 0.2% nigrosin to stain non-viable 
cells. Viable cells could then be counted using a modified-fuchs haemocytometer. 
After calculation of cell concentration the appropriate amount of IMDM could be 
added to achieve the desired cell concentration. Cells were incubated at 37°C.  
 
2.2.2 Virus isolation 
To isolate the virus, cell monolayers were washed twice in Hanks balanced salt 
solution (HBSS). The tissue or swab supernatant suspected to contain virus particles 
was added to cover the cell monolayer in the tubes or flask (2ml supernatant plus 2ml 
HBSS for a 150cm
2
 flask). A control flask was also set up containing HBSS only, to 
check for contamination. The flasks or tubes were incubated at 37°C for 1 hour, 199 
maintenance media (199 (Sigma) with 5% bovine serum albumin, tryptose phosphate 
broth, 20mM Hepes, 3.75mM sodium hydroxide, sodium bicarbonate, 10% yeast 
extract, supplemented for use with 2% FBS, 1mM glutamine, 1% penicillin and 
streptomycin and 0.5% amphotericin) was added and the flasks or tubes were 
returned to 37°C and checked daily for cytopathic effect (figure 2.1). From the initial 
infection in tubes it was possible to identify these cases as BoHV-1 from the 
characteristic cytopathic effect (CPE). From these cases stocks were produced in 
flasks cultured until 100% CPE was observed to get a larger yield of virus that could 
be used for further experiments. The virus was harvested by freezing the flasks at -
70°C and thawing twice. The media containing the cell debris and virus was 
decanted and centrifuged at 2000 x g for 10 minutes at 5°C. The supernatant was 







Figure 2.1. BoHV-1 cytopathic effect. 









For high-throughput sequencing and restriction enzyme analysis it was necessary to 
purify the virus to minimize the presence of cell debris. This was achieved using a 
27% w/v sucrose cushion in TNE buffer (0.1M NaCl, 10mM Tris-HCl, 1mM EDTA 
in dH2O). 5ml of the sucrose cushion was added to the bottom of each centrifuge 
tube. The virus supernatant, harvested as described above, was carefully added on 
top of the sucrose cushion. Tubes were placed in SW32ti centrifuge rotor (Beckman-
Coulter) and centrifuged for 1 hour at 100,000 x g at 4°C using an Optima L-90k 
ultracentrifuge (Beckman-Coulter) (Thiry et al. 2007; Lobanov et al. 2010). The 
supernatant was discarded and the virus pellet was resuspended in 200μl TNE buffer.  
 
2.2.3 Time course infection 
To study two virus isolates at different stages of infection virus was cultured in 
25cm
2
 flasks as described in 2.2.2. Cytopathic effect was recorded and the infected 
cells were harvested at 3 hourly intervals from 3-48 hours post infection to enable 
analysis of viral gene expression at different time points during the infection. When 
the flasks were harvested the cells were collected by using a cell scraper to remove 
cells from the flask surface and decanting the flask contents into a 50ml centrifuge 
tube which was then centrifuged at 2000 x g for 10 minutes at 4°C to form a cell 
pellet, the supernatant was discarded and the pellet of infected cells were frozen for 






2.2.4 Virus Titration   
To quantify the virus for infections the virus stocks were titrated out on 96 well 
plates containing BT cells. 10 fold dilutions of the virus stock were made up in 199 




. 50μl of 199 maintenance media was added to 4 
wells rows A-G and 100μl to row H, the cell control containing no virus dilutions. 
Virus dilutions were added in rows A-G from 10
-2
 in row A down to 10
-8
 in row G.  
100μl of BT cell suspension (2x10
5
 cells/ml) was added to each well. The plate was 
then sealed and incubated at 37°C and 5% CO2. After 2-3 days the cytopathic effect 
for each well was recorded as positive or negative. The TCID50 was then calculated 
using the Spearman-Karber calculation (Hierholzer & Killington 1996). 
 
TCID50 = (Highest dilution giving 100% CPE + 0.5) – No. test units showing CPE           
      No. of test units per dilution 
N.B No. test units showing CPE only includes the highest dilution showing 100% and any positives at 
higher dilutions. 
 
2.2.5 Serum neutralization test 
The serum neutralization test (SNT) was used to identify animal BoHV-1 serological 
status. Serum was collected from a clotted blood sample and was heat inactivated at 
56°C for 30 minutes. A doubling dilution of the heat-inactivated serum was made 
down the plate using 199 media as a diluent, with each sample in duplicate with a 
control row containing no serum to check for cytotoxicity of diluent. On the first 
plate a virus titration was set up using reference isolate, IBR6660 with a 10 fold 
dilution in 199 media series to check the TCID 50 of the virus added to the other 
wells was within the range of 30-300 TCID50 per well. Virus at this working dilution 
was added to each well except the serum and cell controls. Plates were covered and 
incubated at 37°C in 5% CO2 overnight. 100µl of BT cell suspension at a 
concentration of 2x10
5
 cells/ml in IMDM, containing 10% heat inactivated FBS was 
added to each well. Plates were then sealed and incubated at 37°C in 5% CO2 for 2-3 
days. Results were recorded by looking for cytopathic effect using a light 
microscope. Wells containing CPE showed the serum did not contain enough 
antibody to neutralize the virus. Results are expressed as the reciprocal of the highest 
serum dilution that neutralises viral CPE in 50% of the wells.  
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2.3 Virus culture in lung slices 
 
2.3.1 Lung slice preparation 
A BoHV-1 antibody negative cow involved in another experimental procedure was 
identified using a serum neutralization test as described in 2.1.5. For the purposes of 
the other experiment the animal was euthanased according to Home Office 
legislation. Following euthanasia the trachea was clamped and the lungs taken out 
whole. The right apical lobe of the caudal segment was identified and clamped off 
from the rest of the lung. A suitable bronchiole was found to fill the lung segment 
with 150ml of 2% low melting point agarose in HBSS at 37°C. It was then separated 
from the rest of the lungs and placed in HBSS on ice for 1 hour. Lung slices were 
then cut by taking circular cores of lung filled with agarose and outing these into the 
Krumdieck tissue slicer that produced ~600µm thick slices of lung which were then 
washed in HBSS buffer. 
 
2.3.2 Lung slice maintenance and infection 
Lung slices were plated out in 24 well plates, with one slice in each well. On each 
plate there were also control wells containing no lung slices. Lung slices were 
washed 3 times in Dulbecco’s Modified Eagle Medium supplemented with 
glutamine, penicillin, streptomycin, genotomycin and amphotericin (DMEM+). 
0.5ml of the supplemented DMEM+ was added to each well and the plates 
containing the lung slices were placed on a rotor set to 1 rpm overnight at 37°C in 
5% CO2.  
 
After overnight incubation lung slices were washed twice with 0.5ml DMEM+ 
before being infected with 100µl of one of 6 BoHV-1 isolates that had previously 
been titrated and diluted in DMEM+ to a concentration of 10
5
 TCID50/100µl. 
DMEM+ containing no virus was used for control wells. Lung slices were incubated 
for 2 hours on a rotor at 37°C in 5% CO2, then washed 3 times in DMEM+ and 0.5ml 
of DMEM+ was added before returning plates to the incubator. Lung slices were 
harvested at 24, 48 and 72 hours post infection. Harvesting involved taking out the 
lung slice and placing it either in 10% buffered neutral formalin for histopathology, 
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RNAlater for DNA or RNA extraction and snap-frozen in liquid nitrogen for 
immunofluorescence work by placing it on a disc of gelatine to maintain structure. 
Supernatant was also collected for DNA extraction to quantify virus produced on 
each day of infection. If not scheduled for harvest at that time point lung slices were 
washed in DMEM+ each day.  
 
2.4  Experimental infection 
 
2.4.1 Animals 
27 colostrum deprived male calves were sourced from Scottish farms and fed BoHV-
1 antibody free colostrum (CER Groupe, Belgium) to ensure they remained 
susceptible to a BoHV-1 challenge. Blood samples were taken on arrival and serum 
was tested using the SNT method described in 2.2.4 to ensure their BoHV-1 antibody 
negative status. They were also screened for the presence of Pasturella spp. by 
taking a bacterial nasopharyngeal swab. The animals were housed in individual pens 
for the first 8 weeks before being randomly assigned to one of 3 treatment groups. 
Each treatment group consisted of a total of 9 animals and was split into smaller 
groups of 3 and 6 to reduce stress later in the experiment. All animals were fed the 
same diet and were housed in identical rooms 20m
2
 maintained at an average 
temperature of ~15°C and ~68% humidity. Two weeks acclimatization after 
grouping was allowed before the experiment began.    
 
2.4.2 Virus infection 
Two BoHV-1 isolates and an uninfected cell culture control were used to infect the 
different treatment groups respectively. Isolates 05/1570 and 07/1530 (table 2.1) 
were cultured and harvested as described in section 2.2.2. Both virus isolates were 
used on the third pass through cell culture and diluted to a concentration of 1x10
7
 
TCID50/ml, based on results from a virus titration in BT cells. The control inoculum 
was collected from an uninfected flask of cells to ensure none of the observations 
were caused by cells or media. Inoculation was carried out using an intranasal spray 
with 1ml of inoculum sprayed up each nostril with a syringe attached to a fine nozzle 




Sampling was conducted two weeks pre-challenge, daily for the first 11 days post 
infection, then twice weekly until 24 days post infection (figure 2.2). Sampling 
consisted of a blood sample taken from the jugular vein using vacutainer tubes, one 
heparinised to collect buffy coat and one allowed to clot for serum collection. Nasal 
and ocular swabs were taken to measure viral load using flocked swabs in universal 
transport medium (Cat no. 328C, Sterilin). In accordance with project licence no. 
PPL 60/3976 clinical scores were recorded according to table 2.2, and was carried 
out by one of two people assigned a group of animals randomly each day.   Transfer 
of the virus between groups was controlled for by all personnel showering and 
changing clothes/boots between entering rooms containing different treatment 
groups. Control animals were always inspected first. Usually two teams were 
available to avoid the same team sampling the two infected groups.  
 
At post mortem, animals were euthanased according to Home Office legislation by 
barbiturate overdose. Post mortem examination involved collection of 16 tissues: 
turbinates, trachea, palatine tonsil, nasopharyngeal tonsil, retropharyngeal lymph 
node, lung- cranial, and caudal, brain – forebrain, cortex, hindbrain, trigeminal 
ganglia, liver, kidney, spleen, testicle and mesenteric lymph node. Four samples of 
each tissue were placed in RNA later, VTM, formal saline and zinc salts for nucleic 
acid extraction, virus isolation and immunohistochemistry respectively. 
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2.4.4 Sample handling 
Blood samples were centrifuged at 2000 x g for 10 min at 5°C. Serum was collected 
from the clotted samples and stored at -20°C. Buffy coat layers were collected from 
the heparinised samples. Buffy coats were purified by lysing red cells by vortexing 
sample with tris ammonium chloride and centrifuging at 12000 x g for 1 minute, 
supernatant was removed and the process was repeated if red cells were still present 
on the buffy coat pellet. When all red cells were removed buffy coat was washed in 
PBS and then resuspended in fresh PBS ready for nucleic acid extraction.  
 
Swab samples were sonicated in a bath sonicator for 1 minute to release viral 
particles into the universal transport media. 2ml of the media was collected for 
nucleic acid extraction or virus isolation.  
 
Tissues collected in RNA later or VTM were stored at -70°C until needed for nucleic 
acid extraction or virus isolation. Tissues in formal saline were allowed to fix for 
several days before they were processed as described in the histology methods.  
 
2.5 Molecular biology methods 
 
2.5.1 DNA isolation from virus supernatant from cell culture or lung slice culture 
supernatant 
DNA from BoHV-1 grown in cell culture was extracted from the supernatant of the 
harvested flasks after cell debris had been removed by centrifugation. The QIAamp 
DNA minikit (Qiagen) was used to isolate the DNA following the manufacturer’s 
instructions for DNA purification from blood or body fluids protocol. DNA was 
eluted in 100µl AE buffer. 
 
2.5.2 DNA isolation from fresh tissue, swabs, buffy coats 
The QIAcube (Qiagen) was used to extract DNA from tissue collected for the 
abortion study and from the tissues and swabs collected during the experimental 
challenge. Tissue samples were homogenized in VTM or PBS in gentleMACS M 
tubes (Thistle Scientific) on a dispomix machine (Medic Tools AG). Swabs were 
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sonicated in the VTM they were collected in and aliquoted for later use. Buffy coats 
were prepared from heparinised blood samples and resuspended in PBS. 100μl of 
sample was added to sample tubes and set up for the DNeasy animal blood and cells 
protocol according to the manufacturer’s instructions. DNA was eluted in 50μl of the 
supplied AE buffer. 
 
2.5.3 DNA from purified virus  
It was important to get the maximum DNA yield from the purified virus resuspended 
in TNE buffer for restriction enzyme digestion and Solexa sequencing. The Easy 
DNA kit (Invitrogen) was found to be the most suitable for this purpose. Briefly, 
solution A was added to the sample and incubated at 65°C to lyse cells, solution B 
and chloroform was added to precipitate the lipids and proteins. Centrifugation 
separated the different phases and DNA was isolated in the aqueous phase. This 
phase was removed from the solid phase and the chloroform, to be precipitated with 
ethanol. The resulting DNA pellet after centrifugation was resuspended in the TE 
buffer provided. 
 
2.5.4 RNA isolation from virus in cell culture, tissue and lung slices  
RNA was extracted from pellets of virus infected cultured cells resuspended in RLT 
buffer and tissues or lung slices stored in RNA later were homogenized in RLT 
buffer (Qiagen) in gentleMACS M tubes (Thistle Scientific) on a dispomix machine 
(Medic Tools AG). Both cell and tissue samples underwent further disruption to 
ensure RNA was released from the cells by centrifuging samples in qiashredder tubes 
(Qiagen). The RNeasy (Qiagen) animal cells spin protocol was then followed 
according to the manufacturer’s instructions. RNA was eluted in 35µl double 
distilled water. 
 
All RNA was treated with DNase to reduce DNA contamination which would affect 
interpretation of viral gene expression. Briefly, 10u of DNase recombinant I and 5x 
incubation buffer (Roche) was added to RNA samples and made up to 50μl with 
ddH2O and incubated at 35°C for 20 minutes. EDTA was added to a final 
concentration of 8mM and heated to 75°C for 10 minutes to stop the reaction. 
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2.5.5 Nucleic acid quantification 
The nanodrop spectrophotometer (Applied Biosystems) was used to quantify and 
quality check any DNA and RNA. Briefly, after blanking the machine with the 
elution buffer, 1.5μl of the sample was placed on the fluorescence reader. The 
nucleic acid yield was recorded in ng/μl and the 260:280 ratio was recorded enabling 
rejection of any failed or poor quality extractions. The quantification was also used 
to check for gross contamination in the negative control. 
 
2.5.6 Cloning to produce standards for absolute quantification real-time PCR 
Cloning methods were used to produce plasmid DNA containing the inserted DNA 
fragment of interest. A BoHV-1 glycoprotein B DNA fragment was amplified using 
platinum taq DNA polymerase PCR (Invitrogen) following manufacturer’s 
instructions. Briefly, each 50µl PCR reaction was made up of PCR buffer 
(Invitrogen), 0.8mM dNTPs (Bioline), 1.5mM MgCl2, 1U platinum taq DNA 
polymerase (Invitrogen), 200nM of each primer, gB-F and gB-R (table 2.3), 10ng 
DNA and ddH20. The reactions were subjected to the following conditions on a 
thermal cycler (MBS, Thermo), 2 minutes at 94°C, followed by 40 cycles of 94°C 
for 1 minute, 55°C for 1 minute and 72°C for 1 minute. The reaction was maintained 
at 4°C after cycling. PCR products were run using electrophoresis on a 2% agarose 
gel in Tris acetate EDTA (TAE) buffer containing ethidium bromide to bind the 
amplified DNA at 80v for 45 minutes. The DNA bands were visualised using a UV 
transilluminator to check the size of the bands and that only a single product had 
been produced (figure 2.3). 
 
The PCR product was cloned using the TOPO TA cloning kit for sequencing 
(Invitrogen). The cloning reaction was made up of 2 µl PCR product, salt solution 
made up to a volume of 5μl with ddH2O before adding 1μl of the pCR4-TOPO 
vector (figure 2.4). The reaction was incubated at room temperature for 5 minutes 
then placed on ice. Two controls were included: vector only and supplied PCR 
product. TOP10 E. coli cells were transformed by adding 2μl of the cloning reaction 
to the vial of competent cells and incubating on ice for 5 minutes. The cells were 
then heat-shocked for 30 seconds at 42°C and immediately transferred back to ice. 
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250μl of room temperature SOC medium was added and the cells were shaken 
horizontally for 1 hour at 37°C. Cells in SOC medium were spread on LB agar plates 
containing 100μg/ml ampicillin, 2 plates were set up for each transformation, with 10 
and 100 μl to ensure one of the plates produced evenly spaced colonies. Plates were 
incubated overnight at 37°C overnight. All colonies that grew were considered 
successful transformations as the inserted DNA disrupts the lethal E.coli ccdB gene 
(figure 2.4).  
 
To check successful cloning of the gB DNA fragment, a PCR reaction was set up as 
described above using the supplied T7 or T3 primers paired with either the gB-F or 
gB-R with a small amount of the colony added to the PCR reaction mix instead of 
template DNA. Finally, to confirm plasmids contained the correct DNA insert, DNA 
was purified using Wizard Plus SV Minipreps DNA purification System (Promega), 
according to manufacturer’s instructions and eluted into 100µl of double distilled 
water before sending off for sequencing with GATC.  
 
Figure 2.3. Gel image showing 100bp BoHV-1 gB fragment PCR product. Lanes 1-3 IBR6660, Lane 




























2.5.7 Restriction endonuclease analysis 
Restriction enzymes Hind III and EcoRI (Promega) were used to cleave DNA 
extracted from purified viral isolates to identify the BoHV-1 subtype. A restriction 
enzyme digestion containing 2μl restriction enzyme buffer, 2μl acetylated BSA 
(1μg/μl), 1μg sample DNA and 20 units of restriction enzyme made up to 20μl with 
ddH2O was incubated overnight at 37°C. Control reactions, one containing no 
enzyme and one containing lambda DNA were also set up for each digestion.  
  
After the incubation, gel loading buffer was added to the samples and along with 
marker X (Roche) and lambda Hind III digested DNA (Sigma) were loaded into a 
0.75% agarose gel in TAE buffer. The gel was run overnight at 12v and stained using 
SYBRGold (Invitrogen) in TAE buffer according to manufacturer’s instructions for 
40 minutes. The gel was scanned using a laser imaging system (Biorad) to visualise 




2.6 Real time PCR  
 
2.6.1 Primers and probes 
With the exception of the glycoprotein B primers and probe (Wang et al., 2007) all 
primers and probes were designed using Primer Express 2.0 (Applied Biosystems) 
and used minor groove binding taq man probes labelled with a reporter fluorescence 
marker and a non-fluorescent quencher. For each primer/probe combination working 
concentrations were optimised and reaction efficiency evaluated to ensure optimum 
conditions were used. This involved a cross tabulation design to test 3 primer 
concentrations for both the forward and reverse primers (table 2.3). 
 





Forward primer concentration (nM) 
50 300 900 
50 50/50 300/50 900/50 
300 50/300 300/300 900/300 
900 50/900 300/900 900/900 
 
Efficiency was tested by creating a 10 fold dilution of a known positive DNA/RNA 
sample and running with the optimised primer/probe set. Efficiency was calculated 
using the slope of the standard curve produced with the equation: 
 
Reaction Efficiency = (10
(-1/slope)
-1) x 100 
 
An efficiency of 100% shows each cycle is producing double the amount of PCR 
product which should occur if all the conditions are optimum. The assay conditions 
were accepted if the efficiency was greater than 90%. It is particularly important that 
primer/probe sets being used for relative quantification have a similar efficiency. 
Primer/probe sequences, working concentrations and efficiency values are 

















Sequence and labels 
gB-F 500 
104 
57499-57519 5’ TGT GGA CCT AAA CCT CAC GGT 3’ 
gB-R 500 57595-57575 5’ GTA GTC GAG CAG ACC CGT GTC 3’ 
gB probe 200 57525-57545 FAM-AGG ACC GCG AGT TCT TGC CGC-TAMRA 
Circ F 300 
93 
811-830 5’ CCG CCT CGC CGA TTC 3’ 
Circ R 300 828-808 5’ GCT GCT GTA GTC CGG CAG TAG 3’ 
Circ probe 200 832-845 FAM-CTG CAC GAC TTT CT-MGB 
RR F 200 
101 
23285-23263 5’ CCC AAA AAG ACA TCC TGC ATT AC 3’ 
RR R 200 23226-23243 5’ GCG AGT GCA CCA CTT CGA 3’ 
RR probe 100 23261-23245 FAM-ATA TCG AGC AGG AGT CC-MGB 
actin F 500 
97 
N/A 5’GAC AGG ATG CAG AAR GAG ATC AC 3’ 




200 N/A NED-TGA AGA TCA AGA TCA TCG-MGB 
 
 
2.6.2 Real-time PCR as a diagnostic tool 
Real-time PCR can be used as a diagnostic tool for detection of viruses from 
swabs/tissues or cells. A region of BoHV-1 glycoprotein B was targeted to detect the 
presence of BoHV-1 in tissue DNA samples prepared as described previously. This 
assay was previously published for detection of BoHV-1 in semen samples (Wang et 
al., 2007) and was adapted and optimised for use with cell and tissue DNA samples, 
for use in this project. The platinum quantitative PCR supermix-UDG (Invitrogen) 
mastermix containing, 0.1μl ROX reference dye, primer and probes at optimised 
concentrations (table 2.4) in a final volume of 25 μl was plated out on 96-well 
reaction plates (Applied Biosystems) before template DNA was added in a separate 
room to avoid contamination of the PCR setup area. Each plate always included a 
positive control sample, a DNA extraction negative control and no-template control. 
All diagnostic samples were run in triplicate. The plates were run on the 7500 ABI 
Prism system (Applied Biosystems) under the following conditions: 50°C for 2 
minutes UDG incubation, 95°C for 2 minutes, followed by 40 cycles of 95°C for 15 
seconds and 60°C for 45 seconds.  
 
Results were analysed using the supplied ABI Prism 7500 software (Applied 
Biosystems). A baseline and threshold level was set according to manufacturer’s 
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guidelines. Samples were considered positive when at least 2/3 wells were positive, 
or were repeated if only 1/3 wells were positive. If any contamination was suspected 
in the DNA extraction control by detection late in the reaction a cut-off point below 
this detection level was made to ensure no false positives were recorded.  
 
 2.6.3 Real time PCR as a quantification tool 
 
Absolute quantification  
Absolute quantification was used to quantify viral load using standards produced 
with known copy numbers of the BoHV-1 glycoprotein B fragment in the form of 
plasmid DNA. Samples were run on 96-well plates on the ABI Prism 7500 system 
(Applied Biosystems) as described for the diagnostic method, with the exceptions of 









 copies in triplicate. Samples containing 
known viral copy numbers were calculated as follows: 
 
 pCR4-TOPO + gB fragment = 4055 bp 
Weight in Daltons = 2676300 g/mol 
267300g plasmid DNA = 6.02x10
23 
copies 
1µg plasmid DNA = 2.25x10
11
copies 
Samples containing specific copy numbers were made by diluting plasmid DNA accordingly.  
 
The results were analysed by plotting the samples against the standard curve 
produced by the four standards using the supplied ABI Prism 7500 software. This 
provided absolute copy number values of virus genome detected in the template 
DNA. For the swabs this was taken as the final value as there should not have been 
much variation in the amount of non-viral DNA isolated so different swabs could be 
directly compared as it was a good representative for the amount of virus being shed 
in nasal or ocular discharge. For the tissues it was necessary to ensure that the values 
took into account different DNA quantities in the different samples and tissues. 
Therefore assuming the viral genome DNA contributed minimally compared to host 
genome DNA isolated, the number of cells that each sample represented was 
calculated using the DNA quantification values from the Nanodrop, based on each 
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bovine diploid cell containing 6.3pg DNA (Gregory 2010). This allowed calculation 
of viral copy number per million cells to make comparisons between the different 
samples (Islam et al. 2006). 
 
Statistical analysis to compare viral load was done using two methods depending on 
the sample type.  Tissues from BoHV-1 experimental challenge: Minitab was used to 
conduct a two- way ANOVA to compare viral load between groups infected with the 
two isolate types, treatment and time post-infection were used as factors, if p<0.05 
differences were considered significant. Swabs from BoHV-1 experimental challenge 
were not independent from one day to the next as they were taken from the same 
animal, therefore a test was needed that would take into account the relationships 
between the samples. Genstat was used to carry out a REML analysis using 
covariance structure model power-city block distance. If an interaction of p<0.05 was 
identified the predicted means were studied to identify the days post-infection were 
most likely to be significantly different between treatments. T-tests were then carried 
out on these results based on the predicted means table and standard errors of 
differences calculated by the REML analysis, differences were considered significant 
if p<0.05.  
 
Relative quantification 
Relative quantification using real time PCR enables comparison of viral load or gene 
expression relative to other tissues or samples. DNA was extracted from infected 
tissue that had tested positive for BoHV-1 using the diagnostic test previously 
described. For abortion samples the comparative ΔΔCt method (Livak & Schmittgen 
2001) was used to compare virus distribution. The platinum quantitative PCR 
supermix-UDG (Invitrogen) was used to detect a BoHV-1 glycoprotein B fragment 
and also the host reference gene β-actin, to provide a value for normalisation for the 
size of tissue sample and yield of DNA extracted. A calibrator sample was used to 
provide a relative value for viral load in all tissues in comparison with the calibrator 
sample. For this work the brain was used as the calibrator as it demonstrated a 
consistent positive but low level of viral load. The equation used to calculate the 




Relative viral load    =    2 
-ΔΔCt
 
ΔΔCt  =   (sample gB Ct -  sample β-actin Ct) – (calibrator gB Ct- calibrator β-actin Ct)   
(Livak & Schmittgen 2001) 
 
Relative quantification was also used to compare viral gene expression during 
infection. RNA was extracted from infected cells lung slices, or tissue samples from 
animals used in the experimental challenge. Samples were run on 96 well plates 
using the Superscript III Platinum One-Step Quantitative RT-PCR System 
(Invitrogen) according to the manufacturer’s instructions. Briefly, 25µl reaction 
mixes contained Superscript III mastermix with added, forward, reverse primers and 
probe at optimised concentrations (table 2.3), 0.1µl ROX reference dye and 
Superscript III RT/Platinum Taq (Invitrogen) in ddH2O. For each primer/probe set on 
every plate a reverse transcription control was run to check for DNA contamination 
by replacing the Superscript III RT/Platinum Taq mix with Platinum Taq DNA 
polymerase. Plates were run on the ABI Prism 7500 (Applied Biosystems) using the 
following cycling conditions: 50°C for 15 minutes, 95°C for 2 minutes, followed by 
40 cycles of 95°C for 15 seconds and 60°C for 45 seconds. On all plates the viral 
target primer/probes were run alongside the host reference β-actin primers/probes to 
normalise samples. Further normalisation was achieved by using the same quantity 
of RNA from each tissue sample as RNA extraction yield varied significantly 
between samples. The cells produced more consistent RNA yields and therefore the 
β-actin reference was considered adequate for the normalisation of these samples. 
The best calibrator would be an uninfected control or 0 time point. However, as no 
viral gene expression would be present in these samples it was decided to not use a 
calibrator sample for these samples and use the equation: 
 
Relative viral gene expression    =     2 
-ΔCt
    
     ΔCt   =  target Ct – reference Ct 
(Livak & Schmittgen 2001; Morse et al. 2005; Kubota et al. 2008) 
 
Statistical analysis of viral load in abortion study tissue was carried out in Minitab 
using a GLM with tissue and abortion case as factors, a post-hoc Tukey test to 
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identify which tissues contained significantly different viral loads. Analysis of viral 
transcript expression differences in tissues from the experimental challenge and 
infected lung slices were analysed in excel using a two sample t-test to compare the 
two isolate types and were considered significant if the two-tail p-value< 0.05. In the 
statistical analysis BT cell and lung slice infection transcription quantification a one 
way ANOVA and two-sample t test methods were used respectively and a p-value 




2.7.1 Handling of samples for histology 
All samples for histology were fixed in 10% formal saline for at least 24 hours. 
Samples were embedded in paraffin wax by trimming and placing into cassette cases. 
A processing machine was used to dehydrate samples and add paraffin wax to the 
sample, they were then embedded in paraffin wax blocks using standard protocols. 
Blocks were stored at room temperature until sections were cut using a microtome. 
After cutting sections were placed on slides and dried overnight at 37°C. Some 
tissues required decalcification treatment due to high quantities of cartilage or bone. 
Blocks were briefly soaked in Decalcifier II (Surgipath) to enable better sections to 
be cut. Samples for histological analysis were stained with haematoxylin and eosin 
using standard procedures. Other slides were stored at room temperature until used in 
immunohistochemical labelling.  
 
2.7.2 Immunohistohemistry 
Tissue sections of interest were studied in more detail using the Envision-HRP 
system (Dako) to stain the glycoprotein C protein of BoHV-1 with a monoclonal 
mouse antibody to enable localisation of the virus within the tissues. Formal saline 
fixed sections embedded in paraffin wax were cut and placed on superfrost slides.  
Samples were then rehydrated by placing the slides consecutively in xylene, 100% 
ethanol, 70% ethanol and water. Slides were washed with tris buffered saline (TBS) 
buffer (50mM Tris-HCl, 150mM NaCl in dH20 adjusted to pH 7.6) and placed in a 
peroxidase block (3% hydrogen peroxide in methanol) for 30 minutes at room 
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temperature to bind to any endogenous peroxidises so they do not act on the added 
substrate. Slides were washed in water and then TBS after placing slides in cover 
plates (Sequenza). 100μl of 25% normal goat serum in TBS buffer was added to each 
slide as a further block to prevent non-specific binding of the secondary antibody and 
incubated at room temperature for 30 minutes. Slides were washed twice with TBS 
buffer and then 100μl of the primary antibody, anti-gC BoHV-1 (VMRD) (Collins et 
al. 1984), diluted 1:5000 in TBS was added to all positive slides. Each section had a 
corresponding negative control to which TBS was added instead of the primary 
antibody. A positive control was also used in the form of a liver section known to be 
positive for BoHV-1 in each run. The slides were incubated overnight with the 
antibody at 4°C. After the incubation, slides were washed twice with TBS and 100μl 
of anti-mouse labelled polymer (Dako) was added to all slides and incubated for 30 
minutes at room temperature. Slides were washed twice in TBS buffer before 
staining with the chromogen DAB (Dako) for 7 minutes, which binds with the anti-
mouse polymer to result in brown staining at sites labelled with the primary 
antibody. Slides were washed with water, counterstained with haematoxylin and 
dehydrated by placing slides consecutively in 70% ethanol, 100% ethanol and 
xylene. Finally, coverslips were fixed with slide mountant and slides were studied 
using a light microscope to look for DAB labelling indicating presence of BoHV-1. 
 
2.7.3 Immunofluorescence 
Immunofluorescence was used to image localisation of BoHV-1 in lung slice 
cultures. Lung slices that had been snap-frozen in liquid nitrogen on gelatine discs 
and subsequently stored at -70°C were sectioned using a cryostat to cut 10µm 
sections that could then be placed onto slides. The sections were fixed by placing in 
acetone for ~30 seconds and allowed to dry at room temperature, before storing at -
20°C until they were stained. 
 
Sections were double labelled using a parallel approach with one of two 
combinations of antibodies (table 2.5). Briefly, slides were put in coverplates 
(Sequenza) and washed with TBS. 100µl of 10% v/v normal goat serum in TBS was 
added and slides were incubated for 30 minutes at room temperature to block non-
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specific binding of secondary antibodies. After washing twice with TBS 100µl of 
primary antibodies were added at appropriate concentrations diluted in TBS (table 
2.5) and allowed to incubate overnight at 4°C. Slides were washed twice with TBS 
before adding 100µl of secondary antibodies diluted to the appropriate 
concentrations in TBS (table 2.5) and incubated for 30 minutes at room temperature. 
Slides were washed with TBS then PBS before 300mM DAPI in PBS was added for 
5 minutes at room temperature to counterstain cell nuclei. Slides were washed in 
water, any excess water was then removed before Prolong anti-fade mountant 
(Invitrogen) was used to fix coverslips. This was allowed to cure for 24 hours before 
sealing coverslips with clear nail varnish. 
 
Control slides were run with no primary antibodies and also with single sets of 
antibodies to check for cross-reactivity in the parallel approach (e.g cytokeratin 
primary antibody with BoHV-1 secondary antibody). 
 





















Williebrand factor  
1:50 dilution 
(Dako) 





Alex fluor 647 














cytokeratin (IgG1)  
1:50 dilution  
(Dako) 





Alex fluor 647 
(far red) goat anti-




Sections were photographed using the Axiovision software (Zeiss Microscopy) at 
wavelengths of 488nm to detect the green fluorescent antibody and 647nm to detect 
any red fluorescent antibody at sites where positive virus was identified. Negative 
controls were checked to ensure labelling was virus specific. Photographs were taken 
of the negatives using the same exposure as for the positive sections. Images were 
created by merging photos from 488 and 647 wavelengths in Image J. Areas of co-
localisation of red and green secondary antibodies were used to analyse virus 
association with either epithelial or endothelial cells. To reduce the subjectivity of 
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interpreting the co-localisation intensity levels were set and co-localisation marked in 
white at sites where both fluorescent signals reached the specified levels.  
 
 2.8 Comparative genomics 
 
2.8.1 Next generation sequencing 
Whole genome sequencing of 11 BoHV-1 isolates was carried out by Genepool, 
University of Edinburgh on one of their next generation sequencing platforms. The 
DNA was sequenced on the Solexa GAII platform (Illumina) which uses a ‘flowcell’ 
system to immobilise, amplify and sequence the DNA to produce millions of 
sequence reads of ~50 bases at a high coverage to produce reliable base calling.  
 
2.8.2 Sequence read assembly 
As a full sequence of BoHV-1 had already been completed this was a re-sequencing 
project which means the original sequence was used as a scaffold to produce the final 
consensus sequences from the 50 base reads. This was achieved using the MAQ 
program which maps the raw Solexa data onto the reference sequence to produce a 
consensus sequence in a fasta or fastq format (Li, Ruan & Durbin 2009). Sequence 
data was initially converted from the Sanger text format produced by the Illumina 
Solexa technology to fastq format that could be used by MAQ for assembly. Next the 
‘easyrun’ assembly method was used in MAQ to map all reads to the scaffold and 
produce several files for analysis. Coverage and data detailing percentage of the total 
reads mapped was produced to enable comparison between sequencing runs. It was 
also possible to view the assembly using Maqview, where any area of low coverage 
could be easily spotted and further analysed (Trivedi 2008). Further details of this 
analysis will be discussed in more detail in chapter four. 
 
2.8.3 Sequence comparisons 
Comparisons between the isolate consensus sequences were made by looking for 
SNPs. The MAQ software produced a SNP file alongside the consensus sequence. 
By comparing the SNPs between each isolate and the reference it was possible to 
identify the SNP variation across all the isolates. The SNPs were studied for quality 
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score and a filtered version of SNPs was used to draw the final conclusions. All 
statistical analysis was carried out in Excel using a one way ANOVA for more than 
two groups or a two sample t-test for tests, significant differences between samples 
were identified if p< 0.05. 
 
Phylogenetic analysis was also used to look for any patterns in the variation between 
the isolates.  The genome was divided into 3 sections Ul, Us and repeat regions for 
the purposes of the phylogenetic analysis. Sequences were kept in the nucleotide 
format to allow non-coding regions to be included in the analysis. A multiple 
alignment including BoHV-5 and BoHV-1 references alongside all the Solexa 
sequenced isolates was created using ClustalW (Thompson, Gibson & Higgins 
2002). Any aligned columns containing any non-AGTC characters were removed 
using Base-by-Base (Brodie et al. 2004). Using this alignment a neighbour-joining 
comparison with 1000 bootstraps was made using ClustalX. The alignment was also 
put into the Phylip software where multiple data files (100 bootstraps) were produced 
in Seqboot and used as the input for Dnaml to make a bootstrapped maximum 
likelihood comparison of the sequences. Finally, Consense, also part of the Phylip 
package was used to produce the consensus tree (Felsenstein 1989).       
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Chapter Three: Prevalence and 
pathogenesis of BoHV-1 as an 




BoHV-1 is generally not considered an important abortifacient agent in the UK. The 
most recent survey on causes of bovine abortions in Scotland found a prevalence of 
BoHV-1 of less than 2% (SAC VS 2009). Bacterial agents are often more commonly 
associated with infectious bovine abortion outbreaks as reported in a review from 
figures in the United States (Anderson 2007). Diagnosis of the cause of abortion can 
be problematic due to tissue sample autolysis and also the availability of key samples 
such as the placenta. This means investigations often rely on serology even though 
this is not the most reliable method of diagnosis (Davison, Otter & Trees 1999). In 
the case of enveloped viruses such as BoHV-1, virus particles may no longer be 
infectious by the time tissue has been expelled  (up to 7 days post foetal death) 
meaning a negative result would be found from virus isolation in cell culture. 
Secondary causes of bacterial infection may also be over-represented, as bacteria can 
survive without viable cells for longer and are generally easier to grow in culture.  
 
The aim of this study was to evaluate the prevalence of this disease and to compare 
the effectiveness of different diagnostic techniques for these sample types. Four 
hundred UK diagnostic abortion cases were tested for the presence of BoHV-1 using 
a real-time PCR assay, alongside virus isolation and histopathology. The molecular 
approach of real-time PCR provides the advantage of relying on the detection of a 
region of the viral genome rather than replicating virus or intact tissue structure. The 
real-time PCR method used has been validated by an international ring trial for 
screening bull semen (Wang et al. 2007; Wang et al. 2008). It was adapted for use 
with tissue samples for the purposes of this work, the primers and probe were 
optimised and a standard curve was used to check the efficiency of the assay.   
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Secondly, this work aimed to investigate the hypothesized but poorly documented 
transplacental spread of BoHV-1 into the foetus. Since 1963 when BoHV-1 was first 
recorded as the causal agent of an abortion, little progress has been made in the 
understanding of how it reaches the uterus from the respiratory tract and crosses the 
placental barrier to infect the foetus (Ormsbee 1963). In this study relative 
quantification by real-time PCR and localisation of viral antigen by 
immunohistochemistry was used to study the distribution of BoHV-1 in positive 
foetal tissues. Viral load and distribution was compared in foetal tissues, including 
placenta and foetal fluid, liver, heart, lung and brain, with the hope of learning more 
about the mechanisms of transplacental spread and foetal infection. 
 
3.2 Real-time PCR as a diagnostic tool in abortion cases 
 
Real-time PCR targeting a glycoprotein B fragment of the BoHV-1 genome (Wang 
et al. 2007; Wang et al. 2008), was optimised for use with DNA extracted from virus 
isolation and fresh tissue samples by testing different primer and probe  
concentrations (see sections 2.6.1 and 2.6.2 for detailed methods). The results 
showed the best primer concentrations were 500nM for each of the primers and 
250nM for the probe. The assay was further analysed to check the efficiency by 
running a standard curve with a 10 fold series dilution of plasmid DNA containing 
the BoHV-1 gB fragment. This enabled calculation of both the efficiency and 
sensitivity of the assay. The results showed between 1 and 10 viral copies could be 
reliably detected. The efficiency curve gave a value of 104%, also showing a good 
exponential amplification of the target DNA fragment (figure 3.1). BoHV-1 DNA 
was successfully detected in tissue sample DNA and DNA extracted from cells 














3.3 Prevalence of BoHV-1 in bovine abortions in the UK 
 
Different samples from 400 abortion cases were received for testing. Most originated 
from Scottish farms with a smaller number from England (between 2007 and 2009). 
This was a prospective study, and therefore we also had access to the results from 
previous tests and diagnosis, determined without the use of molecular diagnostic 
techniques. 
 
All tissues received from each case were initially pooled and extracted DNA was 
tested in duplicate in the real-time PCR assay. The final results found 10 (2.5%) of 
the tissue pools tested positive for BoHV-1 by PCR. Further tests were conducted on 
the individual tissues that were available from these positive samples (table 3.1). 
Virus isolation used pooled and individual tissue samples to inoculate BT cells. Only 
one of the placenta samples added to cell culture resulted in any cytopathic effect 
typical of BoHV-1. Among the 10 PCR positive samples tested using all techniques, 
histopathological examination and IHC demonstrated pathology consistent with 
BoHV-1 in 8/10 liver samples, 4/9 lung samples and 3/4 placenta samples (table 3.1 
and 3.2). IHC identified a higher proportion of positive results as positive labelling 
was found in heart, lung, brain and placenta samples where histopathological lesions 
were not evident (table 3.2). Observations in both the lesions seen from H&E 
staining and IHC detection of BoHV-1 generally supported the PCR results, (tables 
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3.1 and 3.2). However, some cases such as 09/462 liver and lung and 07/558 heart 
and brain demonstrates positive PCR results but no IHC labelling. No IHC, virus 
isolation or lesions were observed in PCR negative tissue. It should be noted that due 
to autolysis, lesions in the placenta were only visible after IHC identified the location 
of BoHV-1 infection. All other lesions reported were visible on histological 
examination alone. However, cases with lesions did not always correlate with IHC 
positive cases showing some lesions were insignificant for the investigation of the 
cause of abortion.  For details of lesions see appendix 1. 
 
Independently of this study, the 400 cases were investigated in other laboratories. 
The previous findings from the 10 BoHV-1 positive cases found here are detailed in 
table 3.3. Only 2 of the 10 BoHV-1 PCR positive samples (07/128 and 09/334) had 
been diagnosed previously as potential BoHV-1 abortions. One was confirmed by 
IHC and the other suggested by a rising BoHV-1 antibody titre in maternal serology 
results and supported by clinical observations. Testing focussed on BVD and 
bacterial causes such as Leptospira hardjo and Brucella sp. Five of the cases had a 
final diagnosis of a bacterial cause, although at least 3 of these cases showed 
multifocal necrotic hepatitis, characteristic of a BoHV-1 foetal infection (table 3.3). 
However, no IHC was conducted to confirm BoHV-1 as the cause of the lesions. 
Clinical history showed one case which reported clinical signs typical of an IBR 
infection a month prior to the abortion. Two of the cases confirm no respiratory 
disease was evident prior to abortion. No clinical history was available for the other 
cases. Gross pathology revealed lesions of the placenta in two cases (07/327 and 
09/334) but no other gross lesions were reported relating to the foetus in any of these 
cases. Autolysis was reported at varying levels in 8 of the 10 cases. It was also 
reported that at least one of the cases occurred in a BoHV-1 vaccinated herd.   
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Table 3.1. Results for each test for the BoHV-1 positive cases. (PCR – real-time PCR, HP- histopathology and IHC- immunohistochemistry, VI- virus isolation, + or - test 
result testing for BoHV-1 or lesion for  histopath., ns – no sample available for this test). 
  
                        
Table 3.2. Summary of the results from  
table 3.1 showing comparisons between  
the diagnostic techniques (no. positive  




Pool 10/400 0/5  -  -
Brain 9/10 0/3 2/6 3/6
Foetal 
fluid 8/9  -  -  -
Heart 9/10 0/3 0/8 4/8
Liver 9/10 0/5 8/10 8/10
Lung 6/7 0/4 4/9 5/9
Placenta 4/4 1/3 3/4 4/4
PCR VI HP IHC PCR VI HP IHC PCR VI HP IHC PCR VI HP IHC PCR VI HP IHC PCR VI HP IHC PCR VI HP IHC
07/128  +  - ns ns  + ns  +  +  + ns  -  + ns ns  +  +  + ns ns ns  + ns ns ns ns ns  -  +
07/232  +  - ns ns  + ns  +  +  + ns  -  -  + ns  +  -  + ns  +  +  + ns ns ns ns ns ns ns
07/233  +  - ns ns  + ns  +  +  + ns  -  -  + ns  -  -  + ns  -  -  + ns ns ns ns ns ns ns
07/327  +  - ns ns  + ns  +  +  + ns  -  +  + ns  -  +  + ns  -  +  + ns ns ns  + ns  +  +
07/558  +  - ns ns  + ns  +  +  + ns  -  - ns ns  -  +  + ns ns ns ns ns ns ns ns ns ns ns
09/046  + ns ns ns  -  -  -  -  - ns  -  -  -  -  -  -  - ns  -  -  - ns ns ns  +  -  ns ns
09/050  + ns ns ns  +  -  +  +  + ns  -  +  +  -  -  +  + ns  -  +  + ns ns ns ns ns ns ns
09/334  + ns ns ns  +  -  +  +  +  -  -  +  +  - ns ns  +  - ns ns  + ns ns ns  +  +  +  +
09/461  + ns ns ns  +  -  +  +  +  - ns ns  ns ns  +  +  +  - ns ns  + ns ns ns  + ns  +  +
09/462  + ns ns ns  +  -  -  -  +  - ns ns  +  -  +  -  +  -  +  -  - ns ns ns ns ns ns ns
Foetal fluid PlacentaSample 
Ref No.
Pool Liver Heart Lung Brain
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Bacillus cultured.                                                                                                               
BVD antibody negative.                                                                                                  





Autolysis - 3/5.         
.
Salmonella, campylobacter negative.                                                                             
BVD and neospora antibody negative.                                                                              




07/233 Autolysis - 3/5
Salmonella, campylobacter negative.                                                                           
BVD and neospora antibody negative.                                                                               








Salmonella, campylobacter, brucella negative.                                                           
BVD negative.                                                                                                       
Seropositive foetal fluid for L. hardjo.
L.hardjo (based 
on foetal serology)
Abortion in an older 





~ 7 months None
Bacillus lichenformis found.                                                                                           











No bacterial pathogens isolated.                                                                                      
No significant changes seen in histopathology.                                                   
Antibody negative for L. hardjo.
No evidence of 
infectious cause.






Autolysis - 3 /5.    
No lesions.
Bacteriology - no significant organisms isolated.                                                   
Foetal fluid negative for BVD and leptospirosis.                                                           
No histopathology except autolysis.                                                                            
Serology negative for Neospora.









BVD, neospora Ab negative.                                                                                               
L. hardjo MAT negative.                                                                                                        
S. uberis isolated from placenta.                                                                                    
Rising maternal Ab titre for IBR.                                                                             
Multifocal necrosis in liver shown by histopath.
BoHV-1
High temp and drop 
of milk yield 1 month 
before sample 
submission
09/461 Unknown ~5 months
Autolysis - 5/5.     
No lesions 
Negative for BVD and L. hardjo, neospora. None  -
09/462 Unknown ~ 8 months
Autolysis - 3/5.     
No lesions 
noted.
Negative for BVD and L. hardjo, neospora.                                                         
Actinomyces pyogenes.                                                                                             
Maternal serology positive for BVD.                                                                         
Histology showed possible viral infection.
None  -
Simment
al cross - 
Twins
8.5 months




3.4 Molecular investigation of viral distribution in BoHV-1 abortion cases 
 
BoHV-1 distribution during an infection of the foetus was investigated by relative 
quantification of real-time PCR results, to compare BoHV-1 viral load between 
individual tissues from the 10 positive cases. Individual tissues available from the 
original pooled samples submitted were homogenized and DNA was extracted. 
Samples were run in triplicate using the real-time PCR diagnostic method targeting 
BoHV-1 gB alongside the host β-actin target. The β-actin target was needed as a 
reference to normalize the amount of DNA present in each sample type, which can 
vary due to cell density in the tissue and efficiency of DNA extracted from each 
sample type (see 2.6.3 for detailed methods).  The brain was used as the calibrator 
sample as it was present in all cases and showed a consistent low level of BoHV-1 
viral load. These measurements enabled calculation of relative viral load using the 
comparative ΔΔ Ct method (Livak and Schmittgen, 2001). 
 
BoHV-1 DNA was detected in all individual tissue samples from positive pools, with 
the exception of one case (09/046- table 3.1) in which BoHV-1 was detected only in 
the placenta. This set was therefore unsuitable for inclusion in the relative 
quantification analysis. It may also be relevant that this sample was found to be toxic 
in virus isolation suggesting other infectious agents were also present. 
 
The relative quantification of individual tissue viral load showed largely consistent 
differences in each of the cases between the tissues types (figure 3.2). A General 
Linear Model (GLM) with a Tukey post-hoc test identified a significantly higher 
viral load in the liver relative to the other tissues (p<0.01) with a mean value of 
86,000 fold higher viral load than the calibrator brain sample. There was large 
variation seen between the different cases indicated by the outliers (figure 3.2), but in 
all cases there was a comparatively higher viral load in the liver than the brain.  In 
particular, it should be noted that the outlier values showing high relative viral load 
for foetal fluid and heart were from the same abortion case (09/461). The outlier with 
low relative liver viral load was 09/462. No other tissues showed significantly 
different viral loads but there is some suggestion that the placenta shows a higher 
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viral load than the heart, this may have shown statistical relevance if a relative 
number of placenta samples had been available for study. 
 
Figure 3.2. Boxplot showing BoHV-1 viral load found in fetal tissues relative to viral load in fetal 
brain calculated by the ΔΔCt method from real-time PCR targeting BoHV-1 glycoprotein B. (Fetal 
fluid n =  8 ; Heart n = 9  ; Liver n = 9 ; Lung n = 7  ; Placenta n = 3; * represent outlier samples; 




3.5 Histological and immunohistochemical analysis of the foetal samples  
 
The presence of lesions in foetal organs was investigated in formalin fixed tissue 
samples embedded in paraffin from those cases that had tested positive for BoHV-1 
by PCR (tables 3.1 and 3.2). The distribution of the virus was studied by 
immunohistochemical labelling of viral antigen (glycoprotein C). In cases where 
serial sections had been used for H&E and IHC section comparisons could be made 
between lesion sites and IHC labelling.  
 
H&E stained tissue showed that while lesions were consistently identified in the 
liver, they were also less frequently observed in the placenta and the lung. Multifocal 











liver in 8 out of 10 PCR positive cases. These lesions appear to be randomly 
distributed throughout the parenchyma with no clear relation to the portal spaces or 
central veins (figure 3.3A). Inflammatory infiltrate was rarely present, but when seen 
was in the form of mononuclear cells at the periphery of the necrotic foci. IHC on the 
same 8 samples showed consistent positive detection of BoHV-1 antigen. In all cases 
the positive labelling was localised to the sites of the multifocal necrotic lesions 
identified in H&E stained sections (figure 3.3B). 
 
Histological evaluation of the placenta was compromised by the advanced autolysis 
making it difficult to distinguish between occasional necrosis of endothelial cells and 
the effects of autolysis. However, immunohistochemical labelling allowed the 
identification of viral antigen in all cases studied.  Lesions were visible in 3 of the 4 
samples (figure 3.3C) after the likely lesion sites had been identified by the IHC 
labelling. BoHV-1 IHC labelling was localised to the vessel endothelium of the 
microvilli (figure 3.3D). 
 
No lesions were detected in any of the heart samples. However, BoHV-1 was 
localised in 4 of the 8 cases by IHC labelling. The positive labelling was associated 
with the vessel walls of the heart in each of these cases (figure 3.3E). 
 
Lesions were seen in 4 out of 9 lung samples in the form of a multifocal pneumonia 
characterized by a few necrotic foci associated with the alveolar walls with no 
associated inflammatory inflammation. IHC showed BoHV-1 localisation in alveoli 
of the lung (figure 3.3F) in two of the cases where lesions were found and another 3 
cases, in which no lesions were identified. 
 
In the brain, lesions were seen in 2 out of 6 available fixed samples, one in the form 
of glial foci, indicating non-purulent encephalitis and in the other case mild 
haemorrhaging. In the brain BoHV-1 localisation by IHC was found in these two 
cases and a further case showing no lesions. Positive labelling was found in both 




Figure 3.3. Foetal samples from abortions caused by BoHV-1. A) Multifocal necrotic loci (arrows) in the liver (x10 H&E), B) Multifocal necrotic lesions in the liver 
labelled with BoHV-1 specific antibody (x10 IHC), C) Necrosis of endothelial cells (arrow) in the placenta (x20 H&E), D) Placental necrotic lesion labelled with 




Figure 3.3 cont. E) Heart vessel labelled with BoHV-1 specific antibody (x10 IHC), F) Alveolar cells labelled with BoHV-1 specific antibody (x10 IHC), G) Brain 






3.5.1 Diagnosis and prevalence of BoHV-1 in bovine abortions 
The results here provide a current idea of the prevalence of BoHV-1 as a cause of 
abortion in Scotland. This has not been previously reported with the use of molecular 
diagnostic techniques and demonstrates the increased sensitivity PCR can provide 
over other techniques. The real-time PCR showed a high level of efficiency, both in 
tests with BoHV-1 positive tissue samples and also for cells in virus isolation. It was 
therefore considered to be a suitable method to survey abortion cases to identify 
positive BoHV-1 abortion tissue with a high level of sensitivity. Diagnosis of 
abortion cases requires tests that do not rely on the presence of infectious virus or 
good histological structure, as high levels of autolysis have regularly been reported 
due to the retaining of the foetus for several days after death before it is expelled 
(Kirkbridge 1992a). This makes real-time PCR a good candidate for accurate 
diagnosis, but these tests are more expensive and are rarely used in abortion cases. 
Diagnosis can rarely improve the clinical outcome, which can make these test costs 
difficult to justify. However, it can highlight the presence of a BoHV-1 infection in a 
herd and precautionary steps can be taken to prevent spread to other pregnant 
animals, in which case it becomes a highly economical method to prevent further 
losses.  
 
The prevalence of BoHV-1 in abortion cases tested was found to be 2.5%. It shows a 
higher rate of detection than in the most recent UK diagnostic data, which produced a 
figure of less than 2% BoHV-1 prevalence in bovine abortions in Scotland between 
2004 and 2009 (SAC VS 2009). Another bovine abortion study reported no cases of 
IBR (Caldow et al. 1996). However, it is lower than reported in the 1980’s in 
England, which found 13% of bovine abortion cases BoHV-1 positive from samples 
collected from 54 dairy farms, an estimated 3600 breeding animals. This was based 
on a relatively low sample number of just 122 abortion cases, with analysis mainly 
relying on histological and serology studies (Murray 1990). The figure of 2.5% 
prevalence found here is also a lower than that found in a 10 year study in the USA, 
which found a prevalence of 5.41% from a much larger sample size of 8,962 bovine 
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abortions (Kirkbridge 1992b). In other studies in the USA, it could be considered that 
a general trend of reduced BoHV-1 prevalence in bovine abortions has been seen 
since the 1960’s (Anderson 2007). Based on the data reported here and in other 
studies the same could also be concluded from the UK data (Murray 1990; SAC VS 
2009). However, the method used for diagnosis, sample number and area sampled 
have varied between these studies, so it is difficult to make any accurate comparisons 
over time.  
 
Based on the comparisons made between the diagnosis carried out in this study and 
in other laboratories, without the use of molecular techniques, it can be suggested 
that BoHV-1 systemic spread is more prevalent than detected by current routine 
methods, and that as a result BoHV-1 is under-diagnosed as a cause of abortion. This 
difference is most likely to be due to the use of more sensitive and specific diagnostic 
tests in the form of real-time PCR and IHC used in this study as was demonstrated by 
the comparison with findings using virus isolation and histopathology. 
 
Virus isolation detected only one positive result out of the 10 cases, in which BoHV-
1 DNA was detected using real-time PCR. This is most likely to be due to the 
autolysis of a samples compromising viral infectivity. The lipid bilayer envelope is 
sensitive to desiccation and can therefore only survive for short periods of time 
outside viable host cells for example in low humidity (Elazhary & Derbyshire 1979). 
This results in reduced reliability of virus isolation due to loss of viability of the virus 
in natural cases, before the sample is sent for analysis. Histopathological 
observations supported the PCR results with the liver consistently demonstrating 
multifocal necrotic lesions typical of BoHV1 infection. Placental lesions were also 
evident, but due to autolysis were much more difficult to identify without IHC to 
localise the lesion sites associated with BoHV-1. Other tissues such as the heart and 
lung were less reliable in observations of BoHV-1 typical lesions and would 
therefore not be recommended for use in diagnosis using histopathology without 
specific labelling. IHC labelling improved the reliability of using histopathology for 
diagnosis. It confirmed presence of BoHV-1 at sites of necrotic lesions and also 
identified sites of viral infection in the heart and brain where lesions were not visible 
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with H&E staining alone. There were also some cases where lesions were found but 
they were not confirmed by IHC. This shows lesions may not always be reliable 
indicators of the cause of abortion. In the cases where the sample was found to be 
positive by real-time PCR but not IHC, Ct values were all >30, which may suggest 
this represents the limit of detection by IHC labelling. 
 
Real-time PCR clearly showed the highest level of sensitivity and reliability of 
results. However, it should be noted that only PCR positive samples were tested 
using other methods. Therefore it cannot be confirmed that none of the other 
individual samples would have been identified as BoHV-1 positive by other 
methods, when PCR found them to be negative. This study did not cover all the 
diagnostic options for BoHV-1. In particular, the immunofluorescent antibody test 
(IFAT) was not used for comparison, because it is considered to be less sensitive 
than virus isolation that was used in this experiment (Graham 2007).  A study 
comparing diagnostic techniques for bovine diarrhoea virus in aborted foetuses, 
reported that IFAT and virus isolation produced frequent false negatives, whilst real-
time RT-PCR and antigen ELISA were found to be more reliable with a good 
correlation between the two methods (Graham et al. 2009). In cases when there is 
more than one potential cause for abortion, consensus PCR methods have been used 
successfully, for example in the case of equine herpesviruses when EHV-1, EHV-2, 
EHV-3, EHV-4 and EHV-5 are all thought to cause abortion (Leon et al. 2008). 
Based on these previous findings it seems IFAT is generally considered less sensitive 
than real-time PCR and would not have altered these findings if it had been included, 
and overall it correlates well with conclusions drawn from other diagnostic studies. 
 
In this sample set only 2 of the 10 cases had been identified as a potential BoHV-1 
infection by the usual diagnostic protocols, one after IHC labelling and another by 
identifying a rising BoHV-1 antibody titre in serology testing. Several cases showed 
multifocal necrotic hepatitis typical of BoHV-1 abortion. However this was not 
followed up with further testing specific for BoHV-1 such as IHC, serology or PCR. 
This was most likely due to this being a common feature of causes of bovine abortion 
that enter the foetus via umbilical vessels, such as Listeria spp.  and Neospora 
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caninum (Anderson 2007). Half of the positive cases here were previously diagnosed 
as a bacterial cause, based on bacterial culture or serology result, but, this does not 
necessarily represent a misdiagnosis. These agents may also have been present 
alongside BoHV-1, with the possibility that secondary bacterial infection contributed 
to the abortion. Alternatively, the stress of the bacterial infection may have lead to 
reactivation of latent BoHV-1. This provides another example of the advantage of 
PCR, when the original cause of infection may have since been overwhelmed by a 
secondary infection. This makes diagnosis of the original cause, by histopathology 
for example, difficult, but real-time PCR is still able to detect the presence of 
primary causes of the infection. 
   
This study also considered the recent history of the aborting dam or of the herd. At 
least one of the cases came from a vaccinated herd, demonstrating that a BoHV-1 
cause of abortion should not be ruled out in vaccinated herds. This is most likely due 
to infection prior to vaccination that has been reactivated from its latent state during 
pregnancy. Only one case had recorded clinical signs typical of IBR that had 
occurred a month prior to abortion. This could indicate that clinical signs are rarely 
noticed in the dam to support a suspicion of BoHV-1 abortion or that most of these 
cases are due to the reactivation of the virus from latency which rarely causes any 
clinical signs of IBR. Testing serology of the dams was not possible in this study and 
although it may provide good predictions of likely causes of abortion on a herd level 
it is not possible to make a definitive diagnosis using this method. In the case of 
BoHV-1, it has been found that levels of herd seroprevelance do not correlate with 
problems of abortion (Davison et al. 1999).  There has also been some discrepancy in 
the change of serum neutralisation titre measured in the dam, from paired samples, 
that is of significance for BoHV-1 abortion. This is due to the period between BoHV-
1 infection and abortion varying from 18-90 days causing wide variation between 
cases (Murray, 1990).  
 
The results found here add to concern raised about diagnosis of abortion cases in 
other studies (Takiuchi et al. 2005; Rodger et al. 2007; Anderson 2007). They have 
clearly shown the advantage of molecular diagnostic techniques, providing a highly 
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sensitive method of detecting viral agents such as BoHV-1. It is also reliable in 
autolysed tissue, as also stated in a study using semi-nested PCR for BoHV-1 
abortion (Takiuchi et al. 2005). Considering histology, serology and history of the 
dam can also provide key information but confirmation by real-time PCR provides 
the quickest method to reach a reliable diagnosis. 
 
3.5.2 Molecular, histological and immunohistochemical analysis of aborted foetal 
tissue 
The positive BoHV-1 foetal tissue collected in this survey provided the opportunity 
to look at the spread of BoHV-1 in natural cases of bovine abortion. Quantitative 
real-time PCR and histological techniques were successfully combined to investigate 
the distribution of the virus throughout the foetal tissues. It complements previous 
work based on an experimental challenge with findings from natural cases of BoHV-
1 abortion, using molecular techniques. 
 
The primary finding was the significantly higher viral load in the liver, compared to 
other tissues shown by real-time PCR relative quantification calibrated to the viral 
load found in the brain tissue. The liver also showed consistent severe multifocal 
necrotic lesions confirmed by IHC to be caused by BoHV-1. Absolute quantification 
would be needed to confirm this, but relative quantification has been sufficient to 
identify the liver as an important component in BoHV-1 foetal infection. This was 
consistent with many published descriptions of the pathology of BoHV-1 abortion 
tissue (Kennedy & Richards 1964; Owen et al. 1964; Molello et al. 1966; Kirkbridge 
1992b; Rodger et al. 2007; Anderson 2007). However, these findings differ from one 
study based on pathology and serology, which found more lesions in the lung and 
chorioallantoic membrane of the placenta than the liver (Murray 1990). Real-time 
PCR data showed a high level of variation between the abortion cases, which is 
important to consider as it may have reduced the potential impact of these findings, 





BoHV-1 spread throughout the foetus to the lungs, heart and brain was demonstrated 
here by viral detection by PCR in all tissues tested and has also been previously 
reported (Murray 1990; Rodger et al. 2007). There was just one exception, where 
only the placenta tested positive for BoHV-1 in case 09/046. This could have 
occurred due to a placentitis causing an abortion at an early stage of transplacental 
spread. This does not support the theory that placental infection is secondary to the 
foetal infection that occurs after foetal death due to impaired foetal circulation 
(Molello et al. 1966). Other work suggests slow spread through the cotyledons of the 
placenta before a more rapid infection of the foetus (Kendrick et al. 1971). 
Therefore, it is possible that in this case there may have been another cause for 
abortion that was coincidental with BoHV-1 infection of the placenta, and occurred 
before transplacental spread of BoHV-1. The previous investigation of this case 
found no evidence of an infectious cause for abortion, which would support this 
theory. However, there was a toxic result reported for virus isolation, which could 
suggest presence of bacteria. Infection being limited to the placenta has also been 
observed on occasion in EHV-1 abortions, it has been suggested that placental 
separation has occurred due to the infection compromising the vascular supply 
(Smith et al. 2004; Kydd et al. 2006). 
 
The detection of BoHV-1 DNA was generally supported by the presence of 
histopathological lesions and antigen detection by IHC, providing further 
information about virus localisation. BoHV-1 has recently been associated with 
encephalitis in the foetal brain (Brower et al. 2008). This is supported by the results 
reported here, showing low levels of viral load, lesions and positive IHC labelling in 
the brain. This suggests BoHV-1 frequently reaches the foetal brain during an 
infection. In one of the cases (07/327) positive labelling was associated with vessels 
in the meninges. Association of BoHV-1 with vascular endothelial cells in the foetal 
brain was previously reported in an experimental infection study (Rodger et al. 
2007). This is the first time it has been reported in a natural case in the UK that is not 
associated with an intra venous viral challenge. It was suggested the virus would 
have initially infected endothelial cells of the vessels with secondary infection of 
associated neuronal and glial cells (Rodger et al. 2007). The demonstration of 
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positive labelling of a neuron and vessels in the same case supports this suggestion in 
natural cases. Secondary infection of neuronal cells would also explain the more 
prevalent labelling of vessels compared to neurons. Although more cases would be 
needed to confirm this as only 3 of 6 brain samples collected in this study were IHC 
positive. It could also be due to better replication occurring in endothelial cells 
compared to neurons. 
 
There was also positive labelling in the blood vessels of the placenta and heart. 
Unfortunately, the samples were too autolysed to be able to reliably identify the cell 
types that were associated with BoHV-1 infection. Further staining using IHC 
techniques to identify endothelial and epithelial cells was also prevented by the 
degree of the autolysis. Association of the virus with blood vessels was previously 
observed in an experimental infection, although as this was an intravenous challenge, 
association of virus within blood vessels should be interpreted cautiously (Rodger et 
al. 2007). Pathology of placental lesions were also extensively described in an early 
experimental infection that used an intramuscular challenge, which noted coagulative 
necrosis of villus and non-villus chorioallantois membrane, involving both epithelial 
cells and endothelium of the villi (Molello et al. 1966). A similar experimental 
challenge suggested BoHV-1 does not always cause lesions in the placenta, however  
virus was detected by fluorescent antibody in the tissue showing virus was still 
present even though no lesions were observed (Kendrick et al. 1971). The work 
reported here may be the first study to show the association between the BoHV-1 and 
placental vessels in natural cases of abortion.  
 
In this study, the high viral load observed in the liver by real-time PCR and 
localisation of virus in the vessels of several tissues, sometimes without association 
with vessels, provides support for previous suggestions of a haematogenous route of 
spread (Smith 1997). This can be explained by the virus reaching the foetus via 
exchange across the chorioallantoic membrane from the maternal blood supply, after 
spread via replication in the cotyledons the virus enters the foetal blood supply via 
the umbilical vein resulting in the high viral load in the liver. The virus could then 
98 
 
disseminate via the foetal circulatory system to other foetal organs, where virus was 
found at lower viral loads.  
 
Placental tissue collected for this study consisted of combined cotyledons and 
surrounding membranes, further localisation could be useful by testing different parts 
of the placenta separately. In one experimental challenge study, where intact 
placentas were available for analysis, the highest number of lesions was found in the 
chorioallatoic membrane. The placentome also contained several lesions, but no 
lesions were found in the amnion (Murray 1990). The innermost membrane was not 
visibly affected by the virus, whereas the membranes that were highly involved in 
exchange with nutrients and oxygen from blood of the dam were affected, further 
supporting the haematogenous route of transplacental spread.  
Similar results have been seen in studies of the transplacental spread of the closely 
related equine herpesvirus-1 (EHV-1), presence of EHV-1 was demonstrated in the 
trophoblast and chorionic villi using RT-PCR in-situ hybridization to detect viral 
RNA, thought to demonstrate direct cell to cell spread from endometrial cells to the 
trophoblasts (Mukaiya et al. 2000). This has been supported by in situ hybridization 
detecting localised presence of EHV-1 DNA in the endothelial cells of the 
endometrial arterioles. Necrosis in the microcotyledon that could allow spread of the 
virus to the trophoblast epithelium was also demonstrated (Smith & Borchers 2001). 
Due to the close relation of these viruses it could be suggested that BoHV-1 may 
behave in a similar way, although a more detailed study of different parts of the 
placenta would be needed to investigate this. 
 
In EHV-1 abortion, cell associated viraemia has also been clearly demonstrated, 
which explains the spread to the uterus in this case (Allen & Breathnach 2006). Due 
to the close relation between BoHV-1 and EHV-1 it seems likely that BoHV-1 acts 
by similar mechanisms, further study of the placenta would be needed to investigate 
if this also occurs in BoHV-1. However, to date no cell-associated viraemia has been 
clearly demonstrated for BoHV-1, so it remains difficult to explain the presence of 
the virus at the site of transplacental exchange between mother and foetus. There is 
some evidence BoHV-1 interacts with peripheral blood components in vitro. This 
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suggested BoHV-1 is able to replicate in monocytes and is adsorbed to leukocytes, so 
in vivo this could be how the virus reaches the placenta (Nyaga & McKercher 1979). 
An in vivo study of the pathogenesis of BoHV-1 during pregnancy would be needed 
to provide more information in this area.    
 
In summary this study shows BoHV-1 does currently play a role in bovine abortion 
in the UK with an estimated prevalence of 2.5%, although a much larger sample size 
would be preferable to confirm this. It has highlighted the importance of viral 
molecular diagnostic techniques, in that they can produce conclusive results 
identifying a potential causative agent even in autolysed tissue. It has also provided 
support using natural cases of BoHV-1 abortion and molecular quantification 
techniques for previous findings, relating to transplacental and foetal spread of 
BoHV-1 in experimental challenges. Relative quantification and IHC labelling 
allowed us to identify the liver as the main target organ for BoHV-1 in the foetus. 
However, more work is still needed to understand more about the initial stages of 
BoHV-1 infection that allow the spread of the virus from the initial site of infection 















Chapter Four: Comparative 




This section aims to search for virally encoded genetic variation between different 
isolates with known clinical outcomes in the field, to attempt to identify a genetic 
basis, either a specific point mutation or mutations in particular genes associated with 
virulence characteristics. Previous work in closely related equine herpesvirus-1 
found a single nucleotide polymorphism in the viral DNA polymerase (UL30) was 
apparently related to neurovirulence of the virus (Goodman et al. 2007; Nugent et al. 
2006). Mutation of glycoprotein E has been found to be important in the 
neurovirulence of BoHV-5, also closely related to BoHV-1 (Al-Mubarak et al. 
2007). Thymidine kinase has been suggested as a gene that may be involved in 
BoHV-1 abortion after an experimental challenge with a thymidine kinase-negative 
deletion mutant virus showed a decrease in abortion occurrence (Miller et al. 1991; 
Miller et al. 1991). However, an intravenous route of challenge was used, so that a 
systemic infection of BoHV-1 was initiated from the start, which therefore does not 
provide any conclusive evidence of its role in systemic spread. Other 
alphaherpesviruses have also shown decreased virulence or reactivation in TK 
mutant viruses (e.g HSV) (Chen et al. 2006).  
 
The aim of this section of work was to identify any genetic variation between 
‘respiratory’ and ‘systemic’ BoHV-1 isolates that may contribute to the systemic 
spread of the virus. The first approach used here was RFLP which has been 
extensively used to subtype BoHV-1 isolates since the 1980’s (Christensen et al. 
1996; Mayfield et al. 1983; D'Arce et al. 2002). Analysis of the viral DNA with 
restriction enzymes showed similarity was extensive between the isolates, therefore 
an approach achieving a higher resolution was needed to identify any subtle 
differences between them. Next-generation sequencing technology has recently 
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become available and affordable, and was identified as the best approach to enable 
the analysis of the whole genome rather than trying to predict which genes may be 
interesting to look at by comparison with other herpesviruses. Therefore 11 isolates 
(table 4.1) were sequenced using the Illumina Solexa technology (for detailed 
methods see 2.8.1). From this data consensus sequences were derived using the 
published reference sequence (NC_001847) (RefSeq 2010), as a scaffold. SNP 
identification and phylogenetic analysis was conducted to seek differences between 
the isolate sequences that may contribute to systemic spread. 
 
4.2 RFLP subtyping of isolates 
 
DNA extracted from 19 purified BoHV-1 isolates was digested with Hind III 
(restriction site 5’ A/AGCTT 3’) and Eco RI (restriction site 5’ G/AATTC 3’) to 
differentiate between subtypes 1.1, 1.2a and 1.2b (section 2.5.3 and 2.5.7 for detailed 
methods). Restriction digestion with Hind III is known to produce 13 fragments of 
the BoHV-1 genome, ranging from 21.5 – 0.4 kb (figure 4.1). Eco RI digests the 
BoHV-1 genome into 7 fragments in BoHV-1.1 ranging from 58.2kb–3.1kb, and 6 
fragments in subtype 1.2b, with fragments G and D combining to produce a fragment 
of 18.4 kb (figure 4.1). 
 
RE digests were analysed by agarose gel electrophoresis and visualised with SYBR 
Gold staining and UV transillumination. Eighteen isolates were identified as subtype 
1.1 and one, 06/1093, was identified as subtype 1.2b (figure 4.2 and table 4.1). The 
subtypes were differentiated by the 3 bands produced by DNA fragments J, K and L 
ranging from 7-10 kb (figure 4.1). Subtype 1.2b has an extra band (fragment I) at 
approximately 10.4 kb and two slightly smaller bands of 7.7 and 7.2 kb, but has the 
same 9kb fragment as subtype 1.1 (figure 4.2). Eco RI (figure 4.3) was also used to 
attempt to identify any genetic variation between the isolates. Differences found in 
06/1093 by the Hind III digest were confirmed with some evidence of a different Eco 
RI pattern (figure 4.3). There is a band at approximately 18kb representing fragment 
C of the 1.2b subtype pattern in the 06/1093 lane 18 that is not visible in the other 
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lanes which contain 2 smaller fragments, G and D in the subtype 1.1 pattern (figure 
4.3b).  
 
This method was successful in subtyping the isolates and showing that type 1.1 
appears to be the predominant subtype in this random selection of BoHV-1 
diagnostic cases from around Scotland and Northern England from 2004-2007. 
However, as can be seen the DNA was not always fully digested producing faint 
bands that were difficult to type. It also clearly shows the relative crudity of relying 
on RE analysis, targeting only 6 base sequences to type BoHV-1 isolates. A method 
providing better coverage of the whole genome was required to search for genetic 
differences between these isolates was needed.   
 
Figure 4.1 Restriction enzyme maps of BoHV-1.1 and BoHV-1.2b for Hind III and EcoRI.  Letters 
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17       18      19        20 
Gel lanes 
1) Marker X  14) 05/1372 
2) λDNA   15) K1468 
3) Enzyme control  16) K303 
4) 07/267   17) 06/1889               
5) 07/1003                        18) 06/1093 
6) 06/005                         19) 07/1530              
7) 07/282                         20) 06/68   
8) 06/134                         21) K1527   
9) 05/898                         22) 05/1570   
10) K739                         23) 07/184   
11) K514                          24) λ DNA Hind III digest 
12) 08/68                           25) Marker X 
13) 06/108    
1.0kb -  
2.0kb -  
3.0kb -  
5.0kb -  
7.4kb -  
21.1kb 
-  
   1     2    3     4     5    6     7    8     9   10   11  12  13  14   15  16   17  18  19   20  21   22  23   24  25  
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Table 4.1. Summary of RE analysis results determining subtype and isolates chosen for further 
investigation using whole genome sequencing methods.  
Isolate Respiratory or 
systemic source 
Subtype Used for Solexa 
Sequencing 
07/267 Respiratory 1.1 No 
07/1003 Respiratory 1.1 No 
07/282 Systemic 1.1 Yes 
06/134 Systemic 1.1 Yes 
05/898 Systemic 1.1 Yes 
K739 Abortion 1.1 Yes 
K514 Systemic 1.1 Yes 
08/68 Systemic 1.1 Yes 
06/108 Respiratory 1.1 No 
05/1372 Respiratory 1.1 No 
K1468 Respiratory 1.1 No 
K303 Respiratory 1.1 No 
06/1889 Respiratory 1.1 No 
06/1093 Respiratory 1.2b Yes 
07/1530 Abortion 1.1 Yes 
06/068 Respiratory 1.1 No 
K1527 Respiratory 1.1 Yes 
05/1570 Respiratory 1.1 Yes 
07/184 Respiratory 1.1 Yes 
 
4.3 Solexa sequencing 
 
Eleven virus isolates from the twenty that were subtyped were chosen for sequencing 
(table 4.1) including isolates that had caused both respiratory and systemic clinical 
presentations of BoHV-1 and the one 1.2b subtype, ensuring there was a range of 
isolates from a range of locations in Scotland and Northern England and isolates 
collected at different time points from 2004-2008. Viral DNA was extracted from 
isolates that had undergone just one passage in cell culture minimising the amount of 
mutations acquired in comparison with the original isolates. Isolates were sequenced 
using Illumina Solexa technology at The Gene Pool, University of Edinburgh (see 
section 2.8 for detailed methods). DNA from 10 purified BoHV-1 isolates was 
sequenced in 50bp reads and with one as a trial run in 36bp reads. These were then 
successfully mapped to the reference BoHV-1.1 genome (NC_001847) to produce 
whole genome sequences for all isolates, allowing specific genome regions to be 
studied in more detail for identification of single nucleotide polymorphisms (SNP) 
compared to the reference sequence and phylogenetic analysis of the whole genome. 
106 
 
The number of 50bp reads produced from the solexa sequencing ranged from 2.4 
million to 7.8 million reads per isolate, with a range of 1.94-58.87% of these reads 
being mapped onto the reference genome of BoHV-1 with average depth of reads 
ranging from 19-1140 (table 4.2). The reads that were not mapped to the reference 
sequence were considered most likely host DNA (table 4.2). K514 was considered to 
have a too low percentage of mapped reads along with a low overall total no. of reads 
mapped and poor depth of coverage. and therefore was excluded from further 
analysis. To improve the mapping percentage and reduce the number of gaps the 
alignments were studied. At 15 gap sites where all the sequenced isolates differed 
from the reference sequence, the reference scaffold sequence was edited to match the 
sequenced isolates (Davison 2009). When the raw sequence data was re-mapped, the 
gaps were filled with the exception of gaps of less than 50 bp found in UL47 and 
both internal and terminal BICP4 ORFs.   
 
Not unexpectedly, repeat regions showed the lowest percentage of mapped reads and 
were investigated further to ensure the mapped data was as reliable as those in the 
unique regions of the genome (figure 4.4). Phred scores measure the accuracy and 
probability of errors in the base calling of high-throughput sequencing methods 
(Ewing et al. 1998; Ewing & Green 1998). A similar method is used by the MAQ 
software for mapping of short read sequences and was used in the SNP analysis (Li 
et al. 2009). The phred-like consensus quality scores provided by the mapping and 
SNP identifying software, MAQ reflected the lower percentage of mapped reads in 
the repeat regions (figure 4.4). The repeat regions were re-mapped separately from 
the rest of the genome. Much higher phred-like quality scores were produced 
throughout the repeat regions using this method. However, when these separately 
mapped repeat regions were aligned to the original consensus repeat regions mapped 
with the rest of the genome, the sequences were identical. Therefore, despite the 
suggestions of poor reliability in the repeat regions demonstrated in figure 4.4, it has 







Table 4.2 Summary of sequenced isolates including the total number of reads produced by Solexa 
sequencing ,the percentage of those reads which successfully mapped to the reference sequence and 
the average depth of the reads mapped across the length of each consensus sequence (Refseq: 
NC_001847) using MAQ software. 
 
Virus isolate Isolate type
Total no. of 
reads 




07/184 Respiratory 1.1 2417100 18.8 420.73
K1527 Respiratory 1.1 4398945 15.15 171.31
05/1570 Respiratory 1.1 7646052 19.89 530.13
07/1530 Abortion 1.1 7329816 35.9 538.30
K739 Abortion 1.1 4791757 36.52 601.17
05/898 Systemic 1.1 6803731 10.85 225.349
08/68 Systemic 1.1 4936619 24.93 413.87
07/282 Systemic 1.1 7886584 58.87 1139.34
06/134 Systemic 1.1 4747578 17.45 611.80
06/1093 Respiratory 1.2b 5612960 2.97 58.47
K514 Systemic 1.1 2813960 1.94 19.18  
 
Figure 4.4 Average phred-like consensus quality score at potential SNP sites across the BoHV-1 
isolate genomes compared to the reference genome produced by MAQ mapping software. 
 
4.4 SNP identification 
 
SNPs were identified and filtered using MAQ software and studied for conservation 
with other isolates in the same group. All SNPs were identified as compared to the 

















































between 206 and 254 SNPs compared to the reference sequence (table 4.3). 139 of 
these SNP sites were identical in all isolates showing SNPs were conserved between 
all isolates with the exception of the reference sequence. 06/1093 (the 1.2b subtype) 
showed more variation compared to all the other isolates with 871 SNP sites 
identified when compared to the reference isolate and can therefore be considered to 
show variation when compared to the other isolates sequenced.  
 
SNPs in all isolates were fairly evenly spread across the genome with the exception 
of less frequent SNPs being identified in UL42 (DNA polymerase processivity 
protein), UL41 (host-shut-off protein), UL28 (DNA packaging terminase) and BICP4 
(transcriptional regulator) in the terminal region (figure 4.5). The SNPs were also 
fairly evenly distributed between genes classified by different functions, although as 
the figure indicates there was a large amount of variation between the different genes 
in each category (figure 4.6). BoHV-1 genes have been classified as non-essential 
and essential genes in tissue culture (Robinson et al. 2008). A comparison of these 
two gene groups showed non-essential genes had significantly more frequent SNPs 
averaging every 350 bp, compared to essential genes, averaging a SNP every 611 bp 
(t-test; p-value =0.03) (figure 4.7). 
 
After a filtering process step, removal of SNPs present in all isolates compared to the 
reference sequence and removal of any SNPs related to ambiguous bases that were 
unlikely to be true SNPs, 204 SNPs were found with at least one isolate 
demonstrating a different base to the others (table 4.4). As is shown in table 4.4 most 
sites have SNPs in just one of the 10 isolates; i.e. none of the SNPs observed showed 
any conservation between isolates of respiratory/systemic derived strains. Table 4.5 
demonstrates this for SNPs found between two isolates, one respiratory and one 
systemic isolate, as a representative example. 40 SNPs were identified between these 
two isolates, 33 of which were in coding regions. 13 were non-synonymous 
(resulting in amino acid changes) in several genes including glycoprotein C, 
thymidine kinase, tegument and capsid proteins, but there was no specific association 
with either isolate type. When these SNPs were cross-referenced with other isolates 
109 
 
of the same type there was no conservation of SNP sites in other respiratory or 
systemic isolates.  
 
Table 4.3. Total no. of SNPs between sequenced isolates and reference sequence. 
 










06_1093 871  
 
Recent research identified 10 microRNA sites on the bovine herpesvirus-1 genomes 
that are considered important in gene expression (Glazov et al. 2009). As they have 
previously been associated with control of virulence in other herpesviruses the 
isolates were checked for variations in these regions. No variation was found at any 
of the 10 microRNA sites compared to each other or the published sequence 
(NC_001847) at the genomic level from the data collected in this study. 
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Figure4.5. Graph showing average distribution of SNPs across genome length (blue = Ul, red = repeat regions, green = Us). SNP frequency was calculated from the 
average number of SNPs in each coding regions compared to the no. of bases in that coding region to provide a SNP frequency shown in the y–axis of the graph. x-






































































































































































































































Genome position/ coding region
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Table 4.4. Filtered SNPs between all isolates and the reference sequences, excluding ambiguous bases 
that may represent base calling uncertainty. 
Gene P o sit io n R ef K1527 05/ 1570 07/ 184 K739 07/ 1530 06/ 134 08/ 68 07/ 282 05/ 898
circ 1010 C C C C C C T C C C
1021 T W W W W W A W W T
1108 G G G G A G G G G G
UL53 3431 G C G C G C G G C C
3685 G G G C G G G G G G
3686 C C C G C C C C C C
3881 C T T T T T T T C T
3882 T C C C C C C C T C
UL52 5318 G G G G G G A G G G
5781 C C C C C C C C C G
5782 G G G G G G G G G C
6267 C T C C C C C C C C
UL51 7268 C C C C C T C C C C
7595 C C C C C C C C C T
UL50 8291 T T T T T T T T T G
8299 C T C C C C C C C C
8752 C C C C C C C C A C
UL47 12005 G G G G G C G G G G
12006 T T T T T G T T T T
12313 T T T C T T T C T T
13020 T T T K C T T T K T
13157 C C G C G C C C C C
13169 C G C G C G C C C C
13252 T C C C T C C C C C
13364 C G G G C G G G G G
UL46 14346 C C C C C T C C C C
14697 G G A G G G G G G G
15804 G A G G G G G G G G
15921 T C C T T T T T T T
15957 T T T T C T T T C T
15990 T T T T T T T T C T
16287 G A G G G G G G G G
16521 C T C C C C C C C C
UL44 16705 C C C C C C C C T C
18152 A A A A A G A A A A
UL43 18523 G G G A G G G G G G
18916 C C C C C C T C C C
19377 C C C C C C T C C C
19392 C C C C C C T C C C
UL42 20107 C C C C T C C C C C
UL41 21983 C T C C C C C C C C
UL40 22786 A G G G G G G G A A
22791 T T A T T T T A T T
22786 A A T A A A A A G A
22874 C T C T T T T T T T
UL39 23628 C C C C C C C C C T
23761 C C C T C C C T C C
24075 C T C C C C C C C C
25332 G G G G G A G G G G
UL38 27562 G G G G G A G G G G
UL37 28312 G G A G G G G G G G
28892 G G C G C C C C C G
29583 C C C C C C T C C C
UL36 33035 C C C C C C C T C C
33291 C C C C C C C C C T
34033 G A G G G G G G G G
34714 G G G G G G G G A G
35319 G G G G A G G G G G
35348 C C G C G C G C G G





Table 4.4 (cont.) 
Gene P o sit io n R ef K1527 05/ 1570 07/ 184 06/ 134 08/ 68 K739 07/ 1530 07/ 282 05/ 898
UL36 35349 G G C C C G C G C C
co nt 35875 C C C C C C C T C C
36133 G G A A A A A A A A
38532 A R A R G R R R R A
38559 A A G R G R G A G A
38580 C C C T C T C C C C
38734 C C C C C T C C C C
38791 G G G A G G G G G G
38976 C C T Y T Y Y Y T T
38988 C Y C Y T Y C C T C
39047 G G G G G G A G G G
39171 C C C C C T C C C C
39219 G G G G T G G G G G
39222 A A A A C A A A A A
UL32 43135 T T T T T T C T T T
43137 G G G G G G C G G G
43142 C C C C G C C C C C
UL31 44350 C C C T C T C C C C
UL30 46147 C T C C C C C C C C
46232 A A A A A A A A A G
46249 G C C G C C G C G G
46250 C C C C G G C C C C
46261 C C T C C G G C C C
46249 G G G G G G G G C G
46945 C C C C C G G G S C
46962 C C C C C C C C T C
47908 C C C C T C C C C C
48048 C C C C C C C C C T
48698 G G G G G G A G G G
48719 T C T T T T T T T T
UL29 50109 G G G G G A G G G G
50716 C C T C C C C C C C
51450 G G G G G G G A G G
52747 G G G G G G G G C G
52748 G G G G G G G G C A
UL28 55067 C T C C C C C C C C
UL27 56878 C T C C C C C C C C
58180 C C C C T C C C C C
UL26 58736 G G G G G G G A G G
58859 A A A A A A A A G A
59533 C C C C T C C C C C
59878 C C T C C C C C C C
60238 G G A G G G G G G G
UL25 61978 C C C C C C C C A C
62026 G G G G G G G A G G
UL24 62989 G G G G G G G A G G
63166 C C C C T C C C C C
63412 C C C C A C C C C C
UL21 67370 G T G G G C T G G G
67970 G G T T T T G T T T
68017 A A R A R A G G G A
68052 G G C G G G G G G G
68152 G G G C G G G G G G
68246 G G G C G G G G G G
68296 C G C G C C G G G C
68297 G C G C G G C C C G
68307 C C G C G G G S S G
68701 A A A A A A A A G A
UL20 69176 G G G G A G G G G G
UL19 70373 C C C C G C C G G C
70374 G G G G C G G G C C
71158 C G C G C C G G G G
71159 G G G G G G G C C G
71313 C C C C C C C C T C
72000 C G C G G G G C G G
UL18 74356 G G G G A G G G G G
UL15 75944 G G G A G G G G G G
76317 T T T T T T T T C T





Table 4.4 (cont.) 
Gene P o sit io n R ef K1527 05/ 1570 07/ 184 06/ 134 08/ 68 K739 07/ 1530 07/ 282 05/ 898
UL17 76432 G G G G G A G G G G
77084 G G G G A G G G G G
77152 T T C T T T T T T T
77827 G G A G G G G G G G
78207 G G G G G G G A G G
UL16 79094 C C C C C G C G C G
79096 G G G A G G G G G G
79097 A A A A A G A G A G
79367 G C C C C G C C C C
79367 G G G G G C G G G G
UL15 80389 C C C C C C C T C C
UL14 80941 C C C C C C C T C C
81268 G G G G G A G G G G
UL13 81409 C C G C C C C C C C
81414 G C C G G G G G G G
82444 G G G G G G G G A G
UL12 82830 C G C C C C C C C G
82832 C C C C C C C C S C
82984 A A M A C A A C A A
83579 C C C C C C C C G C
83581 G C G G G G G G C G
UL10 84575 C G G G G G G G G C
84577 G T T T T T T T T G
84615 G G G G G G G G G A
84643 G C C G C C C C C C
84910 G C G C G C G G C C
84906 G G A G G G G G G G
84910 G G C G G G G G G G
85331 C C C G C C C C G C
UL9 86994 A A A A A A G A A A
87322 C C G C G G G G G C
87384 C C C C G C C C C C
87390 G G G S G G G G G G
87686 C C C C C C T C C C
88424 G G G A G G G G G G
UL8 89264 C C C C T C C C C C
90116 C C C T C C C C C C
90747 A A A A G A A A A G
UL6 92247 C C G C G G G G C C
92250 G G C G C C C G G G
92508 C C G G G G G G G G
92511 C C G C G G G G G G
92518 G G G G G G G C G G
92747 T G T T T T T T T T
92748 T T C T T T T T T T
92879 C T C C C C C C C C
93099 G A G G G G G G G G
93124 C G G G G G G C G G
93125 G C C C C C C G C C
93367 G G G G G G G G G C
93693 T T T T T G T T T T
UL5 94653 C T C C C C C C C C
94907 C C C C C C C T C C
94913 C C C C C C C T C C
95092 A A A A A A A A A G
95094 T T T T T T T T T C
95362 C C C C T C C C C C
95645 T T T C C T C C C T
95645 T C C T T C T T T C
UL4 96564 C C C C T C C C C T
96566 T T T T C T T T T C
UL2 98384 G G G A G G G G G G
UL0.5 99959 C C C C T C C C C C
100653 G G G G G G A G G G
B IC P 0 101075 C T C C C C C C C C
101282 C C C C C T C C C C
B IC P 4 105282 C C C C C G C C C C
105304 C C C C T C T T T C
US1.67 114594 C C C C C C T C C C
US3 116803 C C C C T C C T T C
116914 G G G A G A G G G G
116998 C C C C C C T C C C
US7 121021 G G G G G G A G G G
B IC P 4 132851 C C C C G G C G G C
132855 C C C C G G C G G C
132865 G G G G G G G C G G
132871 C C C C G C C G G C









Synonymous? Gene function for non-synonymous SNP sites
NC 52 A G
UL52 7268 C T Syn
UL46 14346 C T Syn
14697 A G Syn
15921 C T Syn
UL44 18152 A G S-P
gC type 1 memebrane protein, contains a single peptide, binds cell 
surface heparan sulphate, binds complement C3b to block 
neuralization
UL39 25332 G A Syn
UL37 28891 S C Syn
35875 C T Syn
38559 G A Y-C
Tegument protein complexed with large tegument protein, function - 
virion morphogenesis
38988 T C P-L
UL30 46261 T C Syn
UL29 50716 T C T-M
Single stranded DNA-binding protein for DNA replication and 
possibly gene regulation (contains zinc ring finger)
51450 G A V-I
NC 58649 G K
UL26.5 58736 G A P-L
Capsid scaffold protein for capsid morphogenesis (clipped near C 
terminus)
NC 59878 T C
60238 A G
UL25 62026 G A R-C
DNA packaging tegument protein for DNA encapsidation, located on 
capsid near vertices, possibly stabilizes capsid and retains the 
genome
UL24 62989 G A Syn
UL23 64094 C A T-P Thymidine kinase for nucleotide metabolism
NC 67006 T Y
UL21 68017 R G ?
68307 G S Syn
NC 69671 C A
UL17 77152 C T L-P
DNA packaging tegument protein for capsid transport (capsid 
associated)
77827 A G R-H
78207 G A A-T
NC 80389 C T
80690 C T
UL14 80941 C T A-V Tegument protein involved in virion morphogenesis
UL12 82984 M C Syn
UL6 92518 G C R-G
Capsid portal protein involved in DNA encapsidation, dodecamer 
located at one capsid vertex in place of a penton.
92750 C T Syn
UL5 94907 C T Syn
94913 C T Syn
US1.67 114428 G K Syn
114939 G K Syn
US3 116169 R A Syn










4.5 Phylogenetic analysis 
 
Phylogenetic analysis was carried out to confirm that data extracted from the SNP 
identification, suggesting minimal genetic variation between the isolates, and did not 
indicate a viral genetic basis in terms of coding sequences for systemic spread. Both 
the neighbour-joining (a distance based algorithm) and maximum-likelihood 
methods were employed to analyse the evolutionary differences between isolates 
(section 2.8.2 for detailed methods). The isolate genomes were split into 3 regions 
for the alignment process: unique long, unique short and repeat regions. Alignments 
were kept at the nucleotide level to enable analysis of non-coding regions as well as 
coding regions. Both sets of analysis were bootstrapped to find a consensus tree with 
100 bootstraps used for maximum likelihood and 1000 bootstraps for neighbour 
joining, with the exception of the unique long region which could only be calculated 
with 500 bootstraps due to the length of the sequence alignment.  
 
The phylogenetic trees showed no grouping of the systemic or respiratory isolates in 
any of the genome regions to suggest there was any conservation of genetic variation 
among those isolates (figure 4.8, 4.9, 4.10). This observation is supported by low 
bootstraps consistently found at the nodes separating the sequenced isolates. 
However, in the repeat region analysis, the two abortion isolates K739 and 07/1530 
are grouped together with a bootstrap value of 62 using the maximum likelihood 
method, separating them from their nearest other isolates of 07/282 and 06/134, both 
from the systemic group (figure 4.8A). In the neighbour joining tree they do not form 
a separate branch and are associated more closely with the 07/282 and 06/134 
isolates (figure 4.8B). The BoHV-1 reference sequence was found to be separated 
from the isolates in the unique short region analysis. However, in the repeat regions 
it is associated with 06/1093, indicating similarities in the repeat regions of these 
sequences (figure 4.8). In the unique short region it is associated with the K1527 







Figure 4.8.A) Maximum-likelihood phylogenetic tree of clustalW aligned repeat (rep) regions created 







































Figure 4.9. A) Maximum-likelihood phylogenetic tree of clustalW aligned unique long regions 






































Figure 4.10. A) Maximum-likelihood phylogenetic tree of clustalW aligned unique short regions 







































The RFLP analysis was used to define the conventional subtyping of the isolates. 
Isolates could easily be subtyped using the Hind III digestion, with the differences in 
fragment sizes determined by the subtype used to classify the isolates (Mayfield et 
al. 1983). It showed the majority of isolates collected were subtype 1.1, most 
commonly associated with the respiratory form of the infection (IBR). Only one was 
identified a subtype 1.2b, most commonly associated with the genital form of 
infection (IPV). However, as none of these isolates originated from genital cases of 
disease this indicates that these subtypes are not strict definitions of the clinical signs 
that should be expected (Christensen et al. 1996). This finding was in contrast to a 
similar study in New Zealand when 24 of 28 isolates were identified as subtype 
BoHV-1.2b (Wang, Horner & O'Keefe 2006), indicating a geographical difference in 
predominant subtypes. The main finding from the Hind III digest and the use of other 
restriction enzymes such as EcoRI quickly revealed the difficulty of discrimination 
between isolates using RE analysis due to the poor resolution of this technique and 
reinforced the homogeneity between the isolates. This was supported by a previous 
RFLP study which sequenced a 438bp fragment of the Us region and found 99% 
identity with the published reference strain in Genbank (Wang et al. 2006). 
Therefore it was clear that a more detailed, global analysis was going to be necessary 
to identify any differences, which were likely to be individual SNPs rather than large 
recombination or rearrangement events that could potentially be picked up using 
RFLP analysis. 
 
High-throughput sequencing on the Illumina Solexa sequencing platform provided an 
opportunity to collect a large amount of data on 11 BoHV-1 isolates, which were 
used to analyse and compare the isolates using a range of bioinformatic techniques. 
Just one reference sequence was available for BoHV-1 from a sequencing project in 
the early 90’s (Schwyzer & Ackermann 1996). Therefore, this project provided a 
dramatic increase in the available sequencing data for BoHV-1, with 11 fully 




One of the main challenges with sequencing viral DNA is separating the viral DNA 
from host DNA. An important step in the isolation of viral DNA was the purification 
of virus from the BT cell DNA. This was successfully carried out by 
ultracentrifugation of the viral supernatant through a sucrose cushion to filter out the 
larger cell debris. The DNA extracted from the virus pellet was successfully 
subjected to Solexa platform sequencing. A good percentage of viral reads that 
mapped with significant depth across the reference genome, with the exception of 
isolate K514 that was subsequently removed from further analysis. This may have 
been due to poor quality DNA being produced from the sample. 06/1093 also had a 
relatively low mapping percentage but the overall number of reads sequenced was 
similar to the other isolates so it was included in the later analysis. This was 
considered to be due to 06/1093 being a different subtype to the reference sequence, 
so it would be expected to have a lower mapping percentage. De novo assembly may 
have provided a more reliable sequence, but was not attempted in this study.  
 
The repeat regions also caused some concern with lower depth of reads after 
mapping and lower phred-like consensus scores; most of the small gaps were found 
in these regions. This was an anticipated problem that commonly arises in the 
sequencing of herpesviruses. Although the gaps could not be filled, the data was 
considered reliable after remapping the repeat regions alone, which dramatically 
increased the phred-like consensus scores, while the consensus sequences themselves 
did not change. This leads to the conclusion that the repeat region mapping already 
completed was reliable. This is a known problem for mapping Solexa data, solutions 
include specific mapping programs to address the problem such as GNUMAP 
(Clement et al. 2010). The use of this software should be considered in future 
projects but a brief trial with the BoHV-1 data did not significantly improve the 
amount of repeat sequence data that was mapped. This is likely to be due to the data 
already being reliable, as the further analysis of the data using the MAQ software 
showed. 
 
Minor editing of the reference scaffold sequence was needed to maximise the 
mapped reads (Davison 2009). This was a successful method of getting the most 
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from the data and was most likely to be necessary due to the reference sequence 
being put together from isolates of several strains (K22, Cooper, P8-2, 34, and Jura) 
(Genbank 2006). After minor editing of the reference scaffold sequence and 
subsequent mapping using MAQ, consensus sequences were formed for all isolates. 
A gap was observed in all sequenced isolates in the repeat regions in the BICP4 
ORF. This could be due to several reasons. As the repeat regions are repeats of the 
same bases, regions could be mapping more frequently to either the internal or 
terminal repeat regions rather than equally between the two. This seems unlikely, as 
gaps were seen in both repeat regions. Alternatively, the observed gaps could 
represent true deletions compared to the reference isolate. There was also a 
conserved gap region of 15-30bp (depending on isolate) that were called as N’s. This 
could possibly represent a gap seen in all isolates within the UL47 ORF, which codes 
for a tegument protein VP13/14. However, a protein blast on this region with the gap 
region removed shifts the ORF and produces stop codons mid-gene. Therefore, it 
appears likely that it may just represent a region of poor sequence where base calling 
was difficult due to the characteristics of this region. A previous study has shown 
BoHV-1.1 subtypes have fewer GC-repeats than subtype 1.2b downstream from US7 
coding region for gI (Nadin-Davis 1996). The findings here may suggest the same 
could occur in other regions of the genome, if the gaps represent true deletions.  
 
The search for SNPs between the isolate groups provided several important results; 
SNPs appeared to be random and not conserved between isolate types, the reference 
sequence may not have been a reliable scaffold, and 06/1093 had a very different 
SNP pattern to all the other isolates. Phylogenetic analysis generally provided 
support for these findings, although the bootstrap values were consistently low 
between the sequenced isolates in the maximum likelihood analysis indicating a poor 
level of consensus in the tree structure in terms of the 10 sequenced isolates. The 
close-relationship between the isolates that is indicated makes it difficult to 
distinguish the phylogeny reliably. 
 
A general overview of the SNP distribution was gained by measuring SNP frequency 
in each coding region. This showed a widespread distribution across the genome with 
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just a few sites showing fewer SNPs than others including UL42 (DNA polymerase 
processivity protein), UL41 (host-shut-off protein), UL28 (DNA packaging 
terminase) and BICP4 (transcriptional regulator), showing these genes are very well 
conserved between isolates. There was no significant variation in the frequency of 
SNPs associated with particular gene functions. However, a significantly more 
frequent number of SNPs were identified in genes identified as non-essential 
compared to essential genes in tissue culture. This could represent the ability of these 
genes to evolve at a faster rate due to their non-essential contribution to virus 
replication; therefore random mutations are less likely to be lost as they are less 
likely to affect the successful replication of the progeny virus. However, it should 
also be considered that any passage through cell culture is likely to result in 
mutations of these genes, this seems unlikely to be the cause in this case as only one 
passage in cell culture had occurred. During an in vivo infection these genes are 
likely to be most important for the spread of the virus, not necessary in cell culture. 
A comparison between isolates that had undergone different numbers of cell culture 
would be needed to find out whether this is the cause for the higher number of SNPs 
observed here, or whether this may represent the greater variation in genes involved 
in the in vivo spread of the virus, showing more variation than those involved in 
replication. 
 
SNPs were found to be more prevalent between all the isolates sequenced and the 
reference rather than between the sequenced isolates. This was most likely due to the 
reference sequence consisting of sequence data from several different sequencing 
projects using 5 different strains to produce the reference sequence as discussed 
previously (Genbank 2006). This could explain the poor mapping at the repeat 
regions as most of these regions were sequenced using the K22 1.2b strain and may 
also explain the grouping of 06/1093 and the reference BoHV-1 sequence in the 
repeat region phylogenetic analysis, as in this region they would have shown a higher 
level of similarity. The high bootstrap values seen on the nodes separating the 
reference isolates and 06/1093 from the other isolates, demonstrated this was specific 
to the newly sequenced isolates, and also supported the significantly higher number 
of SNPs found between the reference and 06/1093. This could possibly represent 
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temporal or geographical factors, as all sequenced isolates originated from Scotland 
or northern England over a five year period, compared to the reference sequence 
which was mostly represented by a strain, originally isolated in California in 1956 
(Madin et al. 1956). A geographical cause seems most likely as this was found to be 
a powerful influence in a genetic analysis of varicella-zoster isolates from around the 
world (Muir, Nichols & Breuer 2002). There was one exception in the unique short 
region maximum likelihood analysis which found K1527 associated with the BoHV-
1 reference sequence, but the bootstrap value of 41 is not high enough to consider 
this a significant finding. It is more likely to be a reflection of the short length of this 
region, and therefore fewer SNPs identified.  
 
Very few SNPs were conserved between any of the isolates, just 40 between 05/1570 
and 07/1530; this number was typical of all isolates shown fully in table 4.3. It was 
not considered necessary to make a complete set of pair-wise comparisons as no 
conservation between isolate types was observed. Only 13 SNPs of the 05/1570-
07/1530 pairing were non-synonymous. When cross-referenced with other isolates 
they were not found to be conserved between the groups associated with respiratory 
or systemic clinical signs. This extensive homology was not unexpected and reflects 
finding from a previous study of phylogenetic comparison of the glycoprotein C 
region which found genomic similarity of 98.7-99.8% between BoHV-1 isolates 
(Esteves et al. 2008). A study of varicella-zoster genotypes from different 
geographical regions identified just 16 non-synonymous SNPs, 10 x fewer than the 
genetic diversity observed in herpes simplex virus (Muir et al. 2002). A whole 
genome study of 18 varicella-zoster isolates identified homology at a nucleotide level 
of >99.8 between isolates and the Dumas reference strain and demonstrated the 
occurrence of recombination (Peters et al. 2006). In Varicella-Zoster most variation 
was observed within the reiteration patterns of the repeat regions, origins of 
replication and intergenic homopolymer patterns (repetition of a single base) of the 
repeat regions (Tyler et al. 2007). HSV type 2 isolates collected from Tanzania, 
Norway and Sweden demonstrated 99.6% similarity based on sequencing of 3.5% of 
the genome (all in the unique short region), which also identified evidence of 
recombination (Norberg et al. 2007).  
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Overall, this sequencing data provides information on the natural variation found 
between BoHV-1 isolates collected between 2002 and 2007 in Scotland and northern 
England. It confirms the slow evolution that is expected from the stable genomes of 
alphaherpesviruses, although recent SNP analysis on the varicella-zoster virus 
genome shows a constantly evolving genome in which discovery of new genotypes 
that may contribute to new phenotypes may occur (Faga et al. 2001). As there also 
seemed to be no grouping of SNPs according to gene function or genome position it 
seems likely that the variation observed between isolates is representative of natural 
variation rather than positive selection for virulence. As there is only one reference 
genome, these further sequences are useful information that will be of interest in 
terms of the evolution of BoHV-1. Phylogenetic analysis also supported these 
findings with no grouping of isolates assigned to the same group except the two 
abortion isolates in the repeat regions. The bootstrap value of 62 separating them 
from two systemic isolates on this branch is not entirely convincing as it was not 
conclusively supported by the neighbour joining method. Sequencing of this region 
of further isolates with higher bootstraps would be needed to confirm any 
significance of this, as it was not reflected in the SNP analysis so there is not enough 
evidence to conclude anything from this finding here. However, it does provide some 
evidence that these two isolates may show more similarity with each other compared 
to the other isolates and this should therefore be considered in further investigations. 
In particular it raises the question of whether the abortion isolates should be grouped 
with the isolates from systemic infection in neonates as this result indicates they may 
be different.  
 
Recently discovered microRNAs encoded by BoHV-1 were potential areas of 
interest as they have been associated with virulence in other herpesviruses (Boss et 
al. 2009). However, there is no evidence of variation at these sites at the genomic 
level, although this does not necessarily mean they are all being expressed and able 
to bind with mRNA to influence translation. Further experiments would be required 




Recombination is thought to play a significant role in alphaherpesvirus evolution. An 
in vitro co-infection of two BoHV-1 strains showed this recombination involves 
negative genetic interference, which means one incidence of exchange is likely to 
result in another recombination event in the close vicinity of the first event 
(Muylkens et al. 2009). More single isolate whole genomes are needed to establish 
whether recombination of BoHV-1 has ever occurred in the natural environment, but 
there was no evidence of recombination in the isolates examined here. Specialist 
software was not used to look for potential recombination sites. It may also have 
been hidden by using a reference sequence to map short reads to the predetermined 
scaffold. 454 sequencing or de novo assembly may be more appropriate to identify 
any potential sites of recombination. 
 
In conclusion, unlike the neurovirulence of EHV-1, the systemic spread of BoHV-1 
does not appear to be related to a SNP or other variation such as insertions or 
deletions in the viral genome, as demonstrated by viral genome sequencing. There 
could also be transcriptional factors causing the gene expression to vary between 
isolates. Transcriptomic analysis may be a useful technique to investigate this further 
as was used in the study of pseudorabiesvirus and porcine epithelial cells during 
infection (Flori et al. 2008). The next chapters will use another approach to consider 
this and investigate the pathogenesis of different sequenced isolates in both the 
natural host and model systems, considering both the dissemination of the virus and 
viral gene expression throughout an infection.
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Chapter Five:   
Experimental infection to 
compare pathogenesis of 




The previous chapter compared BoHV-1 genomes obtained from animals showing 
different clinical presentations in the field. No genetic differences were found to 
differentiate between these different clinical outcomes. However, to rule out any 
virally encoded control of the systemic spread of BoHV-1 it was necessary to 
observe how these isolates behaved in a natural experimental challenge in the 
definitive host, and establish whether there were in vivo effects. No other studies 
have directly compared two BoHV-1 isolates in this way, using a natural route of 
infection. Most other studies which have aimed to provide information on the 
systemic route of spread have used an intravenous route of infection, which 
obviously influences dissemination of the virus. Studying viral pathogenesis in the 
natural host also adds the important factor of the host immune response to the 
experiment.  
 
Two of the fully sequenced isolates were chosen, one recovered from a calf with 
respiratory disease (05/1570) and the other representing a systemic infection that was 
isolated from aborted material (07/1530). They will be referred to as 05/1570 and 
07/1530 throughout this chapter. These were used to infect two groups of nine 
calves, by an intranasal route of infection with a dose of 10
7
 TCID50, a third group of 
calves remained uninfected. Daily clinical scores were recorded and blood, nasal and 
ocular swab samples taken for the first 11 days, then twice weekly, thereafter. Three 
calves from each infection group were euthanased 4, 10 and 24 days post infection. 
A post-mortem examination allowed collection of tissues for molecular and 
histopathological analysis. All calves used were BoHV-1 antibody negative to ensure 
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they had no previous exposure to the virus or adaptive immune response. See 2.4 for 
detailed methods. 
 
5.2 Clinical observations 
 
Clinical signs typical of IBR were observed in infected groups and not in the control 
group from day 1 post infection (pi). The clinical signs calculated from the mean of 
each group, increased on day 4 pi which represented the peak for the 05/1570 
infected group. This increase in clinical signs lasted until 8-10 days pi with a peak in 
the 07/1530 infected group on day 8 pi (figure 5.1A). The primary observations were 
a fever with an average body temperature of 40°C recorded in both groups, compared 
to 38.5°C in the uninfected control group. However, this peak quickly subsided over 
the following few days (figure 5.1B). Very little coughing was observed but, when 
observed it was seen most frequently to be associated with the respiratory isolate, 
05/1570 (figure 5.1C). Nasal discharge was observed in both infected groups from 
day 4 pi, peaking on day 5 for the 07/1530 infected group and day 6 in the 05/1570 
infected groups. The score for nasal discharge remained higher than the control 
group until day 11 pi in both groups (figure 5.1D). Signs of rhinitis, including 
reddening and lesions associated with the nasal passage peaked later in both groups 
between days 7-10 pi, and lasted longer for 07/1530 infected animals, although this 
was not statistically significant (figure 5.1E). Conjunctivitis and ocular discharge 
were observed in both groups, but were visibly more severe and lasted longer in the 
systemic isolate infected group. These differences between infected groups did not 
reach statistical significance (figure 5.1F). No significant clinical signs were 
observed in any of the animals in the uninfected control group. No observations of 
depression, loss of appetite, dehydration and body condition were recorded in any of 
the groups and therefore are not shown, but data was included in the average clinical 
score results. One animal suffered from an increased respiratory rate that was found 





Figure 5.1. Clinical scores throughout the experimental infection with BoHV-1 isolates. A) Average 
clinical score from all clinical scores measured (table 2.4). B) Average body temperature. C) Average 
score for coughing. D) Average score for nasal discharge. E) Average rhinitis score. F) Average 
conjunctivitis/ocular discharge score. 
                       Control uninfected group;  
                       Respiratory 05/1570 isolate infected group;  
                      Systemic 07/1530 isolate infected group.  
Days 0-3 n=9, days 4-9 n=6, days 10-24 n=3.  
Fisher’s exact test showed significant differences between infected groups and uninfected control 













5.3 Viral shedding 
 
Ocular and nasal swabs were collected daily for 11 days, then twice weekly until day 
24 pi. Real-time PCR with absolute quantification of BoHV-1 gB was used to 
determine BoHV-1 viral load in the swabs (see 2.6.3 for detailed methods). As 
anticipated, using an intranasal infection, virus was detected in nasal swabs from day 
1 in both groups and virus load peaked on day 4 (figure 5.2A). In the ocular swabs 
viral DNA was not detected  until day 2 pi and virus load peaked slightly later than in 
the nasal swabs, on days 5 and 6 (figure 5.2B). Virus load on nasal swabs was 
consistently detected at similar levels in both groups early in infection, but from day 
8 pi a decrease was detected in the 05/1570 infected group, whilst the viral load in 
the systemic isolate infected animals remained high. This was found to be 
statistically significant on days 8 and 11 (p<0.05). The viral loads detected in the 
ocular swabs demonstrated more differences between the two groups. Early in the 
infection (from day 2 until day 5 pi) the systemic isolate infected group showed 
higher viral loads, which was found to be significantly different on day 3 (p<0.01). 
On day 7 and 8 the 05/1570 infected group showed a higher viral load, but this 
rapidly decreased from this time point onwards, whilst the 07/1530 infected group 
continued to show high viral loads from the eyes until day 10 pi and was still 
detectable on day 17. No virus was detected in any of the swabs collected from the 















Figure 5.2. Viral loads collected from nasal (A) and ocular (B) swabs after experimental infection 
with BoHV-1 isolates. Black – swabs from respiratory 05/1570 isolate infected animals, Grey – swabs 
from systemic 07/1530 isolate infected animals. D1-3 n=9, D4-9 n=6, D10-D24 n=3. A REML 
covariance mode with subsequent t tests was used to compare viral load between infected groups and 











5.4 Viral distribution and lesion characterization throughout infection 
 
5.4.1 Comparison of viral load in tissues measured by RT-PCR 
The viral load of BoHV-1 in tissues including the respiratory tract, brain, lymph 
nodes, viscera and buffy coat was detected and measured using absolute 
quantification by real-time PCR (see 2.4 and 2.6.3 for detailed methods). The aim 
was to look for evidence of viraemia and identify the extent of viral spread over the 
time period of infection. Whole heparinised blood was collected daily for the first 11 
days pi and then twice weekly until day 24 pi. Buffy coat was recovered each day 
and stored at -20°C prior to testing. Calves were euthanased and tissue samples 
collected at 3 time points; day 4 pi representing the expected peak of clinical signs, 
day 10 pi representing expected recovery from clinical signs and day 24 pi when the 
virus would be expected to have entered the latency phase.  
 
No BoHV-1 DNA was detected at any of the time points in the buffy coat samples. 
Serum from clotted blood samples was also tested at the peak of infection, on day 4 
to check for cell-free viraemia, but no BoHV-1 DNA was detected.  
 
BoHV-1 DNA was detected in tissues at each of the three time points sampled. 
Neither of the BoHV-1 isolates were detected outside of the respiratory tract or the 
CNS. No BoHV-1 DNA was detected in the control group, with the exception of one 
trachea sample, which is likely to have been due to contamination at some point in 
the testing process, as it was not seen in any other control samples and was 
histopathology and IHC negative. Due to the high variation between individual 
animals there were not many statistically significant differences in viral load between 
the isolate types, however several trends can be observed (figure 5.3). 
 
On day 4 virus DNA was detected in the nasal mucosa, trachea, tonsils, trigeminal 
ganglia and the retropharyngeal lymph node in both isolate infected groups. There 
was a significantly higher viral load in the nasal mucosa of the 07/1530 infected 
group on day 4, whilst the 05/1570 infected group showed some evidence of a higher 
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viral load in the trachea. In other tissues viral loads detected were similar in both 
groups (figure 5.3). 
 
On day 10 post infection virus DNA was detected in animals infected with isolate 
05/1570 in the same tissue where it was present on day 4 and was also detected in the 
hindbrain. However, those animals infected with isolate 07/1530 no longer had 
detectable levels of virus in the nasal mucosa or trachea. There was also significantly 
higher viral load observed in the trigeminal ganglia of the 05/1570 isolate infected 
group (figure 5.3).  
 
In both infected groups on day 24 virus was detected in the palatine tonsil and 
trigeminal ganglia. Similar levels of viral loads were found in both infected groups in 
both of these tissues. There was also evidence of viral DNA in the retropharyngeal 
lymph node of the 07/1530 isolate group (figure 5.3). 





















Figure 5.3. BoHV-1 viral load found in tissues collected at day 4, 10 and 24 of the experimental 
infection. Viral load was calculated to give a copy number per million cells (see 2.6.3). Black – 





5.4.2 Gross and histopathological examination and immunohistochemical 
localisation of virus 
Gross pathological examination of tissues during post mortem demonstrated lesions 
in the nasal mucosa (figure 5.4). Mild rhinitis characterized by reddening of the nasal 
mucosa, was observed in all infected animals on day 4, and occasionally associated 
with mucopurulent exudate (figure 5.4B). By day 10 local and superficial ulceration 
of the mucosa with an overlay of fibrinous exudation was present in all 3 of isolate 
05/1570 infected calves and one of the 07/1530 infected calves (figure 5.4C) There 
was evidence of mild mucopurulent tracheobronchitis of all 3 07/1530 infected 
calves on day 24 pi (figure 5.5), but not in the 05/1570 infected calves.  
 
Tissues collected on day 4, 10 and 24 pi were also examined histopathologically 
using H&E staining to identify lesions and immunohistochemistry (IHC) to 
demonstrate the localisation of BoHV-1 antigen in the tissues in which at least one 
sample had tested positive for PCR (see 2.7 for detailed methods). Comparisons of 
the results of PCR, histological examination and immunohistochemical labelling are 
summarised in table 5.1. 
 
H&E staining allowed identification of lesions that were consistent with BoHV-1 
infection. There were also some lesions identified in control group animals, mainly 
in the trachea where a non-purulent inflammatory infiltrate was observed in 7 of the 
9 control group animals. Lesions were also seen in the nasal mucosa, palatine tonsil 
and retropharyngeal lymph nodes of 1-3 control animals, although these were 
considered to be caused by other agents than BoHV-1 as they tested negative by PCR 
and IHC specific for BoHV-1. These lesions were considered as background and 
taken into account when looking at lesions in the infected groups. IHC was used to 
label BoHV-1 antigen in sections, from the same paraffin blocks used for H&E 








Figure 5.4. Saggital section of the nasal cavity. A) Control uninfected calf. B) Mild rhinitis on day 4 
pi. C) Focal ulcerative fibrinous rhinitis on day 10 pi. 
 
 




On day 4 pi the nasal mucosa showed evidence of an inflammatory infiltrate, 
consisting of macrophages, lymphocytes and plasma cells in all 3 07/1530 infected 
animals. The nasal mucosa showed BoHV-1 antigen in a necrotic area of the 
epithelium in one systemic isolate case on day 4 pi (figure 5.7D), compared to no 
evidence of necrosis or IHC labelling in the respiratory isolate infected samples 
(figure 5.7C). The trachea also demonstrated differences between the infected groups 
on day 4 pi. The 05/1570 infected group showed a non-purulent inflammation of the 
137 
 
epithelium in all 3 trachea samples that was not considered to be more severe than 
observed in the 07/1530 infected group and control group. The nasopharyngeal and 
palatine tonsil demonstrated evident lesions on day 4 in all infected animals, however 
the characteristics of these lesions differed between the groups. Tonsils from the 
05/1570 infected group showed multifocal necrosis in the lymphoid tissue (figure 
5.6A), whereas in the 07/1530 infected calves a multifocal to coalescent neutrophilic 
infiltrate was seen in the lymphoid tissue and epithelium (figure 5.6B), with only one 
sample showing necrotic foci. Both the palatine and nasopharyngeal tonsils were 
IHC positive in all calves of both infected groups at 4 days pi. Multifocal labelling 
was observed, associated with both epithelial and follicle regions of the tissue, with 
no obvious differences in the localisation of the antigen between the two infected 
groups (figure 5.7A and 5.7B). The retropharyngeal lymph node was reactive and 
showed some focal infiltration in the 07/1530 infected group and control group. 
However, no viral antigen was detected by IHC. The trigeminal ganglia showed mild 
focal inflammation on day 4 pi in 2 out of 3 of the 05/1570 infected animals (figure 
5.6E), which was not seen in any samples from the 07/1530 infected group. In the 
trigeminal ganglia only two samples were IHC positive, both from the 05/1570 
infected group on day 4 pi. Labelling was localised to single neurons (figure 5.7 E). 
The brain showed no sign of lesions on day 4 in either group.  
 
On day 10 pi, inflammatory infiltrate was observed in the nasal mucosa in both 
infected groups, although it was considered to be more diffuse in the 05/1570 
infected group. In the trachea there was a mixed, thick and diffuse infiltrate in the 
samples infected with isolate 05/1570.  More inflammatory infiltrate was observed in 
the trachea of isolate 07/1530 infected animals, compared to day 4, although it 
remained non-purulent, with the exception of one case (figure 5.6C and 5.6D). No 
significant lesions were observed in the tonsils at 10 days pi. However, viral antigen 
was detected in both groups in the palatine tonsil and in one 05/1570 infected animal 
in the nasopharyngeal tonsil. In the trigeminal ganglia, a more severe response 
formed by multifocal non-purulent aggregates of inflammatory cells was observed in 
the 07/1530 infected group samples. Lesions were also observed in the brain samples 
at 10 days pi, with evidence of a non-purulent encephalitis characterized by glial foci 
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and perivascular cuffs. This was observed in both infected groups, but was 
considered to be more severe in the systemic isolate infected samples (figure 5.6F). 
 
On day 24 pi, inflammatory infiltrate in the nasal mucosa was present in both 
infected groups with no significant differences noted between the groups (table 5.1). 
Mild focal non-purulent aggregates of inflammatory cells were observed in 
trigeminal ganglia from 07/1530 infected animals, as seen in day 10 samples. Only 
one trigeminal ganglion sample from the respiratory isolate infected group 
demonstrated a non-purulent inflammatory infiltrate at this time point.  On day 24 pi 
in the brain, non-purulent encephalitis, as described above, was observed in 1 of 3 
respiratory isolate infected samples and in 2 of 3 systemic isolate infected samples. 
Tonsils showed lesions in 1 of 3 05/1570 infected samples from the nasopharyngeal 
tonsil and 1 of 3 07/1530 infected samples from the palatine tonsil. This palatine 
tonsil sample was also positive for viral antigen by IHC. The retropharyngeal lymph 
node remained reactive, but was not considered to be significantly different to the 
response seen in control samples. 
 
Other tissues demonstrated very few or no lesions throughout the infection period. 
Regarding the lungs, where seen, lesions were more frequent in the systemic isolate 
infected group with one or two animals affected at each time point. However, the 
lesion, a non-purulent pneumonia, was very mild and was also observed in a control 
animal at day 10. Lesions in the mesenteric lymph node, liver, kidney, spleen and 









Table 5.1. Summary of presence of lesion, viral antigen and viral DNA in all groups. C1-C9 are uninfected control calves, R1- R9 are respiratory isolate 05/1570 
infected calves, S1-S9 are systemic isolate 07/1530 infected calves. A positive result is indicated with a (+) and a negative result with (-). NS indicates sample was not 
suitable or not tested. 
  
Day Animal
H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR H&E IHC PCR
C1  -  -  -  +  -  -  -  -  - NS  -  -  -  -  -  - NS  -  - NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
C2  +  -  -  +  -  -  -  -  -  -  -  -  -  -  -  - NS  -  - NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
C3  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - NS  -  - NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R1  -  -  -  +  -  +  +  +  +  +  +  +  -  -  +  - NS  -  - NS  -  -  -  +  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R2  -  -  +  +  -  +  +  +  +  +  +  +  -  -  +  - NS  -  - NS  -  +  +  +  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R3  -  -  -  +  -  -  +  +  +  +  +  +  -  -  +  - NS  -  - NS  -  +  +  +  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S1  +  +  + NS  -  +  +  +  +  +  +  +  +  -  -  - NS  -  + NS  -  -  -  +  - NS  -  -  -  -  - NS  -  + NS  -  - NS  -  - NS  -  - NS  -
S2  +  -  +  +  -  -  +  +  +  +  +  +  +  -  +  + NS  -  - NS  -  -  -  +  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S3  +  -  +  +  -  -  +  +  +  +  +  +  -  -  -  - NS  -  - NS  -  -  -  +  - NS  -  -  -  -  + NS  -  + NS  -  - NS  -  - NS  -  - NS  -
C4  -  -  -  -  -  +  -  -  -  +  -  -  -  -  -  - NS  -  - NS  -  -  -  -  + NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
C5  -  -  -  +  -  -  -  -  - NS  -  -  +  -  -  - NS  -  + NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
C6  +  -  -  +  -  -  -  -  -  +  -  -  +  -  -  - NS  -  - NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R4  +  -  +  +  -  +  +  +  +  +  +  +  -  -  -  - NS  -  - NS  -  +  -  +  - NS  -  -  -  +  + NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R5  +  -  -  +  -  -  -  -  -  +  +  +  -  -  +  - NS  -  - NS  - NS  -  +  - NS  -  +  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R6  +  -  -  +  -  -  -  -  -  +  -  +  -  -  +  - NS  -  + NS  -  +  -  +  - NS  -  +  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S4  +  -  -  +  -  +  -  -  -  +  +  +  -  -  -  - NS  -  + NS  -  +  -  -  - NS  -  +  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S5  +  -  -  +  -  -  -  -  +  -  +  +  -  -  -  - NS  -  - NS  -  +  -  -  - NS  -  +  -  +  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S6  +  -  -  +  -  -  -  -  +  -  +  +  -  -  -  - NS  -  - NS  -  +  -  +  + NS  -  +  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
C7  -  -  -  +  -  -  -  -  -  -  -  -  +  -  -  - NS  -  - NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
C8  +  -  -  +  -  -  -  -  -  -  -  -  -  -  -  - NS  -  - NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
C9  +  -  -  +  -  -  -  -  -  -  -  -  +  -  -  - NS  -  - NS  -  -  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R7  +  -  -  +  -  -  -  -  -  -  -  +  +  -  -  - NS  -  - NS  -  +  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R8  +  -  -  +  -  -  +  -  -  -  -  -  -  -  -  - NS  -  - NS  -  -  -  +  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
R9  +  -  - NS  -  -  -  -  -  -  -  -  -  -  -  - NS  -  - NS  -  -  -  +  - NS  -  +  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S7  +  -  -  +  -  -  -  -  -  +  +  +  -  -  -  + NS  -  - NS  -  +  -  +  - NS  -  +  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S8  +  -  -  +  -  -  -  -  -  -  -  +  -  -  -  - NS  -  - NS  -  +  -  +  - NS  -  +  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
S9  +  -  -  +  -  -  -  -  -  -  -  +  +  -  +  + NS  -  - NS  -  +  -  -  - NS  -  -  -  -  - NS  -  - NS  -  - NS  -  - NS  -  - NS  -
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Figure 5.6. Histological lesions at different locations in both infected groups.. A) Respiratory isolate 
infected calf; nasopharyngeal tonsil necrosis, day 4, pi. B) Systemic isolate infected calf; 
nasopharyngeal tonsil neutrophilic infiltrate, day 4 pi. C) Respiratory isolate infected calf; trachea 
inflammatory infiltrate, day 10 pi. D) Systemic isolate infected calf; trachea with no inflammatory 
infiltrate, day 10 pi. E) Respiratory isolate infected calf; trigeminal ganglia inflammatory infiltrate, 









Figure 5.7. Immunolabelling of viral antigen at different locations in both groups. A) Respiratory 
isolate infected calf; nasopharyngeal tonsil showing scattered foci of positive labelling, day 4 pi (x4). 
B) Systemic isolate infected calf; nasopharyngeal tonsil showing scattered foci of positive labelling, 
day 4 pi (x10). C) Respiratory isolate infected calf; nasal mucosa without inflammatory infiltrate or 
viral antigen, day 4 pi (x20). D) Systemic isolate infected calf; nasal mucosa showing positive 
labelling for BoHV-1 in the epithelial cells at the periphery of a necrotic lesion (x20). E) Respiratory 









5.5 Transcript expression in different tissues throughout infection 
 
The expression of three transcripts, circ, ribonucleotide reductase (RR) and 
glycoprotein B (gB), representing each stage of the temporal cascade of transcript 
expression was measured using reverse transcriptase RT-PCR (see 2.6.2 for detailed 
methods). The tissue samples tested (nasal mucosa, trachea, tonsils, trigeminal 
ganglia and hindbrain and retropharyngeal lymph node) had previously tested 
positive for BoHV-1 DNA in one or more animals during the experimental infection. 
The samples were collected at three time points during infection, day 4, 10 and 24. 
 
Positive detection of viral RNA was only consistently detected on day 4 pi, in four 
tissues (nasal mucosa, trachea, palatine tonsil and nasopharyngeal tonsil). On day 10 
viral RNA was detected in one or two animals in the tonsils, trigeminal ganglia and 
retropharyngeal lymph node. On day 24 viral RNA was detected only in the 
trigeminal ganglia. No viral RNA was detected in the hindbrain. The information 
collected from day 10 and 24 samples was not sufficient to make any comparisons. 
For the day 4 samples relative quantification of BoHV-1 transcript expression was 
calculated by comparison to the expression of the β-actin host transcript calculated 
using the 2
-ΔCt
 method (Kubota et al. 2008; Livak & Schmittgen 2001; Morse et al. 
2005).  
 
These results showed differences in viral transcript expression between tissues from 
calves infected with the two BoHV-1 isolate types. In the nasal mucosa a trend of 
higher level of transcript expression was observed for all transcripts in the 07/1530 
infected tissue, although due to the level of variation observed this was not found to 
be a statistically significant (figure 5.8A). In the trachea, only 2 of 3 05/1570 infected 
samples were positive for circ and 1 of 3 for RR and gB. No expression of gB was 
observed in any of the 07/1530 infected group samples. This made these results 
difficult to analyse, with only two samples from each group included in the analysis 
and therefore were not suitable for any statistical analysis. However, the results did 
show a trend for a higher level of transcript expression in the 05/1570 infected 
samples (figure 5.8B). The findings in the nasopharyngeal tonsil provided more 
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conclusive results; all 3 transcripts were expressed at significantly higher levels in 
the 05/1570 infected samples (figure 5.8C). In the palatine tonsils the opposite was 
seen with higher BoHV-1 transcript expression in the 07/1530 infected samples, 
although this was not found to be statistically significant.  
 
Figure 5.8. Relative quantification real-time PCR targeting circ, ribonucleotide reductase (RR) and 
glycoprotein B (gB) fragments of BoHV-1 and normalised targeting β- actin of the host genome on 
day 4 pi (n=9) Black = respiratory 05/1570 isolate infected calves, Grey = systemic 07/1530 isolate 
infected calves. A) Nasal mucosa (n=3). B) Trachea (n=2). C) Nasopharyngeal tonsil (* = p<0.05; ** 








An experimental challenge of BoHV-1 was administered to calves by intranasal 
nebulisation, a natural route of infection. Clinical signs typical of IBR were 
observed, including a fever, ocular and nasal discharge, coughing, conjunctivitis and 
rhinitis as described in other experimental infections (Edwards, Newman & White 
1991; Meyer et al. 2001). Viral shedding was detected via both nasal and ocular 
routes and there was evidence of virus within the respiratory tract and anticipated 
latency sites. Therefore it can be concluded that the BoHV-1 challenge successfully 
resulted in IBR disease and samples collected can be used to study both the virus and 
host response when infected with the two BoHV-1 isolates (respiratory 05/1570 and 
systemic 07/1530).  
 
Clinical signs and tissue viral load demonstrated differences between the two BoHV-
1 isolate infected groups, but there was a large amount of individual variation 
observed within each group, which compromised the statistical analysis and limited 
the conclusions that could be drawn. For example, despite clear visible differences in 
the severity of clinical signs, such as ocular discharge/conjunctivitis, they were not 
found to be significantly different between infected groups. However, they were 
significantly different from the control group, demonstrating a clear effect of the 
BoHV-1 infection. The difficulty in comparing the infected groups is likely to be due 
to the scoring system of 0, 1 and 2 which provided very little difference in the 
average score between groups. The small number of animals in each group is likely 
also to have played a part. 
    
The monitoring of clinical signs showed trends that suggested the different isolates 
may be causing different presentations of the disease, although there were no 
significant differences in the extent of spread between the two isolates. Signs of 
conjunctivitis and ocular discharge were more evident in calves infected with the 
systemic (07/1530) isolate. This is also reflected in the viral load from the ocular 
swabs which was significantly higher on day 3 and lasted longer post infection 
compared to the respiratory infected group.  
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Real-time PCR was used to quantify virus collected from nasal and ocular swab 
sampling to represent viral shedding. Although it should be considered that 
quantitative PCR of swabs does not confirm that infectious virus particles were being 
shed. This provided data on the spread of the virus from the nasal cavity to ocular 
areas. It demonstrated that 48 hours was needed for the virus to spread from the nasal 
passage and being shed via the ocular route, which was also found in another study 
comparing BoHV-1 strains (Kaashoek et al. 1996). This data also showed that viral 
DNA could be detected for at least 21 days pi, which shows a long time period when 
calves would have been a risk factor for the rest of the herd, if they had been infected 
in their natural environment. This contrasted with other studies which showed no 
shedding after day 17 pi by virus isolation (Kaashoek et al. 1996) and day 19 pi by 
immuno-PCR (Mweene et al. 1996). Neither of these studies took measurements 
beyond these time points, but this may also represent the increased sensitivity of the 
quantitative PCR method used in this study compared to virus isolation and immuno-
PCR. The peaks of viral shedding coincide with the initial peak of clinical signs, as 
would be expected, also representing the peak of viral replication.  
 
No cell-associated or cell free virus was detected in the blood buffy coat or tissues 
outside the respiratory tract and CNS. This leads to the conclusion that there was no 
systemic dissemination of the virus, as has been found in natural cases (Higgins & 
Edwards 1986). Systemic spread of the virus has been shown in other intranasal 
experimental infections, although no histopathological or virus isolation evidence is 
provided to support the viral detection by immuno-PCR in the ovaries, spleen and 
peripheral blood leukocytes (Mweene et al. 1996). Another study demonstrated 
presence of BoHV-1 in serum, adrenal glands, kidneys and liver by virus isolation 
with supporting pathological evidence in the tissues after an intranasal BoHV-1 
infection (Kaashoek et al. 1996). Systemic spread has also been demonstrated in 
cases of vaccination with modified-live vaccine for IBR and parainfluenza-3 in 
neonatal calves (Bryan et al. 1994). However, the vaccine had been administered 
intra-muscularly so the natural route of virus dissemination does not apply to this 
case. Serum was also tested from day 4 samples at the peak of clinical signs to check 
for a cell-free viraemia but this also gave negative results. In conclusion, the results 
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show that the isolates tested do not result in the same clinical presentation on 
infection and therefore some host factors must also be involved in control of 
systemic spread. 
 
Despite the lack of evidence of systemic spread there were several observations 
made from the analysis of tissue for the three time points sampled. Comparisons 
between tissues from calves infected with the two isolates demonstrated potential 
differences in their infection of the host. On day 4 pi, at the peak of clinical signs and 
viral shedding, evidence of virus was detected by PCR in the nasal mucosa and 
trachea of the respiratory tract, associated tissues including palatine and 
nasopharyngeal tonsils and retropharyngeal lymph node in both infected groups. 
Other studies have recorded presence of BoHV-1 in lung tissue in experimental 
BoHV-1 infections of 3-5 month year old calves with 10
7.8
 PFU/ml of the LA strain 
(Mweene et al. 1996). However, no evidence of virus in the lungs was demonstrated 
in our study, the virus remained confined to the upper respiratory tract. Another 
study using endobronchial administration of virus has shown that BoHV-1 increases 
the severity of histopathological lesions observed in pneumonia when compared to a 
Pasturella haemolytica only infection and also demonstrates a BoHV-1 only 
infection causing pneumonia (Narita et al. 2000b; Narita et al. 2000c). Lung 
disorders are usually associated with secondary bacterial infections, rather than the 
virus itself due to reduced defences caused by BoHV-1 (Jones & Chowdhury 2007; 
Ellis 2009). Overall in a natural intranasal infection it seems unlikely BoHV-1 would 
reach the lower respiratory tract based on findings in this experimental challenge and 
previous data.  
 
There was also some indication of differences in tissue tropism between the two 
isolate types at day 4 pi. A significantly higher viral load was found in the nasal 
mucosa in the 07/1530 infected group compared to the trend of higher viral load in 
the trachea of the 05/1570 infected group. This was also supported by 
histopathological findings with more severe inflammation observed in the nasal 
mucosa and positive IHC labelling of antigen within a lesion in the 07/1530 infected 
group. The infection of epithelial cells is characteristic of a BoHV-1 infection 
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(Muylkens et al. 2007). Studies in vitro have shown the infection of these cells 
results in cytokine expression and allows secondary infection of bacteria such as 
Mannheimia haemolytica, known to lead to pneumonia (Rivera-Rivas, Kisiela & 
Czuprynski 2009). There was also a higher level of transcript expression detected in 
the nasal mucosa of the 07/1530 infected animals on day 4, suggesting this was a 
viral replication site. In the trachea, more inflammation was observed at this time 
point in the 05/1570 infected tissue, although there was no positive antigen labelling 
by IHC to confirm presence of replicating BoHV-1. There was also evidence of 
inflammation in some of the control cases so this may not have been related to the 
BoHV-1 infection. However, real-time PCR measurement of transcript expression in 
the trachea, confirmed presence of replicating virus in at least some of the samples. 
In positive cases it was found to be higher in the respiratory isolate infected tissue.  
 
The tonsils showed differences in their response to the virus. Similar viral loads were 
detected in both infected groups, however the characteristics of the lesions were 
different depending on the isolate type. Animals infected with the respiratory isolate 
showed multifocal necrosis, whilst the systemic group showed no sign of necrosis, 
but extensive multifocal neutrophil infiltration. However, the IHC labelling did not 
confirm these differences. A multifocal pattern of labelling was observed in the tonsil 
tissues, which was similar in tissues from both isolate types. This suggested it was 
the host response that differed rather than the extent of viral infection. Significant 
differences in the transcript expression detected between the isolates were also 
found. The 05/1570 infected group demonstrated a significantly higher level of 
transcript expression in the nasopharyngeal tonsil for all 3 transcripts. This may 
indicate this isolate was able to replicate more readily at this site than the systemic 
isolate, or that the neutrophil infiltrate response was potentially limiting the 
replication potential of the systemic isolate. A previous study specifically looking at 
BoHV-1 infection of the nasopharyngeal tonsil described the progression of infection 
resulting in histopathological lesions. After an intranasal infection, multifocal 
epithelial erosions and increased infiltration of neutrophils, with erosions then 
becoming ulcerated and necrosis extending into adjacent lymphoid tissue (Schuh et 
al. 1992). This could suggest we observed two of these stages, increased neutrophilic 
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infiltration in 07/1530 associated tissue and the latter stages of necrosis in the 
05/1570 associated tissues. However, we did not observe any necrosis occurring 
alongside the neutrophilic infiltration. A study focussing on the response of 
lymphoid tissue after infection found BoHV-1 infected CD4+ T cells, causing 
apoptosis, at 7 days pi, which was thought to contribute to the immunosuppression 
caused by the virus (Winkler, Doster & Jones 1999), also suggesting cell death at this 
site, is secondary to the peak of clinical signs on days 4-5 pi.  Therefore the 
observations made in our study could represent a difference in host response or 
differences in the speed of infection progression as it was not possible to confirm the 
same response was not observed in either isolate before or after the 4 day pi time 
point. 
 
Finally, with reference to observations on day 4 post infection was the detection of 
virus DNA in the trigeminal ganglia. This showed BoHV-1 was able to spread to the 
trigeminal ganglia in just 4 days, with similar viral loads to those found in the upper 
respiratory tract. Histopathology demonstrated a mild focus of inflammation in the 
05/1570 infected group, which was also positive by IHC, suggesting the presence of 
replicating virus in neurons. No lesions or positive IHC labelling was observed in the 
07/1530 infected tissue, suggesting less spread of this isolate at this stage of 
infection. The positive labelling of neurons in the trigeminal ganglia of 05/1570 
infected animals supports previous studies that have shown gene expression in the 
trigeminal ganglion mainly occurs within the neurons (Schang & Jones 1997). 
Previous studies have also identified an interstitial mononuclear cell infiltration of 
the trigeminal ganglia during acute infection (Winkler et al. 2002), consistent with 
our observations in the 05/1570 infected animals. Another study demonstrated a brief 
period of viral transcript expression at the peak of acute infection (Schang & Jones 
1997),  which may explain the positive IHC at this time point.  
 
On day 10 the clinical signs were resolving and viral shedding decreasing. Studies of 
the tissues at this time point also reflected this. Fewer tissues were found to be IHC 
positive or PCR positive for transcript expression, suggesting little active viral 
replication was occurring for either isolate. However, viral DNA was still found by 
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real-time PCR in the tonsils, trigeminal ganglia, retropharyngeal lymph node and 
hindbrain of both infected groups. Viral DNA was also detected in the nasal mucosa 
and trachea of the 05/1570 infected group only, which suggests the virus had cleared 
from the upper respiratory tract tissues in the 07/1530 infected calves. This may have 
been related to the more severe inflammatory infiltrate provoked by the 05/1570 
isolate, compared to milder inflammatory infiltrate observed in the 07/1530 infected 
tissue. A neutrophilic infiltrate as observed in the 05/1570 isolate has also been 
demonstrated in an in vitro study. Activation of neutrophils was shown during 
BoHV-1 infection of epithelial cells (Rivera-Rivas et al. 2009).  
 
The palatine tonsil showed IHC labelling in animals infected by both isolates and 
PCR indicated it was also the tissue containing the highest viral load. This may be 
related to the tonsils being considered a secondary site of latency (Winkler et al. 
2000). As the tonsils consistently showed high viral load, supported by labelling of 
viral antigen by IHC it may also suggest a tropism for lymphoid tissue. However, as 
this was not supported by detection of transcript expression, it could also be related 
to their immune surveillance role earlier in infection. Further work would be needed 
to differentiate between these possibilities, specifically to establish whether virus was 
replicating, latent or if virus debris from an earlier infection was being detected. The 
trigeminal ganglia demonstrated an inflammatory response in all cases of the 
07/1530 infected samples, which was not seen in the 05/1570 infected samples. 
However, the respiratory isolate demonstrated a significantly higher viral load by 
PCR. This could be considered to be evidence of the respiratory isolate entering the 
latent phase, whilst the systemic isolate was still causing an initial inflammatory 
response, although detection of LAT gene expression would be needed to confirm 
this. Previous findings demonstrated inflammation of the trigeminal ganglion on day 
7 pi after intranasal and ocular infection with the BoHV-1 (Winkler et al. 2002). As 
inflammation was present on day 4 in the respiratory group but not at day 10, it may 
therefore have occurred later in the 07/1530 infected group. However, this does not 
explain the lack of any inflammation in 05/1570 infected group, as in previous 
studies inflammation was observed until day 15 pi (Winkler et al. 2002). More 




On day 10 there was also presence of BoHV-1 DNA in the hindbrain, although only 
one sample from each infected group was found to be positive. There was also 
evidence of inflammation in 5 of the 6 hindbrain samples at this time-point which 
was more severe in the 07/1530 infected group. No lesions were observed in the 
control group so this can be attributed to the BoHV-1 infection, but there was no IHC 
labelling to confirm that this was related to BoHV-1 infection. Spread to the brain 
has also been seen in natural cases, particularly in cases of young calves with lesions 
similar to those observed in our study. Non-suppurative encephalitis, characterized 
by perivascular mononuclear cell cuffing and gliosis was demonstrated during 
histological examination in a calf from a natural systemic BoHV-1 outbreak (Higgins 
& Edwards 1986). Another study has shown it can sometimes be accompanied with 
neurological signs (Penny et al. 2002). It is unknown whether spread to the brain 
occurs by axonal transport in neurons or via a haematogenous route. A study in mice 
infected intraperitonealy with either BoHV-5 or BoHV-1 showed a viraemia was 
needed to cause neuronal infection by BoHV-1, in contrast to BoHV-5 that was 
transported to the CNS by an axonal pathway, based on detection of viral DNA and 
antigen in different tissues sampled on days 3 and 6 days post infection (Abril et al. 
2004). This would suggest a haematogenous route may also be more likely for the 
systemic spread of BoHV-1, although a mouse model with an intraperitoneal route of 
infection may not be a good representation for natural infection with BoHV-1. It also 
raises the question of whether we should consider spread to the brain as evidence of 
systemic spread in this study. 
 
By day 24, when almost all clinical signs had subsided, there was little evidence of 
the presence of virus. Only the palatine tonsil and trigeminal ganglia tested positive 
by real-time PCR for both infected groups, which are both known latency sites so it 
can be suggested that both isolates had reached the latency phase at this time point. A 
potential exception to this is S9, as viral DNA was detected in the retropharyngeal 
lymph node in this animal. All other cases were only positive at latency sites, 
supporting the findings of a previous study. Calves were infected intranasally with 
the Cooper strain and latency related (LR) transcript was detected in the tonsils by 
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nested RT-PCR at 60 days post infection. They also showed successful reactivation 
of BoHV-1 from the tonsils using intravenous dexamethasone, a corticosteroid 
treatment to trigger reactivation from latency providing conclusive evidence of the 
tonsils as a latency site (Winkler et al. 2000). However, these results contrast with 
findings from an intranasal BoHV-1 infection that detected BoHV-1 DNA in ovaries, 
lungs, nasal mucosa, tracheal mucosa, spleen, lymph nodes and peripheral blood 
leukocytes on day 22 pi (Mweene et al. 1996). There was some evidence that the 
systemic isolate was not entirely latent, as there was a positive IHC result in the 
palatine tonsil suggesting the virus was still replicating. In the trigeminal ganglia 
inflammation was detected in all 3 07/1530 infected animals. This was also observed 
in a study that compared lymphocyte infiltration between an LR transcript mutant 
and a wild-type strain of BoHV-1, which found an increased presence of 
inflammatory infiltrate in the LR transcript mutant infected trigeminal ganglia.  It 
was suggested that infiltration of lymphocytes in LR transcript mutant strains results 
in increased apoptosis at the end of the acute infection, and therefore fewer neurons 
available for the establishment of latency (Perez et al. 2006). This was also shown in 
a rabbit model that showed apoptosis of neurons was preceded by viral gene 
expression (Delhon, Gonzalez & Murcia 2002). This could indicate that the systemic 
isolate was not expressing the LR transcript at this time point, resulting in increased 
lymphocyte infiltration. Study of the LR transcript would be needed to confirm the 
latency strategy of the virus.  
 
Overall, this experimental infection has provided an important insight into how 
molecular and histopathological observations of two sequenced BoHV-1 isolates 
may relate to the clinical presentation of disease. Neither of the isolates demonstrated 
systemic spread beyond the respiratory tract or brain, and generally showed similar 
patterns of infection. This leads to the conclusion that previous systemic spread by an 
isolate does not mean it will behave in the same way in the next infection, and 
therefore host factors must also play a role. Differences in host responses were 
potentially demonstrated in the tonsils of infected calves. Further work is needed to 
confirm that this was not simply a difference in the speed of infection between the 
isolates, as it was not possible to confirm from this work that these effects weren’t 
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seen a day later or earlier in animals infected with the other isolate. There was also 
some indication of differences in virus tropism in the upper respiratory tract. 
Unfortunately, these results were difficult to interpret due to a high level of variation 
between samples from the different animals, as was also reflected in the clinical 
signs. More isolates of each type need to be tested to determine whether any of the 
observations made here were significant. In the next chapter the possibility of model 
systems will be investigated, as for a study involving more isolates an experimental 
infection in the natural host is not suitable. This aims to provide data with less 
variation, more repetitions and more isolates of each type which should establish 
whether any of the differences observed here are true differences between 




Chapter Six: Comparison of 
respiratory and systemic isolates 




The previous chapter demonstrated differences in virus distribution and transcript 
expression between two BoHV-1 isolates, in calves challenged intra-nasally. In this 
chapter in vitro model systems were used to study these isolates in a more controlled 
and reproducible environment. It also provided an opportunity to compare a greater 
number of isolates. Respiratory and systemic isolates were compared during an 
infection of BT cells in terms of replication patterns, by measuring production of 
virus and gene expression from the three temporal phases of replication. It also 
provided a comparison of different infection models. BoHV-1 is one of the most 
studied herpesviruses because it grows well in cell culture, making this an easy way 
to study the virus (Peterson & Goyal 1988). This cell culture model was used as the 
first model to compare the isolates used in the in vivo challenge, through the analysis 
of transcript expression over the infection period. 
 
The second part of this work used bovine lung slices kept in culture for four days and 
infected with BoHV-1 on the second day. It tested whether the lung slices remained 
viable and were able to support the replication of virus. Organ culture was first used 
in studies in the late 1970’s (Bouffard & Derbyshire 1978), and is now re-emerging 
as a more commonly used infection model (Booth et al. 2004; McNeilly et al. 2007; 
Niesalla et al. 2009). An air-liquid interface system was previously used for the 
culture of respiratory epithelium, which was then infected with BoHV-1 (Niesalla et 
al. 2009). Similar systems involving submerged tissue, more similar to the original 
techniques have been used to culture sheep tracheal and lung tissue for the infection 
of maedi-visna virus (McNeilly et al. 2007) and also ovine pulmonary 
adenocarcinoma infection in sheep lung (Cousens 2010). Previous studies in our 
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laboratory showed that infection of lung slices was also a suitable method for the 
study of BoHV-1 and demonstrated successful replication of virus.  
 
This method has several advantages in comparison to cell culture infection. A large 
number of lung slices taken from the same organ can be infected with several 
different isolates. It also preserves the range of cell types and structure present in the 
original organ. However, it does have some limitations, for example the influx of 
inflammatory cells or the route of infection cannot be studied. Innate immune 
responses such as the inflammatory response are thought to be maintained and a 
recent study has successfully measured TNF-α in an air-liquid interface infection of 
respiratory epithelium with BoHV-1 (Niesalla et al. 2009). This makes it a good 
approach to compare different virus isolates, ultimately to determine whether viral or 
host factors play the most important roles in systemic infection. If successful this 
system may provide a good alternative to experimental infection in the natural host, 
or other animal models such as rabbits (Lupton et al. 1980).  
 
 
6.2 In vitro time course infection in bovine turbinate cell culture  
  
Two BoHV-1 isolates from natural cases, one associated with respiratory 
presentation (05/1570), and one associated with systemic spread (07/1530) 
(estimated M.O.I of 2) were used to infect BT cells. These were also the same 
isolates used for the in vivo infection described in chapter 5. Both isolates had been 
previously titrated and diluted as necessary to ensure minimal differences in the 
infection titre between isolates. When harvesting infected cells for transcript 
expression analysis cytopathic effect (CPE) was recorded and cell monolayer 
samples were taken at 3 hourly intervals over a 48 hour period post infection to study 
transcripts from each phase of viral gene expression using real-time PCR, to provide 
an insight into the viral infection at a molecular level. RNA for viral transcript 
expression studies was extracted from the infected cells. Transcripts that are known 
to be expressed in each of the temporal phases of gene expression were measured, 
circ in the immediate-early phase, RR in the early phase and gB in the late phase 
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(Muylkens et al. 2007). These genes were also measured in the in vivo infection 
allowing comparison between the two experimental models (section 5.5). The 
detailed methods are described in section 2.2, 2.5.4 and 2.6.3. Relative quantification 
of the transcripts was calculated using the ΔCt method, using the host transcript β-
actin as the reference transcript. 
 
At each time point the percentage CPE was estimated before harvesting the cells. 
This provided a comparison of the viral replication and speed of virus cell to cell 
spread between isolates. Cultured cells infected with the respiratory (05/1570) isolate 
showed a faster development of CPE. Cell rounding and development of plaques was 
observed at 6 hours pi, compared to 9 hours pi in the systemic isolate infected cells 
(figure 6.1). Later in the time course, 100% CPE was observed 6 hours earlier in the 
respiratory isolate infected cells than the systemic isolate (07/1530) infected cells.  
 
Figure 6.1. Development of CPE in BT cells during a time-course infection of either a respiratory, 



















Figure 6.2. Relative viral transcript expression compared to host reference gene β-actin over a 48 hour period of two BoHV-1 isolates. Respiratory (05/1570) – Black; Systemic 
(07/1530) – Grey. y-axis = relative viral gene expression 2
- ΔCt
, x-axis = transcript expressed. Error bars represent standard deviation of the 3 biological replicates. P-values 




The results from the real-time PCR study demonstrated several aspects of viral 
transcript expression during this BoHV-1 infection. The first activity of viral 
transcription was detected 3 hours after infection for both isolates (figure 6.2). 
During the first 12 hours of the infection, in all 3 phases of transcript expression, the 
respiratory isolate (05/1570) showed comparatively higher transcript abundance than 
the systemic isolate (07/1530). A two-way ANOVA demonstrated a significantly 
higher number of respiratory isolate transcripts at 3, 6 and 12 hours pi (figure 6.2). 
From 15 hours pi, the two isolates showed no significant differences, which may be 
due to high levels of variation between the biological replicates. However, there were 
differences observed between the transcript levels of the immediate early, early and 
late transcripts, for both isolates. Expression of the late transcript (gB) was higher 
than RR and circ at 15, 18, 24, 27 and 39-48 hours, although at 27 hours pi circ was 
also highly expressed. It should also be noted that there was a decrease in the host 
beta actin expression which influenced the ΔCt calculations, meaning the results 
could not be compared over time.  
 
6.3 In vitro BoHV-1 time course infection in bovine lung slices 
 
A 3 day time course infection of lung slice cultures with 6 different BoHV-1 isolates 
(table 6.1) was designed to study viral replication, viral gene expression and cellular 
localisation of virus in tissue. This provided an intact organ structure that would be 
targeted in a natural infection. For detailed methods see 2.3, 2.6.3 and 2.7.3. Briefly, 
lung slices were set up in 24 well plates and infected with BoHV-1 isolates (figure 
6.3). Viral replication was measured in the lung slice medium that was replaced each 
day, using absolute quantification real-time PCR to calculate viral load produced 
each day. Viral transcript expression of circ, RR and gB was measured by RT-real-
time PCR and subsequent relative quantification calculation, using host beta actin as 
a reference in RNA samples extracted from whole lung slices. Cellular localisation of 
the virus was studied using immunohistofluorescence double labelling of BoHV-1 
















Figure 6.3 Example of lung slice plate set up for the respiratory isolates. Three of each of the 
respiratory and systemic plates were set up, one to be harvested each day. (NLS = no lung slice 
control; No virus = lung slice with no virus added control; PCR = lung slice and media to be used in 
PCR analysis; IF = lung slice to be used for immunohistofluorescence.)  
 
 
6.3.1 Measuring viral load in lung slice cultures 
Viral load was measured in culture media containing the lung slices using real-time 
PCR absolute quantification to detect BoHV-1 DNA. Plasmid standards of known 
copy number were included on each run to create a standard curve that the tested 
samples could be plotted against. This indirectly checked the lung slice was viable, 
as it was supporting viral replication.  
 
Media tested from the wells containing no lung slices tested positive for BoHV-1 
DNA in one of 3 wells on each of the plates on each day indicating there was some 
virus adherence to the plate surface. In most cases the mean virus copy number 
detected in the wells containing lung slices was still significantly higher than the 
average of the no lung slice control wells (figure 6.4). On the occasions when it was 
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not significantly different, this was due to high variation between samples infected 
with the same isolate type. Overall, there was sufficient evidence of virus replication 
(and therefore viable lung slices) to continue the study of gene expression and 
localisation of virus within the lung tissue. 
 
This study also showed that less virus was produced on day 2 in all isolates than on 
days 1 and 3. There were no significant differences observed between isolates or 
isolate groups in the amount of virus that was produced on each day (figure 6.4).  
 
Figure 6.4. Viral load produced each day in lung culture and comparison with no lung slice (NLS) 
controls on each plate from each day (P1-6). A) Day 1, B) Day 2, C) Day 3; Two sample t-test, * 


























6.3.2 BoHV-1 gene transcription in lung slice culture 
Viral gene transcription was measured using real-time RT-PCR relative 
quantification with the transcript of interest compared to host gene transcription of β-
actin (Livak & Schmittgen 2001; Kubota et al. 2008). This data can be used to 
compare between isolates and between infection models (as this was the same 
method used in the cell culture in section 6.2 and the in vivo challenge in chapter 5). 
 
Viral transcript abundance of all three transcipts measured generally increased over 
the three day infection period (figure 6.5). Both isolate groups showed a similar 
pattern of viral gene transcription, as seen in the BT cell culture, when only one of 
each isolate type was used (figure 6.2), with the exception of RR transcription on day 
2, when a significantly higher relative transcript level was observed in the respiratory 
isolates, compared to the systemic isolates (figure 6.5). There was also a significant 
increase in each transcript with time over the 3 day infection period (one- way 
ANOVA; p< 0.01).  
 
Figure 6.5 Viral transcript expression in lung slice culture. Black – average of three respiratory 
isolates (05/1570, K1527, 07/184), Grey – average of three systemic isolates (07/1530, 07/282, K739). 
A two sample t-test identified any significant differences in transcript expression between isolate 
types (☼ p< 0.01) (n=3), error bars represent s.d). A one-way ANOVA identified significant 












































6.3.3 Immunohistofluoresence labelling to localise BoHV-1 in lung slice culture 
As the lung slices contained a population of different cell types, it was possible to 
determine which cell type was infected by the virus, in order to study differences in 
cell tropism between the isolate types. Immunofluorescence labelling was used as a 
pilot technique for future investigation, to identify virus-infected, epithelial and 
endothelial cells represented by labelling of BoHV-1 gC (a late expressed gene 
indicative of virus production), cytokeratin and von Williebrand Factor (vWF) 
respectively. Co-localization of virus with either vWF or cytokeratin was used to 
indicate the presence of the virus in endothelial or epithelial cells respectively (table 
6.3). See 2.7.3 for detailed methods. 
 
Negative controls (table 6.2), that tested background fluorescence and antibody 
specificity showed no significant labelling (figure 6.6 A, C, E). These control images 
also show the positive labelling of the individual targets when individual labelling 
was used. Cyt and vWF labelling was localised to cellular areas and BoHV-1 was 
shown to be localised within some of these cells (figure 6.6 B, D, F). Specifically, 
cytokeratin labelling was identified by red fluorescence signal within the epithelial 
lining of a bronchiole (figure 6.6B). vWF labelling was identified also by red 
fluorescence signal on the internal lining of a vessel within the lung structure (figure 
6.6F). BoHV-1 positive signal appeared in individual cells or groups of cells as green 
fluorescence (figure 6.6D). Maintenance of lung structure can be most clearly seen in 
figures 6.6E and F. It should be noted that it seems the antibodies were not working 
at an optimum level of sensitivity under the conditions used in this experiment as 
more cells would be expected to be positively labelled using the cell targeted 
labelling.  
 
Virus antigen was not detected in several sections, including all the samples infected 
with isolates 07/1530 and K1527, therefore these samples could not be evaluated for 
any co-localisation (table 6.3). Where virus was detected, co-localization was found 
with both cell types for both isolate types. On day 1 pi virus was only found in 
epithelial cells (figure 6.7 A and B), whilst on days 2 and 3 pi the virus was found to 
be localised in both epithelial and endothelial cell types in two of the BoHV-1 
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infected samples (figure 6.7 C and D). Both viral antigen and areas of co-localization 
were greater on day 3 post infection than on days 1 and 2 (figure 6.7). 
 







Control 1 None BoHV-1 and Cyt  Specificity of fluorescent secondary 
antibody for primary antibodies 
Control 2 None BoHV-1 and vWF Specificity of fluorescent secondary 
antibody for primary antibodies 
Control 3 BoHV-1 only Cyt only Cross reaction between BoHV-1 primary 
and Cyt secondary antibodies 
Control 4 BoHV-1 only vWF only Cross reaction between BoHV-1 primary 
and vWF secondary 
Control 5 Cyt only BoHV-1 only Cross reaction between Cyt primary and 
BoHV-1 secondary 
Control 6 vWF only BoHV-1 only Cross reaction between vWF primary and 
BoHV-1 secondary 
Control 7 None None Background fluorescence of tissue 
 
 
Table 6.3. Co-localization of virus antigen and markers for different cell types.  ns indicates that no 
virus was visible and therefore co-localisation could not be evaluated. + or – indicates the extent of 
co-localisation between the virus and the indicated cell-type marker. 
Cyt vWF Cyt vWF Cyt vWF
05/1570 (R) + - + - + ns
K1527 (R) ns ns ns ns ns ns
07/184 (R) ns ns ++ - ++ ++
07/1530 (S) ns ns ns ns ns ns
07/282 (S) ns ns ns + ++ +











Figure 6.6. Control and individual labelling of the targets using immunofluorescence. A) Negative 
control for Cyt – secondary antibody only. B) Positive labelling of bronchiolar epithelium for 
cytokeratin in red. C) Negative control for BoHV-1 – secondary antibody only. D) Positive BoHV-1 
labelling in green. E) Negative control for vWF – secondary antibody only. F) Positive vWF labelling 












Figure 6.7. Co-localization images after immunofluorescence labelling. Red – cytokeratin (epithelial) or vWF (endothelial), green – BoHV-1, white – co-localisation 
of green and red determined using imageJ software (Rasband 1997). A) K739 BoHV-1 isolate day 1 pi localized to epithelial cells. B) 07/184 BoHV-1 isolate day 2 pi 





These experiments have used in vitro model systems to investigate BoHV-1 isolates 
studied in the in vivo experimental challenge and further respiratory or systemic 
isolates that had also been sequenced.  
 
The infection of BT cells is a common method of studying BoHV-1 due to its rapid 
replication and clearly visible CPE (Peterson & Goyal 1988). Infection of BT cells 
with two isolates found the respiratory (05/1570) isolate resulted in a faster 
development of CPE than the systemic (07/1530) isolate. This could be an indication 
of faster viral replication to produce progeny viruses that can spread, resulting in 
further cell death, creating visible plaques in the cell monolayer. However, this is a 
subjective method of comparing the viral replication. It would have also been useful 
to produce growth curves from the cell cultures by titrating the supernatant to further 
quantify the differences of infection between the isolates. However, as time was 
limited, to provide quantitative measure of viral replication viral transcript 
abundance was measured over the infection period for both isolates using 
quantitative real-time PCR which could be compared to the method used in the 
experimental challenge.  
 
The results of this transcript analysis provided evidence of viral RNA just 3 hours 
after infection, most evident in the respiratory (05/1570) isolate, but also seen in the 
systemic isolate (07/1530). This is similar to previous experiments monitoring 
transcript expression in vitro using the Cooper, Jura and K22 strains, which also 
demonstrated transcript accumulation at 2-3 hours pi (Wirth et al. 1989; Seal et al. 
1991; Schang & Jones 1997). Two of these studies report evidence of immediate 
early transcript expression earlier in the infection compared to the other transcript 
phases (Schang & Jones 1997; Seal et al. 1991). In our study, all three phases of 
transcript expression are represented at the 3 hour time-point, which was also 
observed in a previous BoHV-1 BT cell infection (Seal et al. 1991). More frequent 
measurements of the first 3 hours of infection, are needed to identify the transcript 
phases more clearly, as distinctions between the phases in other studies have been 
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made between as early as 2 hours pi (Wirth et al. 1989). In the first 12 hours pi, 
higher levels of all 3 transcripts tested were detected in the respiratory isolate 
(05/1570) infection than the systemic isolate (07/1530) infection. This correlates with 
the faster CPE development observed in the respiratory isolate infection. Throughout 
the rest of the cell culture infection period studied (12-48 hours), both isolates 
showed similar patterns of transcription for each of the three transcripts detected. gB 
transcription predominated between 15 and 48 hours post infection. 
 
Based on the current knowledge of BoHV-1 replication (Muylkens et al. 2007); 
earlier viral transcription would ultimately be expected to allow faster production of 
progeny virus and spread to neighbouring cells, resulting in plaque formation. 
However, production of progeny virus is dependent on the subsequent increase in 
viral gene translation, leading to faster protein expression, which was not determined 
in this experiment. Previous studies have shown that differences in viral transcription 
timing does not always relate to differences in viral replication in culture (Aguilar et 
al. 2006). Therefore, protein expression needs to be determined to investigate viral 
replication in culture. It would also be useful to study the transcription of more viral 
genes, in pseudorabies virus this has been achieved with the use of transcriptomic 
analysis (Aguilar et al. 2006; Flori et al. 2008). The timing of transcription is largely 
dependent on the expression of tegument protein α-TIF and its subsequent binding to 
promoter regions, which stimulates immediate early transcription (Muylkens et al. 
2007). This may make the monitoring of α-TIF expression an interesting starting 
point for future studies.  
 
This study in BT cells found that, in comparison with the other transcripts studied, 
gB transcription was higher 15-48 hours post infection. Transcripts of in vitro cell 
culture systems have been studied previously only up to 16 hours post infection 
(Wirth et al. 1989; Seal et al. 1991) and, with the exception of recent transcriptome 
studies in HSV and pseudorabiesvirus, have not been quantitative (Aguilar et al. 
2006; Flori et al. 2008). Therefore comparisons with previous work are not possible. 
Further work, looking at transcript accumulation of other glycoproteins and 
subsequent protein expression is needed to establish whether this is an important 
167 
 
finding. Investigating BoHV-1 protein expression in infected cells was trialled in a 
recent project, and indicated this may be a good starting point for future work in this 
area (Dryburgh 2009). Increased expression of gB could potentially relate to the final 
packaging and enveloping of progeny virions, as glycoproteins surround the virion 
envelope. It could also influence spread to surrounding cells, as many glycoproteins 
are essential for cell entry (Muylkens et al. 2007). Circ was also expressed later in 
the infection. Although it is known as an immediate-early transcript due to the timing 
of its initial transcription, it is known to be expressed throughout all phases of 
infection but its exact function is not fully understood (Fraefel et al. 1993). 
 
This is not the first time the speed of transcript accumulation has been compared 
between two herpesvirus isolates representing different clinical signs. Previous 
analysis using northern blot RNA analysis of BoHV-1 isolate transcripts also 
demonstrated differences between two isolates (Jura and K22), representing different 
subtypes (1.1 and 1.2b respectively). Evidence of transcription in the Jura strain 
appeared earlier, at 3 hours pi and in higher abundance than K22, though a similar 
pattern of transcription was found later in the infection period (Wirth et al. 1989). A 
slower transcript accumulation has also been shown in HSV-2 during a 
transcriptomic study comparing it to HSV-1. In addition, four transcripts were 
identified, UL4, UL29, UL30 and UL31, all involved in nuclear organization and 
viral DNA localisation, showing a low correlation between the two strains 
throughout the transcription cascade. The clinical significance of these differences, in 
terms of the pathology demonstrated by the two HSVs could not be concluded from 
this data (Aguilar et al. 2006).  
 
There was also variation between the three replicate time courses that were run, 
which compromised statistical comparison between isolates. There are several 
possible reasons for this. The ΔCt calculations result in small differences in Ct values 
between samples, becoming much larger when made relative to the host reference 
gene, β-actin. Alternatively, it may represent biological variation between different 
infections of the same isolate that could be caused by variation in the host cells, for 
example in the stage of the cell cycle or degree of confluence. This could either 
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indicate that this model does not provide the reproducibility that would be expected 
from an in vitro system, or it could be caused by rapidly changing expression 
patterns in BoHV-1, which would mean the three hour snapshot would provide 
variation between repeat infections.  
 
This experiment has also highlighted the problem of relative quantification, as 
variation was seen in the host reference gene over time, most likely due to the 
decrease in viable cells due to viral infection. Finding appropriate reference genes or 
calibrator samples is a particular problem for viral infections. This is due to the 
possible effect of virus infection on host cell transcription making comparison with 
host genes problematic. Other reference genes are available such as ubiquitin and 
glyceraldehyde-3-phosphate dehydrogenase. No studies have been conducted to 
identify the most suitable reference to use for BoHV-1 transcripts. Future relative 
quantification of viral transcription would be improved by a survey of possible 
reference genes that are unaffected during BoHV-1 infection, in order to find the 
most suitable host reference gene for time course transcript studies such as this. 
Another possible approach would be to measure viral gene expression using an 
absolute quantification method, but this experiment has still provided a good 
comparison at different time points of infection between two isolates. As some 
differences were observed between isolates using this method, it highlighted the 
importance of testing more than one of each isolate type, this could have been done 
using this system had time allowed but it was decided that the lung slice model had 
the potential to provide more information if successful. 
 
The infection of lung slices was a more complex system of infection than BT cells, 
with maintenance of tissue structure and multiple cell types. As it was not possible to 
observe CPE, as in BT cells, it was important to establish the viability of the lung 
slices and their ability to support BoHV-1 replication. This was assessed by 
measuring the release of virus into the culture medium over time. The virus genome 
copy number produced on each day of the infection was measured using real-time 
PCR absolute quantification. Infected lung slice viral load was also compared to 
control wells containing no lung slices, but were still infected with virus to measure 
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any residual virus that stuck to the wells between washes. These control wells should 
contain significantly less virus than infected lung slices if the lung slices were 
supporting viral replication. 
 
The results showed that most lung slices produced significantly more virus than the 
no lung slice controls. On 3 of the 6 plates no virus was detected in the no-lung-slice 
control wells. On the other 3 plates where a small amount of virus was detected in 
the control wells, values were much higher than in the control wells, with the 
exception of one plate. However, the extent of variation between lung slices meant 
that at some time points this did not achieve levels of statistical significance. This 
was due to the high variability of virus copy number detected, perhaps due to 
differences in viability of individual lung slices. The viability of the lung slices may 
have been compromised by the method of euthanasia used for the donor animal, 
which was killed by barbiturate overdose, which could cause toxicity and interfere 
with cell culture. Overall, it was considered that as 13 of the 16 triplicate wells 
demonstrated significantly higher viral load compared to the no-lung-slice control 
wells that this provided enough evidence to continue with the analysis of transcript 
expression and localisation of virus. 
 
There was no difference in the amount of virus produced each day between the two 
isolate groups, based on mean values from the 3 respiratory isolate and 3 systemic 
isolate lung slice infections. In all cases, there was less virus produced on day 2 of 
the infection than days 1 and 3. This is in contrast to a BoHV-1 infection of upper 
respiratory tract in an air-liquid interface, which shows a consistent increase in viral 
production over 6 days (Niesalla et al. 2009). There is also a possibility that the 
higher viral load on day 1 could represent residual virus left from the infection, 
compared to day 2 sampled after another wash stage. As lower transcript levels were 
not observed in the lung slices on day 2, this provides further support that it may be 
due to residual virus in the media on day 1 or could alternatively indicate the viral 




Transcription of 3 genes was measured using relative quantification by real-time RT-
PCR. The results showed an accumulation of gene transcripts over the three days. 
This provided further confirmation of the replication of the virus in the lung slices 
and therefore of the suitability of this in vitro model. The two isolate types, 
respiratory (05/1570), and systemic (07/1530) showed a similar pattern of gene 
transcription throughout the 3 days of infection, with the exception of RR on day 2, 
when the 05/1570 infections showed a higher gene transcription than the 07/1530 
infections.  
 
Comparing these in vitro studies with the in vivo experiment described in chapter 5, a 
higher level of transcript expression was also apparent in the respiratory isolate in the 
nasopharyngeal tonsil and possibly the trachea. In the nasal mucosa (which could be 
considered most similar to the BT cells) no clear difference was demonstrated in vivo 
between the isolates, though a trend was observed of higher transcript accumulation 
by the systemic (07/1530) BoHV-1 isolate. The differences between in vitro and in 
vivo models could be due to the limitations of in vitro systems to mimic all the 
mechanisms involved in the pathogenesis of disease, for example the involvement of 
the immune system, which also stimulates immune evasion responses from the virus 
(Babiuk, van Drunen Littel-van den Hurk & Tikoo 1996). These results could 
demonstrate that the immune response, not present in this model system, can 
influence viral transcription and subsequent viral replication when comparing these 
isolates. A higher RR transcript abundance was observed on day 2 in respiratory 
isolate infected lung slices. This could be considered to correlate with the 
observations in the in vivo study on day 4 pi, in the trachea and the nasopharyngeal 
tonsil, which also showed higher transcript expression of all 3 transcripts after 
infection with the respiratory isolate (05/1570). The consistency of this finding, both 
in the in vivo and in vitro infection with 3 ‘respiratory’ isolates suggests this may be 
of significance in the replication of this isolate type. Increased expression of RR 
could be related to an increase of viral DNA replication at this time point as RR is 
important in the synthesis of dNTPs (Schang & Jones 1997). However, further 
experiments to measure RR protein expression and other early genes or proteins 




The use of lung slices provided a further opportunity to study the cell tropism of the 
different virus isolates. Immunofluorescent double labelling was used to determine 
whether BoHV-1 was present in epithelial, endothelial cells or both cell types, over 
the three days of infection. Co-localization of virus in both epithelial and endothelial 
cells was found in a number of cases. Unfortunately, many of the slices did not 
contain enough viral antigen to be detected by the antibodies used, which limited the 
analysis of the results. In the limited samples available for analysis, it was found that 
both respiratory and systemic isolates of BoHV-1 localised to epithelial cells on day 
1 of infection, and in both epithelial and endothelial cells by day 2 pi. Further 
optimisation of the antibodies and conditions should improve the labelling reliability, 
but the initial results are encouraging and this technique could be used to provide an 
insight into viral tropism and the progress of infection.  
 
More extensive examination of this system is needed to establish whether these 
observations are of any significance. If this was demonstrated in more cases there are 
several explanations. Initial infection of epithelial cells would be expected as this is 
the first site of entry in the upper respiratory tract (Muylkens et al. 2007). Later, 
infection of endothelial cells could represent a potential mechanism for systemic 
spread via the circulatory system as seen in closely related viruses such as 
pseudorabies virus and EHV-1 (Nauwynck & Pensaert 1992; Allen & Breathnach 
2006). Tropism for endothelial cells has been previously associated with virulence in 
EHV-1. An in vivo study found tropism for endothelial cells may be an important 
factor in the increased virulence of EHV-1 strains (Smith et al. 2000). Alternatively, 
this could occur due to both epithelial and endothelial cells being equally exposed to 
virus, and reflects slower replication in endothelial cells. No evidence of differences 
between the isolate types was detected, although the data set available was too small 
to confirm this. Both quantitative PCR and immunohistofluorescence techniques 
showed an increase, of either viral transcripts or antigen on day 3, compared to days 
1 and 2. The increased presence of viral antigen on day 3 provides more evidence of 
the suitability of lung slices to support viral replication, and also suggests that the 
increase in transcript production is related to an increase in protein expression. 
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This technique has advantages over classical in vitro cell culture, and with further 
optimisation it may also provide an initial approach when targeting a specific aspect 
of pathogen behaviour such as cell tropism in an environment when it is possible to 
test many variables. This should enable better design and refinement of any 
subsequent in vivo studies. It provides information on cell tropism that an infection 
of BT cells cannot provide, and did not present the same problems with relative 
quantification of real-time PCR data, as no decrease in beta actin expression was 
observed over the infection period. It also uses multiple replicate samples from the 
same organ and animal, which adds to the power of any statistical analysis. The 
system could be optimised for more tissue types, and could make a good model for 
tissue tropism by measuring viral replication in the different tissue types and 
demonstration of cell type specific localisation of virus. Bovine tracheal and nasal 
epithelium has been used in the study of BoHV-1 using an air-liquid interface 
system. This system provided the possibility of measuring early host responses at the 
molecular level, as well as demonstrating a viable BoHV-1 infection, showing there 
are many potential opportunities in the use of these organ culture systems (Niesalla et 
al. 2009). In the lung slice system used in this study, the tissue was submerged in 
medium, similar to the trachea culture system developed earlier (Bouffard & 
Derbyshire 1978), more recently in Maedi-Visna infection of the trachea and lung 
(McNeilly et al. 2007), and also in the study of the herpesvirus that causes infectious 
laryngotracheitis (Williams et al. 1992). However, our study shows that like the air-
liquid interface system, it can be used to investigate molecular aspects of viral 
expression whilst the structural integrity of the organ can be maintained, to allow 
imaging of the viral infection to investigate factors such as cell tropism.  
 
Overall, the use of in vitro model infections has not clearly confirmed the differences 
in transcript expression between the two isolate types that were observed in vivo, but 
it has provided further evidence of subtle differences between the isolates. Further 
experiments such as growth curve analysis and comparison of more isolates in BT 
cells would be useful to clarify these observations. Further information has been 
provided on the transcript expression of BoHV-1 using two infection models, 
complemented by imaging of infection, which showed potential for cell tropism 
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studies. A system that provides a relatively simple way of studying BoHV-1 has been 
developed, which with further optimisation could be transferred to upper respiratory 
tract tissue. This could provide a good model for further investigation of BoHV-1 
tropism with limited need for experimental animals.  
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Chapter Seven:  
General Discussion 
 
This project has studied BoHV-1 from the molecular level of the viral genome and to 
its pathogenesis in the natural host. It has focussed on the comparison of isolates that 
have been associated with different pathology in the field, isolated from either a 
respiratory IBR infection, or tissue from a BoHV-1 abortion case or systemically 
infected calf. 
 
Before any direct comparisons between the isolates were started a survey of the 
prevalence of BoHV-1 in abortion cases in Scotland and Northern England was 
conducted. This showed BoHV-1 may be more prevalent as a cause of abortion than 
recent reports suggest (SAC VS 2009) (Murray 1990). Molecular diagnostic methods 
such as real-time PCR appear to play an important role in accurate diagnosis. It also 
highlighted that specific tests are needed to identify BoHV-1 in abortion cases, 
histopathology provided little reliable evidence without specific IHC labelling. 
Specific tests can be expensive but in the case of real-time PCR this could be made 
more economical several causes could be targeted in a multiplex real-time PCR assay 
that includes likely viral causes such as BoHV-1 and BVD alongside bacterial 
causes. 
 
The molecular mechanisms of BoHV-1 systemic spread from the upper respiratory 
tract to other organs or across the placental barrier have not been clearly 
demonstrated. This study quantified BoHV-1 in the foetal tissue from BoHV-1 cases. 
It found the highest abundance of BoHV-1 in the foetal liver by real-time PCR, and 
localisation of virus to vessels in the placenta and also foetal tissues such as the 
heart. This provided support for previous studies that have suggested a 
haematogenous route infection from the placenta to the foetus (Smith 1997; Rodger 
et al. 2007). However, the route from the respiratory tract to the placenta still 
remains undetermined and needs further investigation. 
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The sequencing of 10 BoHV-1 whole genomes provided an in-depth insight into the 
variation between the isolates and added extensively to the BoHV-1 genome data 
available. No conserved differences were found between the isolate types confirmed 
by SNP and phylogenetic analysis. This suggests coding differences are not related to 
virulence or tropism as was found in EHV-1(Nugent et al. 2006; Allen & Breathnach 
2006). However, it does not rule out differences at a transcriptional level and also did 
not distinguish between circulating isolates and reactivated isolates which both may 
be key to understanding systemic infection in terms of viral factors. 
 
Despite no differences found between the whole viral genomes, this did not rule out 
differences at the transcriptional level contributing to the different pathology 
produced by the isolates. It was also not known whether isolates would reproduce the 
same pathology or if it was entirely dependent on the host. An in vivo infection 
allowed this to be tested. Differences were observed in the clinical outcome of the 
infection with more respiratory clinical signs caused by the respiratory (IBR) isolate 
and more ocular signs caused by the systemic (abortion) isolate. There were also 
differences observed in tissue tropism at day 4 post infection and the host immune 
responses observed in the nasopharynegeal tonsil. A study of transcript expression 
representing the three phases of temporal BoHV-1 gene expression showed 
differences between the isolates. This was most clear in the nasopharyngeal tonsil 
where gene expression was significantly higher in all genes tested in the respiratory 
(IBR) isolate on day 4 pi. As the clinical signs suggested that the systemic isolate 
was affecting the hosts at a slower rate, it is not clear whether this is simply 
representative of the stage of infection rather than an actual difference in transcript 
levels associated with the isolate type. There was also evidence of spread to the brain 
in a couple of cases that could be considered as evidence of systemic spread. 
However, with the exception of the brain no evidence of BoHV-1 was found in either 
the buffy coats or any tissue outside of the respiratory tract or associated tissues. This 
contrasted to previous intranasal challenges that had found BoHV-1 in the spleen, 
kidneys and liver (Mweene et al. 1996; Kaashoek et al. 1996).  Overall, the results 
from this study lead to the conclusion that an isolate previously causing a systemic 
infection does not reproduce this in the infection of another host. This adds further 
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weight to the sequencing data showing no virally encoded evidence for systemic 
spread. 
 
Model systems were used to provide more replicative conditions to look at BoHV-1 
transcript expression in an in vitro infection of BT cells and lung slices from a donor 
animal. The lung slices allowed for imaging of the viral infection at different stages 
using histopathology and immunofluorescence techniques, to potentially investigate 
virus tropism at the cellular level. The differences observed in the cells between the 
isolates showed a more rapid development of CPE and higher levels of transcript 
abundance the respiratory (IBR) isolate infected cells. To confirm the observations 
made that have suggested differences between the isolates, both in BT cell infection 
and the in vivo challenge several isolates from each classification needed to be 
studied in the same system. The lung slice infection used 3 isolates of each type to 
provide biological replicate data. This aimed to establish whether the differences 
observed were just showing natural isolate variation as the sequencing results suggest 
or something specific to the previous pathology they were known to have 
demonstrated in the field. No differences were observed except for higher RR 
transcript expression on day 2 in the respiratory group of isolates. It would have been 
useful to gain further information from this using growth curves and more isolates 
but as time was limited the lung slices were focussed on to provide a more complex 
model and the potential to provide more detailed results. For example the use of lung 
slices demonstrated the potential to investigate cellular localisation of the virus 
which would not be possible from basic cell culture or growth curve experiments. 
With further optimisation the cellular tropism of different isolates or strains could be 
established. 
 
In both cases when more than one of each isolate type was used (the sequencing and 
the lung slice model) few differences were observed. This indicates that virally 
encoded involvement in the systemic spread of BoHV-1 is likely to be minimal. 
However, there were some clear differences identified in the in vivo infections 
between the isolates. Overall, it is likely that the host immune response and 
environmental conditions are the major factors determining systemic spread. The 
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immune response has also been noted of importance in equine abortion caused by 
EHV-1 when presence of cytotoxic lymphocytes have been found to protect against 
abortion (Kydd et al. 2003). 
 
If this project were to continue several directions of further work could be followed. 
As some evidence was observed in differences in transcript expression between the 
isolates, further work is needed to establish how the differences in transcript 
expression translates if at all, into variation in protein expression. A more thorough 
study including a wider representation of BoHV-1 transcripts would also be needed 
to rule out involvement at a transcriptional level, for example transcriptome 
sequencing during an infection. There is also much work that could be done on the 
host immune response, as this research suggests it is likely to be a major factor in the 
systemic spread of BoHV-1 as viral control appears to be limited. To investigate any 
of these areas further it is also important to try to establish the mechanisms involved 
in the initial dissemination of the virus from the respiratory tract, which is the initial 
cause of any systemic infection and remains unclear. Comparisons could then be 
made between bovine immune responses during respiratory and systemic infections. 
 
This project has provided several areas of novel research that can be summarised 
below: 
 The extent of bovine abortions related to BoHV-1 in Scotland and Northern 
England were established suing molecular diagnostic techniques.  
 Next-generation sequencing technology was used or the comparison of 
multiple BoHV-1 genomes significantly adding to the BoHV-1 sequencing 
data available.  
 Two field isolates have been tested in an in vivo challenge of the natural host 
to provide the information that an isolate that has previously demonstrated 
systemic spread does not necessarily cause systemic spread in a new 
infection. It has also used lung slice culture for molecular and imaging studies 





The main findings from this research are: 
 BoHV-1 abortion is potentially under diagnosed and molecular diagnostics 
such as real-time PCR could play an important role in producing more 
accurate data. 
 Comparison of BoHV-1 genome sequences demonstrated no significant 
difference between islates limited to the respiratory tract infections and those 
spreading systemically to cause systemic disease or abortion. 
 An in vivo study comparing two of the sequenced isolates demonstrated 
clinical differences, potentially different routes and speed of spread through 
the respiratory tract and differences in transcript expression which could 
relate to viral replication. However, this could not be attributed with certainty 
to the respiratory/systemic classification of the isolates. 
 In vitro work using more of the sequenced isolates supported the sequencing 
work with no clear differences in the transcript expression or tropism at a 
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Appendix 1. Table detailing findings from histopathological and immunohistochemical labelling of 
BoHV-1 positive foetal tissues. 
 
Case Tissue Lesion IHC Labelling localisation
07/128 Placenta None Positive Vessel endothelial cells/white blood cells
Heart None Positive Vessel endothelial cells/white blood cells
Lung Multifocal necrosis Positive Alveoli
Liver Multifocal necrotic hepatitis Positive Necrotic foci and endothelial cells of vessels
Brain  -  -  -
Fetal fluid  -  -  -
07/232 Brain Glial foci Positive? 2 sites within neuropile
Liver Multifocal necrotic hepatitis Positive Necrotic foci and endothelial cells of vessels
Heart No lesion Negative  -
Lung Haemmorage Negative  -
Fetal fluid  -  -  -
07/233 Brain No lesion Negative  -
Heart No lesion Negative  -
Liver Multifocal necrotic hepatitis Positive Necrotic foci and endothelial cells of vessels
Lung No lesion Negative  -
Fetal fluid  -  -  -
07/327 Lung No lesion Positive Vessels and scattered cells in alveoli
Brain No lesion Positive Endothelial cells/white blood cells in vessels of meninges
Heart No lesion Positive Endothelial cells of vessels
Liver Multifocal necrotic hepatitis Positive Necrotic foci and endothelial cells of vessels
Placenta Focal necrosis Positive Endothelial cells/white blood cells in vessels of the villi
Fetal fluid  -  -  -
07/558 Lung No lesion Positive One area of focal necrosis positively stained in alveoli
Liver Multifocal necrotic hepatitis Positive Staining associated with sites of multifocal necrosis
Heart No lesion Negative  -
Brain  -  -
09/046 Liver No lesion Negative  -
Heart No lesion Negative  -
Lung No lesion Negative  -
Brain No lesion Negative  -
Fetal fluid  -  -  -
Placenta  -  -  -
09/050 Lung No lesions Positive Vessels and scattered cells in alveoli
Liver Multifocal necrosis Positive Vessel associated
Heart No lesions Positive Vessel associated
Brain  No lesions Positive Scattered small foci
Fetal fluid  -
09/334 Liver Multifocal necrosis Positive Necrotic foci and endothelial cells of vessels
Heart No lesions Positive Scattered cells and some association with vessel walls
Placenta Multifocal necrosis Positive Vessels and necrotic foci
Lung  -  -  -
Fetal fluid  -  -  -
Brain  -  -  -
09/461 Placenta Multifocal necrosis Positive Necrotic foci and endothelial cells of vessels
Liver Multifocal necrosis or could 
be autolysis
Positive Vessels and scattered cells in alveoli
Lung Multifocal necrosis Positive Mainly in villi endothelial cells?
Heart  -  -  -
Brain  -  -  -
Fetal fluid  -  - -
09/462 Liver No lesions Negative -
Lung Small focis of inflammatory Negative -
Brain Haemmoraging Negative  -
Heart  -  -  -
Fetal fluid  -  -  -
 
